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Abstract
Alternative splicing is a critical component of human gene control that generates functional diversity from
a limited genome. Defects in alternative splicing are associated with disease in humans. Alternative
splicing is regulated developmentally and physiologically by the combinatorial actions of cis- and transacting factors, including RNA binding proteins that regulate splicing through sequence-specific
interactions with pre-mRNAs. In T cells, the splicing regulator hnRNP L is an essential factor that
regulates alternative splicing of physiologically important mRNAs, however the broader physical and
functional impact of hnRNP L remains unknown. In this dissertation, I present analysis of hnRNP L-RNA
interactions with CLIP-seq, which identifies transcriptome-wide binding sites and uncovers novel
functional targets. I then use functional genomics studies to define pre-mRNA processing alterations
induced by hnRNP L depletion, chief among which is cassette-type alternative splicing. Finally, I use
integrative genomic analysis to identify a direct role for hnRNP L in repression of exon inclusion and an
indirect role for enhancing exon inclusion that supports a novel regulatory interplay between hnRNP L and
chromatin. In two appendices, I present CLIP-seq studies of two additional RNA binding proteins: the
splicing factor CELF2 and the RNA helicase DDX17. In conclusion, I provide comparisons of these three
CLIP-seq studies, providing high-level insights into the capabilities and limitations of CLIP-seq. In sum,
this dissertation expands our knowledge of hnRNP L splicing control in the context of broader studies of
RNA binding proteins in multiple cell types and conditions.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Cell & Molecular Biology

First Advisor
Kristen W. Lynch

Keywords
Alternative splicing, CLIP-seq, hnRNP L, integrative genomics, RNA-seq, T cells

Subject Categories
Allergy and Immunology | Biochemistry | Bioinformatics | Immunology and Infectious Disease | Medical
Immunology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/1664

TERRAE INCOGNITAE: INTEGRATIVE GENOMIC ANALYSIS OF hnRNP L SPLICING
REGULATION
Brian Sebastian Cole
A DISSERTATION
in
Cell and Molecular Biology
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2015

Supervisor of Dissertation

______________
Kristen W. Lynch, Ph.D.
Professor of Biochemistry and Biophysics

Graduate Group Chairperson

_________________
Daniel S. Kessler, Ph.D., Associate Professor of Cell and Developmental Biology

Dissertation Committee
Russ P. Carstens, M.D., Associate Professor of Medicine
Brian D. Gregory, Ph.D., Assistant Professor of Biology
Yoseph Barash, Ph.D., Assistant Professor Genetics
Stephen A. Liebhaber, M.D., Professor of Genetics and Medicine

TERRAE INCOGNITAE: INTEGRATIVE GENOMIC ANALYSIS OF hnRNP L SPLICING
REGULATION
COPYRIGHT © 2015 Brian Sebastian Cole
Permission is granted to copy, distribute, and/or modify this document under the terms of
the GNU Free Documentation License, Version 1.3 or any later version published by the
Free Software Foundation; with the Invariant Sections being DEDICATION and
ACKNOWLEDGEMENTS, with the Front-Cover Texts being TITLE and COPYRIGHT,
and with no Back-Cover Texts. To view a copy of this license, visit:
https://www.gnu.org/licenses/fdl.html

DEDICATION

I dedicate this dissertation to my thesis advisor, Kristen Lynch. Her wisdom and
strength of character will be with me always.

iii

ACKNOWLEDGMENT

I acknowledge the many who have supported me in my research, both
technically and personally. I’d like to thank the legions of open source programmers
who have worked for Freedom. Without open source programs, I’d never have been
able to take the journey I’ve taken over the past five years. I’d like to thank my family
and friends for all their support over the past five years: my mom, my dad, my brother,
Leksa, Mike, Ian, Roland, Sheila and Dan, Matt, the Venez Voir crew, Kyle and Andy
and everybody at PBG, Rohit and Christina and everybody at WHIT, Craig and Charles
over at Penn Health, Jordan and Bren and Luigi and the Data Incubator crew from New
York City, Matt and the Beer Club, Mr. Nap the mathiest lawyer who ever drummed
sevens and fives, and everybody else who has kept me afloat.

iv

ABSTRACT
TERRAE INCOGNITAE: INTEGRATIVE GENOMIC ANALYSIS OF hnRNP L SPLICING
REGULATION
Brian Sebastian Cole
Kristen W. Lynch, Ph.D.

Alternative splicing is a critical component of human gene control that generates
functional diversity from a limited genome. Defects in alternative splicing are associated
with disease in humans. Alternative splicing is regulated developmentally and
physiologically by the combinatorial actions of cis- and trans-acting factors, including
RNA binding proteins that regulate splicing through sequence-specific interactions with
pre-mRNAs. In T cells, the splicing regulator hnRNP L is an essential factor that
regulates alternative splicing of physiologically important mRNAs, however the broader
physical and functional impact of hnRNP L remains unknown. In this dissertation, I
present analysis of hnRNP L-RNA interactions with CLIP-seq, which identifies
transcriptome-wide binding sites and uncovers novel functional targets. I then use
functional genomics studies to define pre-mRNA processing alterations induced by
hnRNP L depletion, chief among which is cassette-type alternative splicing. Finally, I
use integrative genomic analysis to identify a direct role for hnRNP L in repression of
exon inclusion and an indirect role for enhancing exon inclusion that supports a novel
regulatory interplay between hnRNP L and chromatin. In two appendices, I present
CLIP-seq studies of two additional RNA binding proteins: the splicing factor CELF2 and
the RNA helicase DDX17. In conclusion, I provide comparisons of these three CLIP-seq
studies, providing high-level insights into the capabilities and limitations of CLIP-seq. In
v

sum, this dissertation expands our knowledge of hnRNP L splicing control in the context
of broader studies of RNA binding proteins in multiple cell types and conditions.
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INTRODUCTION

Alternative pre-mRNA splicing is a nearly ubiquitous mechanism by which
eukaryotic cells generate multiple protein-coding mRNAs from a single genetic locus1.
As many as 95% of human genes that give rise to multiexon mRNAs generate more
than one processed product by alternative pre-mRNA splicing2,3,3. Importantly,
alternative splicing allows an abundance of distinct proteins to be encoded by a limited
genome. Recent technological advances in high-throughput sequencing have made
possible genome-wide studies of alternative splicing and the factors that regulate
splicing. These high-throughput studies have necessitated commensurate software
development efforts to process the large volumes of data generated. In this thesis, I
present the design, analysis, and interpretation of several high-throughput sequencing
studies that together aim to uncover the scope of alternative splicing in human
lymphocytes, as well as key proteins that regulate alternative splicing.

The spliceosome catalyzes splicing through serial assembly and rearrangements
Pre-mRNA splicing is orchestrated by the stepwise assembly and two-step
transesterification enzymatic catalysis of the macromolecular ribonucleoprotein (RNP)
complex known as the spliceosome4. The spliceosome contains no preformed active
site and instead relies upon a vectorial, multistep assembly and catalysis mechanism5.
The core of the spliceosome is composed of five distinct subunits called the U1, U2, U5,
and U4/U6 snRNPs (small nuclear ribonucleoprotein particles) that contain RNA and
protein components. In addition to the snRNPs, the spliceosome contains more than
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100 accessory proteins, together forming a heterogeneous and complex macromolecular
machine4.
During pre-mRNA splicing, the snRNPs assemble at their cognate splice sites on
pre-mRNA in a stepwise manner, beginning with the recognition of the 5’ splice site
(5’ss) by the U1 snRNP, whose RNA component, the U1 snRNA, engages the 5’ss
through RNA-RNA interactions. Recognition of the 3’ss at the other end of the intron is
performed first through protein-RNA interactions: SF1 binds to the intronic branchpoint
sequence (BPS) and the U2AF binds to the polypyrimidine tract and 3’ss6. The result of
the recognition of the 5’ and 3’ splice sites is the E complex. Subsequent replacement of
the proteins engaged at the 3’ss by the U2 snRNP forms the A complex.
After the A complex has formed, the trimer of the U4/5/6 “tri-snRNP” is recruited,
forming the pre-catalytic B complex. Through a series of structured rearrangements, the
U1 snRNP is displaced from the 5’ss, with U6 replacing it. These rearrangements
generate a catalytically competent spliceosome, or C complex. The U4 snRNP is then
released and the first transesterification reaction is catalyzed, in which a lariat structure
is formed between the 5’ end of the intron is cleaved and a lariat formation is created
through attachment of the 5’ end of the intron to the branchpoint adenosine. The second
transesterification reaction cleaves the 3’ end of the intron and ligates the exons
spanning the intron together, resulting in release of the lariat and the splice pre-mRNA7.

Regulation of splicing is achieved by RNA binding proteins
Importantly, the spliceosomal assembly pathway is characterized by several
resolvable complexes that require multiple RNA-RNA, RNA-protein, and protein-protein
2

interactions to allow progression to later complexes8,9,9. This mechanism provides many
opportunities for regulation, enabling alternative splicing to exert fine-grained control
over the structure of processed mRNAs. Regulation of alternative splicing is achieved
by the interaction of trans-acting RNA binding proteins (RBPs) with cis-regulatory RNA
sequences5. These interactions can serve to both positively and negatively regulate
assembly and progression of the spliceosome at multiple steps of the spliceosomal
assembly pathway.
Several well-studied examples of regulated alternative splicing highlight the
importance of the location of protein-RNA interaction. One of the first systems used to
understand splicing regulation was sex determination in Drosophila melanogaster. The
RNA binding protein Sex lethal (Sxl) is expressed in females and represses splicing of
male-specific mRNA isoforms. Biochemical studies of the Sxl target mRNA Transformer
(Tra) indicated that Sxl binds to a sequence in the 3’ss of Tra exon 2, resulting in
competition with the U2AF protein10,11,11,12,12. Additionally, Sxl can block binding of the
U1 snRNP to the 5’ss of an exon in another target transcript, Msl213. In both cases, Sxl
binding prevents formation of the E complex, demonstrating a simple mechanism of
competitive binding that results in splicing repression.
Another splicing regulatory protein involved in the Drosophila sex determination
pathway is the Sxl target Transformer (Tra). Tra cooperates with a binding partner,
Tra2, bind to a splicing enhancer sequence in the fourth exon of the doublesex (Dsx)
pre-mRNA. When Tra and Tra2 bind to this enhancer, U2AF is recruited to the relatively
weak 3’ss of the Dsx exon14. These two cases highlight the regulatory roles that RNA
binding proteins can play in enhancing or repressing splicing, and additionally
underscore the importance of the location of binding in determining splicing regulation.
3

Importantly, while these early studies implicated splicing regulation at the early steps of
spliceosome assembly, subsequent research has identified instances of splicing
regulation by RNA binding proteins at later steps (see below). While alternative splicing
in humans is often complex and multifactorial, the insights gleaned from studies of the
Drosophila sex determination pathway and the factors that regulate it provide a basis for
investigating alternative splicing in humans.
Two major, conserved families of RNA-binding proteins (RBPs) with splicing
regulatory functions are the SR and hnRNP protein families. SR proteins contain one or
more RNA recognition motifs (RRMs) and a serine/arginine rich RS domain15,16,16. Both
the RS and RRM domains may be involved in protein-RNA and protein-protein
interactions. SR proteins were initially identified as splicing enhancers capable of
activating splicing reactions in vitro17,18,18,19,19,20,20. The hnRNP proteins were originally
identified by their association with pre-mRNA21,22,22, and splicing regulatory roles for
hnRNP proteins were later identified23. The development of high-throughput sequencing
has enabled transcriptome-wide functional studies of SR and hnRNP proteins, and
recent work has demonstrated that members of these protein families control virtually all
aspects of RNA processing.
Several previously studied examples of alternative splicing events regulated by
the interaction of SR and hnRNP proteins with cis-regulatory pre-mRNA motifs
demonstrate overarching paradigms for the mechanisms by which these RNA-binding
proteins are believed to exert control over pre-mRNA splicing. The human hnRNP A1
protein is a well-studied splicing factor with generally repressive activity24. hnRNP A1
can repress cassette exon inclusion by binding to exonic or intronic splicing silencer
sequences, termed ESS and ISS respectively, and directly block formation of the
4

spliceosome through steric hindrance25,26,26. In addition this bind-and-block mechanism,
hnRNP A1 can bind to a high-affinity site and propagate interactions to neighboring premRNA sites in a spreading mechanism. Importantly, this spreading allows hnRNP A1 to
interfere with binding of splicing activators to nearby exonic splicing enhancer (ESE)
sequences, as was observed in HIV tat exon 327. This latter case highlights one
instance in which multiple trans-acting RNA binding proteins interact with each other in
an exonic context to regulate splicing, highlighting the integrative and combinatorial
modes of regulation that characterize alternative splicing in humans. Another dimension
of complexity in the regulation of alternative splicing is underscored by the fact that
hnRNP A1 can also act as a splicing activator28,29,29,30,30, an observation common to
many other splicing factors, which have been observed to exert both positive and
negative regulation of splicing.
Another well-studied splicing regulator in humans is SRSF1 (formerly denoted
SF2 or ASF), an archetypical member of the SR protein family. In many described
cases, SRSF1 positively regulates cassette exon splicing by binding to exonic splicing
enhancer (ESE) sequences31. When SRSF1 is bound to the pre-mRNA, direct
interactions with the U1 snRNP help to recruit U1 and initiate assembly of the
spliceosomal E complex32. While this simple model of splicing enhancement is a mirror
of the bind-and-block mechanism of splicing repression by hnRNP A1, genome-wide
analysis of SRSF1-regulated splicing events has uncovered more complex scenarios33.
In some instances, loss of SRSF1 results in compensatory splicing enhancement by
other SR proteins, such as SRSF2. In other cases, there is negative coordination, in
which loss of SRSF1 results in loss of binding by other SR proteins, leading to exon
skipping. The mechanisms underlying the coordinate versus compensatory regulation
5

remain unclear, but SRSF1 emphasizes another key concept in regulated alternative
splicing: regulation of splicing likely involves a complex interplay of RNA binding proteins
with complex interactions, motivating a systems-level understanding of splicing
regulation.

hnRNP L is an essential regulator of alternative splicing in T cells

Human T lymphocytes are a critical cell line of the adaptive immune system that
utilize alternative splicing to regulate the proteome during development and physiological
activity34. One example of dynamic alternative splicing in T cells is the CD45
transmembrane protein tyrosine phosphatase, encoded by the gene PTPRC. The CD45
protein contains a heavily glycosylated extracellular domain that maintains the
phosphatase activity by inhibiting homodimerization which would result in loss of
activity35,36,36. This extracellular domain is encoded by three tandem alternative exons in
the CD45 pre-mRNA which are increasingly skipped in response to T cell activation37.
This splicing switch results in a shift toward CD45 isoforms that do not contain the
glycosylated extracellular domain and therefore can homodimerize, resulting in loss of
phosphatase activity in activated T cells.
Studies of sequences responsible for this activation-responsive splicing switch in
CD45 exon 4 identified an exonic splicing silencer motif, ESS138. The ESS1 motif
establishes a reduced basal level of inclusion. Importantly, this basal repression poises
the exon for further activation-induced repression enabled by the activation-dependent
repressive activity of other factors such as PSF39 and hnRNP LL40.
6

Subsequent in vivo studies of hnRNP L have identified a physiological role for
hnRNP L in T cell development and function. A lymphoid-specific hnRNP L gene
ablation model system in Mus musculus displays defects in thymic development of T
cells, with a specific block of the double negative to double positive stage observed
among thymic pre-T cells41 and defects in migration of hnRNP L -/- T cells in the
periphery. The T cells of this mouse model display a noticeable shift towards higher
molecular weight CD45 isoforms, indicating decreased repression of the exons that
encode the activation-responsive extracellular domain. However, additional
physiological defects in chemokine-induced migration among hnRNP L -/- T cells were
observed, indicating that hnRNP L ablation results in additional physiological defects not
attributable to CD45 misregulation alone.
hnRNP L is an abundant nuclear splicing factor with four conserved RRM
domains, a glycine-rich N-terminal domain, and a proline-rich linker domain42.
Biochemical evidence reveals that sequences within the latter two domains are required
for exon repression, but maximal repressive activity requires at least one RRM
sequence. The hnRNP L protein is ubiquitously expressed and is required for viability,
and while the paralog protein hnRNP L-like exhibits cell type-specific expression40,43,43,
hnRNP L expression remains constant between unstimulated and stimulated T cells.
Accordingly, hnRNP L repression of CD45 exon 4 splicing is observed in both T cell
conditions.
A second exon in the CD45 pre-mRNA, exon 5, is also repressed by hnRNP L
through exonic interactions, but the mechanism of repression is distinct for these two
exons44. In the case of CD45 exon 5, hnRNP L binds to an exonic splicing silencer to
block the activity of a neighboring splicing enhancer45 that is bound by SF2/ASF to
7

enhance exon inclusion. When this splicing enhancer is removed, hnRNP L regulation
becomes enhancing, demonstrating that location of hnRNP L-RNA interaction alone is
not sufficient to predict regulatory outcome. In addition, when the 3’ and 5’ splice sites of
an hnRNP L-bound exon are weakened by mutagenesis, repression by hnRNP L is
abolished and then reversed at extremely weak splice site strengths. In contrast,
hnRNP L interaction with CD45 exon 4 recruits another splicing factor, hnRNP A1, to the
exon, resulting in an extended interaction between the U1 snRNA and the 5’ splice site
of the exon, resulting in exon repression by blocking the transition of spliceosomal E
complex to higher order complexes46. Taken together, these results support a model for
context-dependent regulation of splicing by hnRNP L wherein splice site strengths and
co-associated proteins form a combinatorial code that leads to positive or negative
regulation of splicing by hnRNP L.
In addition to CD45, hnRNP L is directly involved in regulation of several other
mRNAs. In a mechanism common to many splicing regulatory proteins across diverse
species of life47, hnRNP L protein binds to an evolutionarily conserved, CA-rich region in
its own pre-mRNA upstream of an exon that contains a premature termination codon, a
type of exon called a poison exon, as its inclusion leads to unproductive mRNAs that are
degraded by the nonsense-mediated decay (NMD) pathway. This binding event is part
of an autoregulatory mechanism wherein increased hnRNP L protein levels result in
increased binding to the conserved, CA-rich region, which in turn results in increased
inclusion of the poison exon, causing a shift toward unproductive mRNA isoforms that
result in decreased protein expression48. This example also highlights a positive
regulatory role for hnRNP L on alternative splicing, indicative of a potential direct splicing
enhancer function for hnRNP L.
8

Another well-studied protein that is subject to alternative splicing is CD44. CD44
is a cell adhesion protein49 encoded by a pre-mRNA that contains a variable exon whose
inclusion is directly regulated by hnRNP L50. In this case, hnRNP L binds to CA repeats
upstream of the variable exon to repress exon inclusion, providing evidence that hnRNP
L can act as a splicing repressor from an upstream intronic binding site. Interestingly,
the CD44 variable exon whose inclusion is repressed by hnRNP L, exon V10, has been
implicated in leukocyte migration51 as well as tumor progression52, providing an
additional instance of hnRNP L-mediated alternative splicing that is critical to T cell
function and cancer biology.
In addition to the regulation of alternative splicing, hnRNP L-3’UTR interactions
have been implicated in the hypoxia-induced stabilization of the VEGFA mRNA53. In this
case, hypoxia induces cytoplasmic localization of hnRNP L protein, allowing it to interact
with a CA-rich hypoxia-stability region in the 3’UTR of the VEFGA mRNA54. This
interaction blocks miRNA-mRNA interactions that would otherwise result in translational
repression, thereby increasing VEGFA translation. Importantly, this mechanism
highlights an extranuclear function for hnRNP L that is induced by abnormal cellular
conditions which underscores the importance of nuclear localization for hnRNP L.
While several cases of hnRNP L-regulated alternative splicing have been
identified, including CD45 and HNRNPL, the impact of hnRNP L on the T cell
transcriptome has not been determined, and the physical and functional targets of
hnRNP L are unknown. Recent experimental advances with high-throughput
sequencing technology have enabled genome-wide characterization of RNA targets of
RNA binding proteins, and functional studies utilizing RBP knockdown followed by
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transcriptome sequencing and bioinformatic analysis have enabled detailed
characterization of the direct and indirect functional targets of splicing factors.

Technologies for transcriptome-wide investigation of RNA binding proteins

The CLIP protocol (Crosslinking and immunoprecipitation) was developed to
capture associations between proteins and the RNAs with which they are in direct
contact55,56,56. This procedure utilizes UV irradiation to induce covalent crosslinks
between proteins and RNA across short distances, and subsequent immunoprecipitation
of an RBP of interest under stringent conditions followed by proteinase digestion purifies
RNA targets of the protein under study. In a landmark study, Jernej Ule and Robert
Darnell used CLIP to identify physical targets of the Nova splicing factor57. This study
identified Nova-dependent splicing targets among physical targets of Nova,
demonstrating that CLIP can be used to identify physical as well as functional targets of
critical splicing regulators. Importantly, CLIP can utilize biological tissues as well as cells
in culture, allowing physical targets to be identified in vivo, as was demonstrated for
Nova in brain tissue.
The advent of affordable high-throughput sequencing technology allowed deep
characterization of UV-crosslinked RNA-protein complexes, an experimental approach
known as CLIP-seq or HITS-CLIP (Crosslinking and immunoprecipitation followed by
high-throughput sequencing). This method was applied to Nova-RNA complexes
isolated from brain tissue58, greatly expanding the scope of discovered interaction sites.
By digesting the RNA liberated from Nova-RNA complexes to short oligonucleotide
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fragments, the high-throughput sequencing reads generated from these fragments can
be aligned to the reference genome of the organism under study, allowing identification
of specific regions of protein-RNA interaction within physical target RNAs. This
approach allowed identification of novel Nova-RNA interactions in 3’UTR regions,
revealing a novel role for Nova in alternative polyadenylation.
The CLIP-seq method has been successfully applied to many RNA binding
proteins, including splicing factors59,60,60,61,61,62,62,63,63,64,64,65,65, the miRNA effector protein
Argonaute66,67,67,68,68, the RNA editing factor ADAR69, oncogenic fusion proteins involving
RNA-binding domains70, RNA helicases71, and others. Through these studies, CLIP-seq
has emerged as a powerful tool for identifying sites of RBP-RNA interactions, a critical
step in understanding the role a particular RBP plays in regulating the transcriptome in
vivo. Recent efforts to centralize the findings of these experiments have led to the
creation of a curated database containing CLIP-seq studies and their data72.

Functional studies of splicing factors with next-generation sequencing reveal
splicing regulatory activity

Technological advances have enabled wide-scale characterization of alternative
splicing in eukaryotic transcriptomes. Early high-throughput studies of alternative
splicing utilized microarray technology. Evidence of the applicability of microarrays to
the discovery of alternatively spliced exons came from early genome and exome tiling
array studies aimed at elucidating the structure of the human transcriptome73. This
technology developed into exon-junction arrays74,75,75 that provided probes focused on
splicing junctions, enabling large-scale profiling of alternative splicing within and
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between cell types76,77,77,78,78. These pioneering studies provided evidence of the
massive complexity of transcriptome processing and brought an appreciation of
alternative splicing as a means of increasing proteomic complexity and diversity from a
limited genome.
Comparative microarray studies were soon applied to the identification of
functional targets of splicing factors. A study of brain tissue from Nova2-/- murine brain
tissue identified hundreds of Nova-dependent splicing targets55, paving the way for
studies of other splicing factors in a plethora of different tissues and cell types79. One
important overarching theme that arose from these studies was a coupling of pre-mRNA
processing events, including splicing, to Pol II elongation, providing evidence for a cotranscriptional model of pre-mRNA processing80,81,81.
While microarray technology facilitated wide-scale characterization of RNAs, the
reliance upon pre-designed probes prevented de novo characterization of splice
variants. Transcriptome characterization by high-throughput sequencing has recently
enabled transcriptome-wide detection of novel splice variants in addition to those probed
by splicing-sensitive microarrays82,83,83. High-throughput sequencing of cDNAs derived
from cellular RNAs, or RNA-seq, spurned the development of new bioinformatics tools to
meet the challenges of sequencing reads that align to the genome in multiple segments
due to their origin in spliced mRNA molecules, such as the Tophat aligner that is aimed
specifically at RNA-seq reads84. Alignment tools such as Tophat have enabled the
development of downstream statistical algorithms for quantification of alternative splice
junction utilization between two sample groups85,86,86, allowing studies of alternative
splicing controlled by differentiation, signaling, and specific splicing factors.
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In this dissertation, I describe the application of CLIP-seq to identify the
transcriptome-wide binding profile of hnRNP L in primary and cultured human CD4+ T
lymphocytes. Analysis of hnRNP L CLIP-seq sites identifies novel cases of hnRNP Lmediated alternative splicing. I further describe depletion of hnRNP L followed by
complementary high-throughput sequencing approaches, which allows transcriptomewide characterization of hnRNP L-dependent alternative splicing events. Finally, I
analyze hnRNP L occupancy in the context of hnRNP L-responsive alternative splicing
events, providing mechanistic insights into direct and indirect regulation of alternative
splicing by hnRNP L.
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MATERIALS AND METHODS

CLIP-seq read processing and alignment

Raw CLIP-seq reads are single, continuous oligonucleotide sequences in FASTQ
formatted-files, which include sequencing basecall quality scores for each nucleotide
encoded in PHRED quality scores. The first step in the processing raw CLIP-seq reads
is to remove 3’ sequencing adaptors and any sequence that might remain to the 3’ of the
end of the adaptor, which might result from an extremely short CLIP-seq fragment and a
long sequencing read length. I utilized the cutadapt version 0.9.4, invoking the cutadapt
program with default options and providing the RL3 linker sequence (5’-

GTGTCAGTCACTTCCAGCGG-3’).
Next, homopolymeric stretches of 6 or more nucleotides of the same basecall
were removed from the 3’ end of the reads. The FASTQ quality string was also trimmed
to match the length of the trimmed sequence read. The resulting trimmed reads were
discarded if they were fewer than 8 nucleotides in length, and the remaining reads were
utilized for alignment. Homopolymeric runs were removed with the program
trim_homopolymeric_ends of the clipseq_analysis distribution, a collection of Perl
programs and libraries I wrote to process the CLIP-seq datasets described in this
dissertation.
To obtain alignments for trimmed CLIP-seq reads, bowtie version 0.12.7 was
used to map reads against the hg19 build of the human genome, allowing for a
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maximum of 2 mismtaches and disallowing more than 1 alignment position per read.
Because the CLIP-seq library preparation involves 39 cycles of PCR, multiple reads that
align to the same genomic coordinates are not guaranteed to represent separate RNA
fragments that were crosslinked to the protein under study. For this reason, any set of
two or more aligned reads that share the same 5’ coordinate was reduced to only 1
representative, and all other alignments from that 5’ coordinate were discarded. To
collapse these potential PCR duplicates, I used the program collapse_duplicates in the
clipseq_analysis distribution. For hnRNP L and DDX17 CLIP-seq experiments, one
barcode was applied to each sequencing library, therefore libraries from replicates within
sample groups were combined after collapsing PCR duplicates. For CELF2 CLIP-seq,
however, a new strategy was employed to aid discrimination of PCR duplicates: before
the PCR reactions, the post-doctoral researcher performing the CLIP-seq library
preparation, Dr. Ganesh Shankarling, split each replicate into three aliquots and applied
a different barcode to each of aliquot. Subsequent processing, alignment, and removal
of potential PCR duplicates from each barcoded library separately allowed me to pool
the three barcoded aliquots from each individual replicate such that there can now be a
maximum of three alignments with a 5’ end at any given genomic coordinate. This
approach thus allowed me to discriminate bona fide multi-copy RNA-protein complexes
from PCR duplicates.
After PCR duplicates were removed and replicates were combined, the aligned
reads were ready to be searched for peaks: regions of CLIP-seq coverage that exceed
that which is expected by random chance. Initially, I had attempted to call peaks on
each replicate separately and then combine them, however discovery power suffered
under this approach: overlap between replicates was less than 50%, and the hnRNP L
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binding site within CD45 exon 4, a site of known hnRNP L-RNA interaction, was lost
(see results sections below). In accordance with methods employed by prior CLIP-seq
analyses, I combined replicates within sample groups before peak discovery rather than
calling peaks on individual replicates and attempting to define shared sites based on
overlap between individual replicates (figure M1). In order to preserve replicate support,
I arrived upon a strategy in which peaks were called on the pooled replicates from each
sample group, and then individual peaks were discarded if they did have coverage in the
aligned reads of at least 2 replicates from that sample group. The resulting strategy
provides a balance between the greater discovery power provided by pooled replicates
within sample groups and the requirement that all CLIP-seq peaks had replicate support
among constituent high-throughput sequencing libraries.
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Figure M1. CLIP-seq processing pipeline flowchart. One sample group (“s1”) of a
representative CLIP-seq experiment with three replicates (“r1-3”) is displayed. File formats at
each step of the pipeline denote the type of data contained within: fastq = raw reads, sam =
aligned reads, bed = CLIP-seq peaks.

CLIP-seq binding site definition: peak calling

CLIP-seq aligned reads form broad coverage traces across the genome, with
most areas experiencing low or no coverage, and some areas exhibiting tall peaks of
coverage. In order to isolate these signal peaks and remove the background coverage, I
developed an implementation of an empirical peak calling algorithm that utilizes iterative
within-transcript permutation of aligned reads to define an empirical false discovery rate
(FDR) associated with each coverage height observed within the transcript, thus
allowing a minimum peak height for each transcript to be separately computed. I based
this implementation on a method initially developed in the Yeo and Ule groups, but no
source code was available. For this reason, the algorithm had to be reimplemented to
be of use in my CLIP-seq analyses.
This algorithm first iterates over each transcript in a provided set of transcripts,
for instance the refSeq transcriptome annotation. Within each transcript, the CLIP-seq
reads that align to that transcript are isolated and grouped into “islands” of nonzero
coverage bounded by zero coverage. The maximum coverage of each island is
computed through an associative array, and the number of islands at each height in the
transcript are tabulated. This table is transformed into a table of empirical p-values
defined as the sum of all islands with maximum coverage as or more extreme than the
given maximum coverage. Next, iterative permutations of the coordinates of the aligned
reads within that transcript are generated. At each iteration, each read is assigned a
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random start coordinate within the transcript such that the read is still contained within
the transcript and does not hang off of the end of the transcript. This is achieved by
generating a pseudorandom number between zero and the last valid start position within
the transcript, which is defined as the length of the transcript minus the length of the
current aligned read. After all reads aligned to the transcript are thus permuted, islands
of overlapping aligned reads bounded by regions of zero coverage are identified and a
table of empirical p-values of the number of islands at or greater than each maximum
coverage value is generated. This process is repeated iteratively, and after the last
iteration, a new table of the average and standard deviation of the empirical p-value at
each maximum coverage value is computed from all of the iterations of permutations.
This table is then converted to an FDR table, where the FDR value for each maximum
coverage is defined as the mean p-value for that height plus one standard deviation,
then this quantity is divided by the observed cumulative distribution value for that height.
From this FDR table, a minimum peak height for that specific transcript is
generated. Given a provided FDR cutoff of 0.001, which is also parameterized and
therefore can be customized by the end-user, the minimum peak height is defined as the
height in the FDR table that has an FDR value of at most 0.001. The islands of
overlapping coverage in the aligned CLIP-seq reads are then called as a peak if their
maximum coverage is at least the minimum peak height for that transcript. Continuing
this iteration across all transcripts in the provided transcriptome annotation allows
comprehensive, transcriptome-wide discovery of CLIP-seq peaks.
This implementation is available as both a standalone program called
discover_peaks and a library of refactored subroutines in the clipseq_analysis
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distribution. Importantly, several computational optimizations are utilized in this
algorithm.
First, to provide a balance between memory consumption and execution speed,
the algorithm first discovers the chromosomes contained within the aligned CLIP-seq
reads files to be searched for peaks and iterates separately over each strand of each
chromosome encountered, building a data structure of aligned reads and transcripts on
that strand of that chromosome. This strand-specific algorithm prevents the entirety of
the transcriptome and the entirety of the aligned CLIP-seq reads from needing to be
contained within memory at any given point in time, greatly decreasing the required
memory and allowing execution on a commodity personal computer instead of a
dedicated compute cluster node with increased memory.
Second, any transcript that does not have at least one CLIP-seq alignment is
immediately discarded and never subjected to randomization. Additionally, any
transcript that has CLIP-seq alignments that do not overlap each other is also discarded
because a maximum coverage of 1 will always be generated by iterative permutation.
Third, an associative array of CLIP-seq coverage is constructed during the
parsing of CLIP-seq reads that align to the current strand of the current chromosome as
the alignments are parsed. This data structure allows rapid extraction of maximum
coverage from each observed island of overlapping CLIP-seq reads. Additionally, while
associative array lookup is significantly slower than array lookup given identical numbers
of elements, the sparsity of CLIP-seq coverage across a given strand of a given
chromosome of the human genome is such that an array of CLIP-seq coverage would
contain a vast majority of zero values across its indices: a sparse array. In contrast, an
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associative array does not instantiate key-value pairs at all for nucleotides that had no
CLIP-seq coverage, and the resulting data structure consumes much less memory than
an analogous array implementation.
Finally, significant refactoring of subroutines and variables between this and
other programs in the clipseq_analysis distribution was achieved by migrating code into
modules (Table M1). In addition to the benefits of code reuse, this allows unit and
integration testing to cover multiple specific programs by testing modular subroutines in
addition to high-level subroutines defined in specific programs that import those
modules. Documentation for low-level subroutines is confined to modules, while
documentation in programs focuses on higher-level logic and algorithm descriptions.
This modularization of refactored subroutines also aids future enhancements to the code
via a version-controlled repository.
Program name

Program type

Description

Clipseq.pm

Perl module

Z_score.pm

Perl module

discover_peaks

Perl program

compute_z_scores

Perl program

binding_mapper

Perl program

centric_binding_mapper

Perl program

compute_randomized_overlap

Perl program

Library of subroutines for I/O,
permutations, and data structures for
genomic coverage, empirical pvalues, and FDR
Library of subroutines for sequence
extraction, kmer counting, and data
structures for motif enrichment
analysis
Implementation of the empirical
randomization peak discovery
algorithm of Yeo and Ule
Motif enrichment algorithm focused
on kmers within CLIP-seq peaks
Prints plottable datafiles containing
total, average, or normalized
complexity of CLIP-seq binding within
and around provided intervals (e.g.
exons)
Similar to binding_mapper, but
computes binding relative to center of
provided intervals, useful for miRNA
hairpins e.g.
Computes Z-scores for overlap
between two provided sets of CLIPseq peaks using within-transcript
randomization

Table M1. The clipseq_analysis distribution. Programs and modules (libraries)
developed for computational analysis of CLIP-seq datasets. Documentation, unit and integration
testing, and version control are provided in the distribution.
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To establish version control and provide source code for future users, I initialized
a git repository of this and other CLIP-seq programs, described above and below, and
hosted this repository as a public repository on GitHub, the world’s largest webserver for
git repositories. This repository allows users to download the most recent version of the
distribution, which contains specific programs tailored to individual tasks like CLIP-seq
peak calling as well as modules of refactored subroutines, embedded documentation,
unit and integration tests, and an automated installation mechanism specific to Perl
distributions. The programs contained within this distribution have no dependencies
outside of the Perl core, although bedtools, the genome arithmetic distribution, can be
utilized to increase execution speed. Additionally, adapter removal and alignment
functionalities are not provided by the clipseq_analysis distribution as well-established
tools such as cutadapt and bowtie are already widely distributed. The clipseq_analysis
distribution is available at https://github.com/bryketos/clipseq_analysis for download and
collaborative development.

CLIP-seq motif enrichment analysis

To identify enriched motifs within CLIP-seq peaks, I implemented another
empirical algorithm, compute_z_scores, that relies upon iterative within-transcript
permutation and has found use in analysis of CLIP-seq motifs in prior studies. In this
motif enrichment strategy, CLIP-seq peaks are first converted to FASTA files containing
genomic sequences. Sequences are extracted from these FASTA files and a table of
each kmer is constructed, relating the frequency of each kmer within the dataset to the
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total number of kmers in the entire sequence space within that dataset, in this case the
number of sliding substrings of length k within all CLIP-seq peaks. Next, iterative
permutation is performed exactly as for CLIP-seq aligned reads in the case of the CLIPseq peak caller, except CLIP-seq peaks are permuted within transcripts, and an
additional requirement is enforced that a permuted CLIP-seq peak cannot overlap a
previously permuted CLIP-seq peak within that transcript at that iteration. This
requirement is necessary to preserve the legitimacy of the permuted peaks, because the
original CLIP-seq peaks cannot, by definition, overlap one another.
Within each iteration, at the end of permutation of CLIP-seq peaks within each
transcript, coordinates for the permuted CLIP-seq peaks are written to a BED file. At the
end of iterations, BED files are converted to FASTA. A sequence table of kmer
frequencies for each permuted set of binding sites is then extracted, and this table is
converted to a mean and standard deviation for each kmer across all sets of permuted
CLIP-seq peaks. Finally, for each kmer encountered within the original CLIP-seq peaks,
the frequency of the kmer is utilized to report the z-score: the number of standard
deviations above or below the mean frequency among permuted CLIP-seq peaks. A
high z-score indicates strong enrichment and a negative z-score indicates depletion.
This implementation is also provided within the clipseq_analysis distribution as
compute_z_scores, and several subroutines are shared between the CLIP-seq peak
caller and the CLIP-seq motif enrichment programs.
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CLIP-seq peak overlap comparison

To compare the fraction of CLIP-seq peaks that are shared between two sets of
peaks, I applied the refactored permutation subroutines developed for motif enrichment
analysis to a new program: compute_randomized_overlap. Two sets of CLIP-seq peaks
are first compared by computing the fraction of peaks in the first set that overlap peaks
in the second set. This is most rapidly achieved using bedtools intersect, however an
alternative pure Perl implementation is also provided that uses a hierarchical genomic
coverage data structure. This fraction, expressed as the union divided by the
intersection, is then compared to a similar fraction achieved by comparing the first set of
peaks to a permuted copy of the second set of peaks. Several optimizations are
additionally implemented to speed computation. First, if a transcript contains peaks only
in the first set of peaks, permutation is entirely unnecessary as it is impossible to achieve
any outcome that creates an overlap. Instead of permuting the second set of peaks, the
total unshared peaks are simply incremented by the number of peaks in the second set
of peaks and randomization is skipped. Second, memory footprint is minimized by
discarding any transcript that does not have peaks in either set of CLIP-seq peaks,
therefore runtime is also reduced. Third, a strand-specific algorithm is implemented that
only operates on a given strand of a given chromosome at a time, thereby reducing
memory footprint at the expense of runtime, however this strategy will facilitate
parallelization in the future, as no state is shared between computations on separate
strands. Fourth, the hierarchical data structure of genomic coverage utilizes associative
arrays instead of conventional arrays to account for the sparseness of coverage, an
analogy to sparse matrix algorithms which do not instantiate matrix entries at all for zero23

valued or undefined elements. Together, these optimizations increase runtime and
minimize resource consumption, allowing efficient operation on a single processor. This
allows a compute cluster user to conduct several comparisons concurrently.

Gene ontology analysis

To analyze enriched gene ontology (GO) terms in sets of genes of interest, the
Database for Annotation, Visualization, and Integrated Discovery (DAVID) version 6.7
was utilized. Where applicable, expressed transcripts within the given cell type were
provided as a background, and Biological Process (GO_BP_FAT), Molecular Function
(GO_MF_FAT), and KEGG pathways were searched. P-values are reported with the
multiple hypothesis testing correction of Benjamini and Hochberg.

Splicing analysis from RASL-seq data

The Fu lab at UCSC provides pre-processing of raw RASL-seq data that
generates a spreadsheet of junction pairs with numbers of reads mapping to each
member of a junction pair. This necessary first step eliminates the need for downstream
analysts to understand the specific probe pool and barcoding strategy utilized by RASLseq and allows researchers to provide simple analyses of junction counts to generate
predictions.
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To obtain significant alternative splicing predictions from RASL-seq data, junction
pairs were first discarded if the average number of reads across replicates was less than
10. The remaining junction pairs were analyzed by a dependent, two-sample T-test in
Microsoft Excel, generating p-values for intergroup comparisons, e.g. hnRNP L
knockdown versus mock depletion sample groups in unstimulated JSL1 T cells.
Significant predictions were then filtered based on two criteria: first, the p-value for the T
test must be less than 0.05, demonstrating significant difference of inclusion levels
between the two sample groups, and second that the inclusion level difference must be
at least 10%. Inclusion levels are calculated for each alternative splicing event as the
total inclusion reads divided by the sum of the inclusion and exclusion reads, generating
a Percent Spliced In (PSI) value, a portable metric that allows direct comparison
between experiments. Inclusion level changes between sample groups are thus
reported as deltaPSI, or the PSI value of the second sample group (e.g. hnRNP L
depletion in unstimulated cells) minus the PSI value of the first sample group (e.g. mock
depletion in unstimulated cells). Positive deltaPSI values thus indicate an increase in
inclusion upon hnRNP L depletion, which indicates potential repression of splicing by
hnRNP L, and negative deltaPSI values indicate the potential for enhancement by
hnRNP L.

Splicing analysis from mRNA-seq data

To analyze alternative splicing using mRNA-seq data, I utilized the Multivariate
Analysis of Transcript Splicing (MATS) software. MATS is a Python pipeline that utilizes
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algorithms implemented in the Scipy and Numpy packages to perform Bayesian
inference and estimate the significance of inclusion level changes observed in RNA-seq
aligned reads. MATS internally utilizes Tophat to perform alignment, therefore raw
sequence reads in FASTQ format can be provided as input. MATS has many
parameters that must be fine-tuned to the specific RNA-seq dataset under analysis, and
the developers of the MATS software recommended that I explore a range of different
parameter values when I observed that the default parameter settings generated no
statistically significant alternative splicing predictions.
To find the set of optimal parameter values for this RNA-seq experiment, the
unstimulated and stimulated sample groups that were not subjected to hnRNP L
depletion were utilized, and performance metrics were extracted from confusion matrices
utilizing a set of 169 existing RT-PCR results performed in at least triplicates in
unstimulated and stimulated cells (see Results). The optimal parameter set was defined
as the set that maximized Positive Predictive Value (PPV), a measure of the fraction of
significant alternative splicing predictions that are validated by RT-PCR. This set of
parameters also resulted in the highest overall accuracy (ACC). The parameters thus
discovered were –c 0.001, -analysis P, and the ReadsOnTargetAndJunctionCounts
scoring method output files. This set of optimized parameters was then utilized to
discover hnRNP L-responsive alternative splicing by comparing the hnRNP L-depleted
to mock-depleted sample groups in unstimulated and stimulated conditions (separately).
A third sequencing replicate was performed but the sequencing and/or library quality
was too low to be used.
The output from MATS was then filtered for the significance and magnitude. The
p-value for the significance of differential exon inclusion between the two sample groups
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under comparison must be below 0.05 and the magnitude of the differential inclusion
(deltaPSI) must be greater than 10% in either direction.

Stringent union of RASL-seq and RNA-seq alternative splicing predictions

After mRNA-seq libraries were prepared, sequenced, and analyzed, the Fu lab at
UCSD subsequently performed a series of RASL-seq analyses of splicing in JSL1 and
CD4+ T cells. Multiple sample groups were analyzed by RASL-seq, including hnRNP L
depletion samples that were generated by lentiviral transduction. Data from RASL-seq
were subsequently merged with data from RNA-seq to increase discovery power.
To incorporate the significant alternative splicing predictions from both RASL-seq
and MATS analyses, a variety of methods were explored. First, the union and
intersection were calculated. For the union, any exon that had a prediction of significant
alternative splicing in either the RASL-seq or MATS analysis were retained. This was
found to be too liberal as some of the predictions were in opposite directions in the two
experiments and thus should be avoided. At the other extreme, the intersection was
found to be too conservative because the total number of junctions queried by RASL-seq
is more than an order of magnitude lower than the total number of junctions queried by
RNA-seq. To find a compromise between these two extremes, I developed a method
called the “stringent union” in which the union of RASL-seq and MATS analyses is first
compiled, then any prediction from one experiment that had a deltaPSI value of less
than 5% in the same direction in the other experiment was discarded from further
analysis. This stringent union approach provides a balance between liberal and
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conservative analyses: as for the optimization of MATS parameters, the gold standard
RT-PCR results from stimulation-responsive alternative splicing were utilized as a guide,
and indeed a high false positive rate was found to result from the union of RASL-seq and
MATS, and a high false negative rate was found to result from the intersection. I
therefore conclude that the stringent union successfully incorporates splicing data from
both experiments where an exon is queried by both, and allows the much greater
breadth-of-coverage from RNA-seq to expand the scope of predicted alternative splicing
events.

Differential gene expression analysis

To analyze gene expression changes from RNA-seq alignments, counts of
aligned reads per transcript in the refSeq transcriptome annotation were generated. A
linear model was used to test the significance of differential gene expression between
two sample groups (limma). First, read counts were normalized by library size and
variance of the observed mean (voom). Transcripts with fewer than 1 read per million in
at least half of sequencing libraries were discarded. Empirical Bayes fitting was used to
fit the model and extract p-values. Significant gene expression changes were defined as
genes with at least 1.5 log2 change in either direction with an accompanying p-value
less than 0.05.
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Integrating CLIP-seq with splicing predictions

An informative step in integrating CLIP-seq and splicing predictions is to
generate graphs of the CLIP-seq binding signal within and around regulated exons.
Regions of overrepresented or underrepresented binding can subsequently identified. In
this analysis, it is important to control for peaks that are of variable height by
investigating the fraction of regulated exons that have a CLIP-seq peak at each
nucleotide.
To achieve this, I first extracted coordinates for 350nt intervals containing 50nt of
exonic sequence and 300nt of exon-proximal intronic sequence were generated for the
C1 exon 5’ss (the exon upstream of the alternative exon), both splice sites of the
alternative exon, and the 3’ss of the C2 exon. Next, for each nucleotide in each of these
intervals, the fraction of cassettes containing a CLIP-seq peak at that position was
computed. Output files relating the fraction of intervals with at least one CLIP-seq peak
at each position were then generated. Plots of the fraction-bound at each position were
then generated.
Combined with the CLIP-seq peak caller described above, this analysis provides
a means of describing RNA binding protein occupancy patterns within and around
regulated exons. Source code is available in the clipseq_analysis distribution.
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Modular splice site scoring

The maxEntScan algorithm was developed to provide a quantitative splice site
score separately for 5’ and 3’ splice sites based on the maximum entropy of splice sitesnRNA interaction. I refactored the MaxEntScan source code available on the
developer’s website into a self-testing, self-documenting, and self-installing Perl module
available on the Comprehensive Perl Archive Network (CPAN).

Binomial motif enrichment analysis of exonic and periexonic intervals

In order to investigate potentially enriched sequence features within and around
exons of interest, for example exons that are enhanced by hnRNP L, I developed an
analysis that compares the fraction of intervals of interest containing each kmer to the
fraction of intervals containing that kmer of the same type (e.g. 300nt upstream of an
exon) from all internal refSeq exons. First, the intervals upstream of the exon, within the
exon, and downstream of the exon are extracted for the exons of interest. For the
upstream interval, I did not extract sequences that include the 3’ss as defined by the
maxEntScan algorithm, namely the 20nt of intronic sequence to the immediate 5’ of the
exon of interest. For the exonic region, the first and last 3nt of the exon were not
extracted for the same reason. For the downstream intronic interval, the first 6nt of the
intron were not extracted. This was performed so as not to conflate splice site signals
with cis-regulatory motifs that are targets of potential coregulators of splicing as my
primary interest was on sequences that are not part of the core splice sites themselves.
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For each of these intervals, I extracted sequences around all refSeq internal
exons, namely exons that are not first or last in all transcripts in the refSeq transcriptome
annotation that have at least 3 total exons. Then, the fraction of intervals from each
dataset containing each kmer were extracted. This analysis allows comparison by the
binomial test because each interval can either contain or not contain a given kmer. As a
computational optimization, I used an associative array instead of a one-zero matrix to
represent kmer occurrences within each interval of interest. This considerably improves
execution speed as the intervals are typically short, 50-280 nucleotides, and the number
of unique kmers contained within each interval is a small subset of the number of
possible strings of length k. Additionally, some kmers are not encountered at all in sets
of exons that contain only a few hundred intervals, and this sparsity is reflected in the
uninstantiated nature of the associative array data structure, whose uninstantiated
values are undefined and thus may be used in Boolean expressions, in which instance
they return a False value.
An output file was then generated for each interval: upstream, exonic, and
downstream, containing each kmer encountered in the input regions on a separate row.
Columns included the fraction of input intervals that containing that kmer, the fraction of
corresponding refSeq intervals that contained that kmer, and the total numbers of each.
This was then utilized as input into the R statistical package, from which the exact
binomial test was called and p-values and confidence intervals were extracted.
Importantly, the binomial test in R was automated from a Perl program by invoking R as
a subprocess via a named pipe. Instructions and input data were passed to R without
the need to separately generate an R script or an R input datafile, thus removing the
filesystem from the interprocess communication (IPC) entirely. In this way, the invoking
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program can dynamically handle errors and parse output from R by utilizing the standard
error (STDERR) and standard input/output (STDIN/STDOUT) output streams. This
provides an automated alternative to invoking R manually and utilizes the speed and
extended numerical precision of the R statistical package for performing statistical tests
such as the binomial test.
To control for multiple hypothesis testing, p-values from individual binomial tests
were adjusted by the Bonferroni correction, where a new alpha level was computed as
0.05/4**k, which for hexamers (kmers of length 6nt) is approximately equal to 1.22e-5.
All kmers with p-values below this corrected alpha level were then aligned together with
ClustalW2 and the multiple sequence alignments were used to generate sequence logos
with WebLogo version 2.8.2.

Software

Software development was performed in Emacs v23.1.1 and later. Programs,
scripts, one-liners, and interactive computation utilized Perl v5.10.1 and later, Python
v2.7.2 and later, R v3.0.1 and later, and platform-dependent versions of the GNU
compiler collection, the Bourne-again shell, the GNU core utilities, and the standard
library headers. In addition to software packages mentioned in the above methods
sections and core/standard libraries, software distributions from the Comprehensive Perl
Archive Network, the Python Package Index, the Enthought Python Distribution (numpy
and scipy), the Comprehensive R Archive Network, the Synaptics Package Manager,
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and the Bioconductor Project were utilized. All software use was performed in
accordance with provided licenses.
Computation was performed on the Penn Genome Frontiers Institute’s compute
cluster and the Penn Medicine Academic Computing Services’ High Performance
Compute Cluster (HPC) in addition to commodity computing using multiple distributions
of the GNU/Linux system as well as mintty version 1.2.0.1 and associated Cygwin
distributions.

Cell culture, cell stimulation, and hnRNP L depletion

JSL1 cells were cultured in RPMI medium with 15% heat-inactivated fetal bovine
serum (FBS). Stimulation of JSL1 cells was achieved by supplementing culture medium
with the phorbol ester PMA (Sigma-Aldrich) at a final concentration of 20 ng/mL.
CD4+ cells were purified from human peripheral blood mononuclear cells to a
purity of at least 90% by the Human Immunology core at the University of Pennsylvania
(IRB #811028). These cells were cultured in RPMI medium supplemented with 10%
FBS. Stimulation of CD4+ cells was achieved by the addition of antibodies to human
CD3 and CD28 (Clontech).
Protein depletion by antisense morpholino oligonucleotide (AMO) was achieved
by electrotransfection of 20 million cells that are first pelleted and washed twice with
serum-free RPMI medium. Cells were then resuspended in 400uL for electoporation.
Control samples (mock transfection) were electroporated with no AMO and knockdown
samples were electroporated with 10uL of 1nmol/uL AMO. Electroporated cells were
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allowed to recover in RPMI medium supplemented with fetal bovine serum for 24 hours
before stimulation.

RNA extraction, RT-PCR splicing assay, and qRT-PCR gene expression assay

RNA was isolated with the RNA-bee (Tel-Test) reagent and protocol.
Semiquantitative radiolabeled RT-PCR assay was carried out as described previously37.
Briefly, reverse transcription of isolated RNA was achieved by annealing reverse primer
to total RNA at 90 degrees, with the reaction subsequently cooled to 43 degrees before
addition of MMLV reverse transcriptase and RT-PCR master mix containing dNTPs.
Reverse transcription was incubated for 30 minutes at 43 degrees, then heated to 95
degrees for 5 minutes.
PCR was carried out with 2.5ng each of 32-P end-labeled forward primer and
unlabeled forward primer and 5ng unlabeled reverse primer. A mixture of PCR cycle
numbers was utilized to determine the linear range of detection for the given analyte.
Primer sequences for all RT-PCR primers I designed are listed in Table M2.
Gene expression changes were assayed using qRT-PCR. Total RNA isolated as
described above were reverse transcribed with a cDNA reverse transcription kit (Applied
Biosystems) which uses random primers. In biological and technical triplicates, 5uL of
cDNA were loaded with 20uL of SYBR green PCR master mix (Applied Biosystems) into
optical plates (Applied Biosystems) and primers that span exon-exon junctions to
minimize the possibility of genomic DNA amplification. For each primer pair, a standard
curve of 4 serial dilutions, each of 1:5 dilution ratio, was analyzed on the same plate to
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enable quantitation. Additionally, a no-template control and a no-RT control were
analyzed in every plate. After 40 cycles of amplification on the SDS7000 qRT-PCR
thermal cycler (ABI), standard curves were inspected for linearity and PCR products
were analyzed by 1.5% agarose gel electrophoresis to confirm expected amplicon size
and no nonspecific amplification. Quantitation was by ABI Prism software and
normalized to ACTB quantitations achieved by qRT-PCR from the same RT-PCR
reactions, and gene expression changes were computed as the average of the log2
(knockdown / mock-depleted) for hnRNP L depletion and as log2 (stimulated /
unstimulated) for stimulation-responsive differential gene expression analyses. qRTPCR primer sequences are included in Table M2.
Gene

Forward primer
sequence

Reverse primer
sequence

CDK5RAP2

CCA AAA GTT AAT GCA AGC TGG CAA 127/250
TCT GGC TGA AGC GGT CAT CAG GTG
AGT GAT GG
GGC

E22-E24 RT-PCR

DMD

CCC AGG CAG AGG CTC CAT CGC TCT
CCA AAG TGA ATG GCC CAA ATC ATC
GC
TGC C

246/278

E76-E79 RT-PCR

H2AFY

GTC CAC CAA GAC GCT TCT TCT GGG
GTC CAG GTC TGC ATG GAG ACT TGG
C
CC

352/459

E2-E4

RT-PCR

KRBOX4

GTT GCG AAG CCA GTT CTG GAT TCT
GAT GTG ATC TTC TGA CCG CTT TCA
AGG
TCC

224/268

E5-E7

RT-PCR

SIRT2

GGA CAG AGC GGT CGC TCT GCA TGT
CGG TGA CAG CC ACC GGG CCA CC

165/219

E1-E4

RT-PCR

TPD52L2

GTC ACT CTG CGC
CAG GTC CTG GC

CAT GTC TCC AAG
CTT CCT GCT GAT
GGC

234/294

E3-E5

RT-PCR

ZNF232

GGG TGA GGG CTG CTG GTC TCA TAC
TAA GTG GCG CG TCA CAA GAC TGT
TCC

238/384

E2/E3

RT-PCR

MTRR

TGT TAC ATG CCT
TGA AGT GAT GAG
GAG G

GCC GGG CTC CAA
GCT CTT GAA GTC
G

DOCK7

GGA GGA TCA GTG TTG ACG TCT CTG
CAT TAT GCC ACA TGT GCG AAG ACA
ATG GC
TAC G
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Amplicon Exon
Primer
sizes
number type

RT-PCR
387/233

E2-E4
RT-PCR

295/205

E22-E24

GAT CTT GCA GTA
ATG GGT ATA GGG
CTC C

RT-PCR

MARS

CGA AAT GAG ACT
GTT CGT GAG TGA
TGG C

PPP2R5E

TCC GTC AGA AAA CCC TTG AGG CAT
GCC AGA CAG AAG CGT GGC CAC ACT
AGG
T

ITGA6

GAC TGT AGC TCA
GTA TTC GGG AGT
ACC

FYN

AGA GAG CTG CAG CTC GGT GAC GAT
GTC TCT GCT GCC GTA GAT GGG CTC
G
C

FYN-E9-B

GTT TCG CTG AAG
TGT GGC TTG GTA
CC

N/A

PABPC1

GGA ACC AAG AGA
CCG AGG CCT TCC
C

CCG GCT GCT GGA
AGT TCA CAT ACG C 394/118

E1-E2

RBMX

GGT CAT TCC AGT
TCA CGT GAT GAC
TAT CC

TCC ACC ATA TCC
GTC ACG TGA GCT
GC

228/154

E5E7A/E7B

RBMX-E7B-R

N/A

CTT TAT CTA CTG
TGA ATC AAT CAG
CAC TCC

228/154

E5E7A/E7B

MIF

TAC ATC GCG GTG CTG TCC GGG CTG
CAC GTG GTC CCG ATG CGC AGG CG

AAA TCA GTC CTC
AGG GAT TGA GCA
GGC

GAC CAA GCC TAT
TTG GAC CAG AAA
HSP90AB1-E6-F CCC

GCC AAC ATG CAA
AGG CTT CTC ACA
CC

HEXB

GTG AAG TCT TCA
CTA CCA TCC AGC
CC

TAC TGA ACA CTT
GAC ATG TGG CTA
ATG C

APPL2

TCA CTT GAG GCC
AGG AGT TCA AGA
CC

CTC ACT ACA ACC
TCC GCC TCC TGG
G

RC3H1

CCC ACA AAA CTC
CAT GAA GAA TTA
AGC C

CCA TAA ATG TGG
ATT ATG ACT CTT
GGG AT

NCK2

GGA AGA ACA GCC GTT TGT TCT TCC
TGA AGA AGG GCT CTG ACG CTT TAA
CC
GGG

IKZF2

GGT GAA CGC CCC GAC AGC AGG TCT
TTC CAC TGT AAC CTC AAA AGG CAC
C
C

PAK1

GAT ATT TGA TGT
GCC GAG AGG AGC CTG AAG CAA GCG
TGA GCG AGC GC
GGC

ACTB

GCAAAGACCTGTAC AGTACTTGCGCTCA
GCCAAC
GGAGGA

EGR1

GCAGCAACAGCAG
CAGCAGC

CGTTGTTCAGAGAG
ATGTCAGG
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515/210

E1-E5
RT-PCR

292/195

E2-E4
RT-PCR

475/345

E24-E26

310/168

E9A/E9B
-E10

310/168

E9A/E9B
-E10

RT-PCR

RT-PCR

RT-PCR

RT-PCR

RT-PCR

RT-PCR
173 E2
RT-PCR
131 E6/I6
RT-PCR
172
RT-PCR
169
RT-PCR
140
RT-PCR
822/100

E3-5
RT-PCR

365/227

E5-7
RT-PCR

385/174

E1-4
qPCR

144 E5-6
qPCR
111 E1-2

CD7

GATCTCCTTCCTCC CCTCGTACACCACA
TCGGGC
CATGCC

TNFAIP3

AACTGGTGTCGAGA AGAGACTCCAGTTG
AGTCCGG
CCAGCG

B2M

GGCCTTAGCTGTGC CAATGTCGGATGGA
TCGCG
TGAAACCC

TAF1D

GCAGAGGATCTGG
CTTCCC

TRIB2

CGTGCATCTGCACA CATAGGCTTTGGTC
GCGG
TCACCC

CTSW

CCGCTAGAGCTGAA AGGTCACTGAATGG
AGAGGC
AGTCACC

CD1C

AGCTCTTCTTCTCC
CAGGTGG

VGF

TGTCTCCGGCAGCC AGGCTGCGCCTCAG
TCTTGG
GGCG

TRIB1

CGAGCGCGAGCAT
GTGTCC

TGGCAGCTGGATGT
AAGGCC

SCG2

GAAGCTCGCCCGG
AGAACG

TGAAATGAAGCTGC
TTCAGCC

GPR84

CTTCCATTATAGAA
AGAATTGAAGG

GTCACAGCCACCAC
CACCC

IER3

GCACCGAAAGCGC
AGCCGC

CTTCAGCCATCAGG
ATCTGGC

LIME1

GGTGGCCGAGTAT
GCCCGC

CCCTGGAGTACAGG
ACGTCC

IL32

GCTCCTTGAACTTT
TGGCCG

CGTCCTGATTCTGC
ATTTTGC

EGR2

AGATGAACGGAGT
GGCCGG

GAAGGTCTGGTTTC
TAGGTGC

IGLL1

CTCGGTCACTCTGT GGGTACCATCTGCC
TCCCG
TTCCAGG

TMEM173

CTAGCTCCCTGCAG CAGGCCCGCACAGT
CTGG
CCTCC

LYL1

GCTGCAAGAACAGT GGGCAGGCGCTGG
GCTGGG
GCTGG

GZMA

CTCTCAGTTGTCGT AGTGAGCTGCAGTC
TTCTCTCC
AACACCC

GCTTCAATGATTCTT
TCAGGTGG

GTCCAGCCATCCTG
AGCCC
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qPCR
116 E3-4
qPCR
189 E2-3
qPCR
149 E1-2
qPCR
155 E3-4
qPCR
150 E1-2
qPCR
200 E2-3
qPCR
137 E1-2
qPCR
119 E1-2
qPCR
115 E1-2
qPCR
171 E1-2
qPCR
144 E1-2
qPCR
137 E1-2
qPCR
119 E5-6
qPCR
129 E2-4
qPCR
122 E1-2
qPCR
121 E3
qPCR
113 E3-4
qPCR
151 E1-2
qPCR
175 E1-2

CLEC11A

GAGAGGGAGGCCC CCTGGTCCTCCTCC
TGATGC
ATCTCC

C1orf233

GATGCGCGCCCCG
CCGC

TIMP1

CTTCTGGCATCCTG GTGTCCCCACGAAC
TTGTTGC
TTGGCC

GGGCCCTCGGGCA
GCACC

qPCR
144 E1-2
qPCR
137 E1
qPCR
146 E2-3

Table M2. RT- and qRT-PCR primer sequences.

mRNA-seq Library Preparation

Illumina TRU-seq v2 paired-end high-throughput polyA mRNA sequencing
libraries were prepared according to the manufacturer’s protocol. Briefly, 1ug of total
RNA extract as described above was diluted to 50uL with ultrapure water and mixed with
50uL of RNA purification beads (poly-dT beads provided with kit), mixed, and incubated
for 5 minutes at 65 degrees. Beads were magnetically held as supernatant was
aspirated, then beads were washed with 200uL of bead washing buffer. After removing
the bead washing buffer, mRNA was eluted from the beads with 50uL of elution buffer in
a 2 minute 80 degree incubation followed by bead extraction with provided bead-binding
buffer.
Purified mRNAs from the above polyA purification were mixed with 19.5uL of
elute-prime-fragment buffer for fragmentation at 94 degrees for 4 minutes to generate an
expected median fragment size of 160nt as per the manufacturer’s protocol.
Fragmented mRNAs were then subjected to first-strand synthesis using the
supplied first strand master mix with an incubation at 25 degrees for 10 minutes, 42
degrees for 50 minutes, and then 70 degrees for 15 minutes. Second strand synthesis
was achieved by incubation at 16 degrees for 1 hour in the presence of second strand
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master mix. Products were then purified with Ampure beads at room temperature for 15
minutes before magnetic stationing of beads, discarding of supernatant, washing with
200uL of fresh 80% EtOH two times, and subsequent resuspension of cDNA products
with 52.5uL of resuspension buffer per sample.
cDNA ends were repaired with the 40uL of end repair mix at 30 degrees for 10
minutes before Ampure bead purification as described above. Repaired cDNAs were
then eluted from the beads with 17.5uL of resuspension buffer. Adenylation was
performed with 12.5uL of A-tailing mix at 37 degrees for 30 minutes before proceeding
immediately to adapter ligation.
Adapters were individually added to each sample according to a unique
barcoding strategy in which each sample received its own barcode. This strategy
allowed flexible multiplexing wherein each sample could be pooled with any other
sample in the set of prepared libraries within the same lane of the flow cell. To ligate
adapters onto fragmented cDNAs, separate samples of 2.5uL of adapters and 2.5uL of
ligation mix were added to each cDNA sample before incubation at 30 degrees for 10
minutes. Ligated products were then purified with Ampure beads as above, this time
repeating the purification twice. 20uL of purified products were aspirated and subjected
to PCR fragment enrichment with 5uL of the provided PCR primer cocktail and 25uL of
the provided PCR master mix for 13 cycles of amplification with the manufacturer’s
provided PCR cycling program.
PCR products were then purified by a single round of Ampure bead purification
before 1uL of the resulting libraries were used for Bioanalyzer analysis to verify
concentration of the libraries and the distribution of fragment sizes. The resulting
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libraries were submitted to the Next Generation Sequencing core at the University of
Pennsylvania for normalization, pooling, and high-throughput sequencing on the Illumina
HiSeq 2000 apparatus.
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CHAPTER 1 - MAPPING TRANSCRIPTOME-WIDE hnRNP L-RNA INTERACTIONS
BY COMPUTATIONAL ANALYSIS OF CLIP-seq DATA

Introduction

RNA-based gene regulation encompasses many universal processes that are
essential to shaping the composition and function of the proteome in eukaryotic cells1. In
particular, mechanisms such as alternative splicing, alternative 3′-end processing, and
microRNA (miRNA)-directed processes control not only the level of expression of a
transcript but also the distinct protein isoforms encoded by a given gene. Therefore,
such regulatory mechanisms allow for both the expansion and the control of genetic
information.
Virtually all processes of RNA-based gene regulation are controlled by the
activity of a family of RNA binding proteins known as hnRNPs (heterogeneous nuclear
ribonucleoproteins)87,88,88,89,89,90,90. Most members of the hnRNP family are ubiquitously
expressed and bind to RNA substrates through RRM (RNA recognition motif) or KH
(hnRNP K homology) domains89. Depending on the location of binding and associated
proteins, hnRNPs have been shown to either enhance or repress the inclusion of
particular exons, promote or inhibit splicing efficiency, alter the use of competing 3′
cleavage and polyadenylation sites, control mRNA stability, and regulate miRNA access
to target genes87,88,88,89,89,90,90. All hnRNPs that have been well studied appear to be
capable of carrying out all of these activities; therefore, the location of binding appears to
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be a primary determinant of whether and how a specific hnRNP controls the expression
of a particular gene87,88,88,89,89,91,91.
Given the intricacy of T cell development and function, it is not surprising that
RNA-based gene regulation is increasingly recognized as a critical determinant of the
growth and activity of T cells92,93,93. In particular, one hnRNP for which there is much
evidence of a functional role in T cell biology is hnRNP L94,95,95,96,96,97,97. hnRNP L is a 65kDa hnRNP family member that contains 4 RRM domains spaced throughout the length
of the protein. These RRMs bind preferentially to CA repeat sequences98, although at
least one biologically relevant target sequence of hnRNP L does not conform to a strict
CA repeat motif94.
hnRNP L was first implicated in T cell biology through its role in regulating the
splicing of the CD45 gene, which encodes a transmembrane phosphatase essential for
T cell activation94,95,95,96,96,97,97,99,99. The CD45 gene contains three cassette exons (exons
4 to 6) that are independently regulated at the level of alternative splicing to control
phosphatase activity. We and others have shown previously that hnRNP L is a key
determinant of CD45 splicing and expression94,95,95,97,97,100,100. Each of the three CD45
variable exons contains an exonic splicing silencer (ESS) that is constitutively bound by
hnRNP L96,101,101. The binding of hnRNP L to these ESSs directly induces skipping of
these exons both in vivo and in vitro44,44,94,95,95,96,96.
Recent investigation of the in vivo consequences of hnRNP L ablation in mouse
thymocytes revealed a broad impact on thymic cellularity, T cell development, and the
egress of mature T cells to the periphery97. The effect of hnRNP L on CD45 splicing may
account for some of the T cell development phenotypes observed; however,
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dysregulation of CD45 splicing is not sufficient to explain all of the functional
defects102,103,103. Therefore, the phenotypes of hnRNP L-deficient mice suggest that
hnRNP L mediates a broad range of yet unidentified RNA-regulatory events critical to T
cell development and function.
Here we have used in vivo cross-linking and immunoprecipitation (CLIP)55,104,104
to comprehensively identify the spectrum of hnRNP L targets within the transcriptome of
human peripheral CD4+ T cells. In agreement with the idea that the primary role of
hnRNP L in T cells is the regulation of alternative splicing, we observe extensive hnRNP
L RNA interactions in the introns of protein-coding genes. While a subset of hnRNP L
binding profiles may differ in different cell states, we find significant overlap between the
hnRNP L binding profiles in the two primary functional states of CD4+ cells (resting and
activated), as well as between those in primary CD4+ cells and JSL1 Jurkat cells, a
common T cell model cell line. Such an overlap suggests a broadly conserved role for
hnRNP L in T cell physiology. Importantly, we use the conserved binding sites for
hnRNP L to identify several hnRNP L-regulated alternative splicing events in genes
known to impact T cell development and function, and we demonstrate that 5′ splice site
(5′ss) strength is a strong predictor of hnRNP L-regulated exons. Together, our data
greatly expand the understanding of the cellular activity of hnRNP L, provide a
transcriptome-wide profile of hnRNP L RNA interactions in human T cells, and identify
hnRNP L-dependent splicing regulation of cellular pathways as critical for T cell
development and immune function.

Results
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hnRNP L has been well documented to control the splicing of the CD45 gene in
both mouse and human T cells94,95,95,96,96,97,97. However, the dramatic developmental
defect observed in hnRNP L-deficient thymocytes, together with the high abundance of
this protein in T cells, suggests that hnRNP L controls the expression of a large set of
functionally important genes. Therefore, to begin to understand the physiological impact
of hnRNP L on T cell function, I worked with a postdoctoral fellow in the lab, Dr. Ganesh
Shankarling, to map the in vivo association of hnRNP L with mRNAs and pre-mRNAs in
primary human T cells using crosslinking and immunoprecipitation followed by highthroughput sequencing55,104,104. Additionally, CLIP was performed in parallel in JSL1
cells, a monoclonal Jurkat T cell line that is a model for primary T cells94,95,95,97,97,105,105.
All previous studies of in T cells have shown hnRNP L to function similarly in
resting and activated cell states, with no data suggesting a widespread change in the
binding specificity of this protein in response to T cell stimulation54,54,95. Nevertheless,
since our goal is to understand the role of hnRNP L in promoting T cell function, Ganesh
Shankarling, performed CLIP in parallel in resting (unstimulated) cells and cells activated
through the T cell receptor, since these two cell conditions represent critical states of T
cell physiology. Briefly, purified CD4+ T cells were obtained from three healthy donors.
For each donor, half the cells were stimulated in culture with antibodies against CD3 and
CD28 (T cell receptor and coreceptor), while the other half were maintained in medium
alone. Direct protein-RNA interactions were fixed in living cells by treatment with UV
light, which induces covalent cross-links between proteins and the RNAs to which they
are directly bound55. Cells were then lysed; RNA was fragmented to a size range of 30 to
110nt; and hnRNP L RNA complexes were stringently purified using a well-described
antibody to endogenous human hnRNP L (figure 1.1). The efficiency of the
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immunoprecipitation and the consistency of hnRNP L expression in resting and
stimulated CD4+ T cells are shown in Fig. 2a. Following isolation of the hnRNP L RNA
complexes from cells, RNAs were released from the protein, tagged with RNA linkers,
and subjected to high-throughput sequencing.

Figure 1.1. Autoradiograms of hnRNP L-RNA complexes isolated for sequencing.
Representative autoradiogram from the CLIP procedure conducted from JSL1 cells (left
panel) and CD4+ cells (right panel). Cells were subjected to UV crosslinking, digested with
varying amounts of RNase T1, and subjected to immunoprecipitation using anti-hnRNP L or
control (FLAG) antibodies. The immunoprecipitated RNA-protein complexes were resolved
on 10% bis-tris NuPAGE gels. The brackets denote hnRNP L RNA-protein complexes
containing RNAs of ~30-110 nucleotides. The line denotes the point of migration of the
uncrosslinked hnRNP L protein. RNA-protein complexes were excised from the gel for
further processing. (Figure courtesy of Ganesh Shankarling.)

hnRNP L RNA interaction profiles in T cells

Dr. Shankarling obtained a total of ∼200 million reads from the 3 pools of
unstimulated CD4+ cells and ∼100 million reads from the stimulated samples (Fig. 2b),
which I proceeded to analyze with computational genomics approaches. In each case,
more than 80% of reads mapped unambiguously to the genome, corresponding to a final
total of 13 to 15 million unique alignments (Figure 1.2b, Table 1.1). Of these unique
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aligned reads (i.e., “CLIP tags”), ∼23% mapped within protein-coding transcripts (Figure
1.2b, refSeq alignments), 6% to established noncoding RNAs, 19% to antisense RNAs,
and the remaining 51% to mitochondrial RNAs or RNAs deriving from intergenic regions
of the genome (Table 1.2). Notably, the numbers of unique alignments, as well as the
genomic distributions of reads, are virtually identical for the resting and stimulated
samples despite the 2-fold differential in raw reads. Thus, the sequencing depth of the
stimulated samples is essentially a saturating sampling of hnRNP L binding and that the
increased sequencing depth from the resting samples provides little extra discovery. Of
further note, the majority of intergenic alignments were typically represented isolated
reads (singletons: not overlapping any other aligned read), suggesting that these are
due to spurious binding events and/or background noise in the sequencing (Table 1.2).
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Figure 1.2. Transcriptome-wide hnRNP L-RNA interactions in primary human CD4+
T cells revealed by CLIP-seq. (a) Western blot of hnRNP L expression in resting and anti-CD3and anti-CD28-stimulated human CD4+ T cells. Shown are both total expression (Total) and the
efficiency of immunoprecipitation (IP) versus the protein remaining uncollected (Sup). Note that
“Total” and “Sup” levels are 5% of IP levels. (b) Flow chart of analysis of CLIP-seq reads obtained
from CD4+ cells from three independent donors. Each sample was analyzed before and after
stimulation by anti-CD3 and anti-CD28. Data from resting CD4+ cells are shown in blue, while
data from stimulated CD4+ cells are shown in red. Numbers of reads passing key filters in the
analysis are shown, including the final number of binding sites defined within refSeq transcripts in
resting and stimulated human CD4+ cells (see Materials and Methods and Table S1 in the
supplemental material for details). (c) Distribution of hnRNP L binding sites that map to each
indicated feature of RefSeq mRNAs compared to the distribution of each feature in the total
refSeq transcriptome. (d and e) Z-scores for the enrichment of hexamers within binding sites in
resting (d) and stimulated (e) cells were calculated by comparing observed hexamer frequencies
within CLIP-defined hnRNP L binding sites to randomized binding profiles within bound
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transcripts. (Insets) The top 20 hexamers were aligned to generate sequence logos. (Panel a.
courtesy of Ganesh Shankarling.)

Table 1.1. Alignment and processing statistics for hnRNP L CLIP-seq. Total data
points are listed for each major step of the CILP-seq alignment and processing pipeline, as
described in Materials and Methods. “Aligned reads” refer to the total initial alignment of CLIP
reads from all three samples of a particular cell type/condition to the human genome index hg19.
“Unambiguous” and “duplicate-removed” are as described in Materials and Methods. Those
alignments that fell within portions of the genome overlapping a refSeq mRNA were then
identified. These “refSeq mRNA alignments” were then used to define binding sites (“preliminary
peaks”) as described in Materials and Methods. Final reported refSeq binding sites (“replicable
sites”) were generated by merging preliminary peaks that fell within a 50nt window of each other,
and removing sites that were not supported by reads from at least 2 biologic replicates. (See
table 5 for numbers of sites at different replicate stringencies.)

Table 1.2. CLIP-seq alignments by genomic feature and percent singletons. Total
CLIP-seq alignments, with duplicates removed, were assigned to one of four types of genomic
feature, in decreasing order of precedence: refSeq mRNAs, refSeq ncRNA or UCSC lincRNA,
antisense to refSeq mRNA, or intergenic (all remaining alignments). For each resulting pool of
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unique alignments, the percentage of alignments that did not overlap any other alignment was
calculated (singletons).

Because our primary interest is to understand the role of hnRNP L in shaping
protein expression in T cells, I focused on those reads within protein-coding transcripts
(Figure 1.2b, refSeq alignments). In order to identify a reliable binding profile of hnRNP L
within transcripts, I defined binding sites empirically, using an iterative permutation
algorithm similar to published methods that accounts for transcript length and
sequencing depth-of-coverage by comparing observed CLIP-seq alignment distributions
to those expected by random chance106 (see Materials and Methods). To identify sites of
reproducible hnRNP L RNA interaction, I required that a binding site be represented in at
least two of three biological replicates. By this criterion I identified, in total, 49,619 sites
of hnRNP L binding in resting CD4+ cells and 47,137 in anti-CD3- and anti-CD28stimulated cells (Figure 1.2b). Importantly, the overlap between biological samples was
high: ∼85% of total peaks met the requirement of being present in at least two of the
replicates. Moreover, on average, each site was supported by 8 to 12 reads, although a
subset of sites were supported by many more (Table 1.3).

Table 1.3. Read statistics for binding sites defined from hnRNP L CLIP-seq.
Minimum, maximum, mean, median, and mode number of reads comprising the binding sites
defined in table S1 for each experimental condition.
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As expected from general predictions of hnRNP function in pre-mRNA splicing,
the majority of the binding sites I identified occur within proximal (within 300nt of an
exon) and distal intronic regions (Figure 1.2c). Furthermore, hnRNP L binding sites are
depleted within coding exons but are enriched in 3′ UTR exons (Figure 1.2c), in
agreement with previously identified roles for hnRNP L in the regulation of 3′-end
processing and the modulation of miRNA regulation54,54,90. Finally, hexamer enrichment
analysis revealed a strong preference for CA repeat elements, as evidenced both in the
2 most enriched hexamers and by multiple sequence alignment of the top 20 enriched
hexamers (Figure 1.2d and e). Such a bias toward CA repeats is anticipated from
previous biochemical studies of the binding specificity of hnRNP L98. In sum, the
concurrence of the locations and sequence bias of the CLIP-identified hnRNP L binding
sites with those from previous studies, together with the presence of sites of known
hnRNP L RNA regulatory interactions within CLIP-derived binding profiles (see below),
provides confidence that I have reliably identified major binding sites of hnRNP L across
the transcriptome of CD4+ T cells.
In order to correlate our findings in primary CD4+ cells to Jurkat cells and to
determine the utility of Jurkat cells for future mechanistic studies of hnRNP L function,
Ganesh prepared CLIP-seq libraries in parallel with the CD4+ libraries described above
using JSL1 Jurkat cells (Figure 1.1). As with the CD4+ cells, Ganesh used triplicate
biological samples of JSL1 cells grown in medium alone (resting) or stimulated with the
phorbol ester PMA, which mimics T cell signaling in these cells37. In these experiments,
Ganesh collected a total of 51 million and 68 million reads from the resting and
stimulated cells, respectively, from which I defined 41,440 binding sites in resting cells
and 32,156 binding sites in stimulated cells by using the criteria described for CD4+ cells
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(Figure 1.3a). Notably, the distribution of transcript features bound by hnRNP L in JSL1
cells is similar to that in CD4+ cells (Figure 1.33b). Additionally, the sequence motifs
enriched within hnRNP L binding profiles are consistent both with previous
experiments98 and with the results for CD4+ primary T cells (Figure 1.3c and d).
Interestingly, using expression data for resting and stimulated JSL1 cells from previous
studies107, I found that there is no general correlation between the density of CLIP tags
aligning to a gene and its overall expression level (Figure 1.4). This lack of correlation of
CLIP detection and gene expression confirms that the abundance of CLIP tags is a true
reflection of the binding preference of hnRNP L.
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Figure 1.3. Transcriptome-wide hnRNP L-RNA interaction profiles obtained in JSL1
T cells. (a) Six biological replicates of JSL1 T cells, representing triplicate samples of resting and
PMA-stimulated cells, were subjected to CLIP-seq analysis. Data were processed by a pipeline
identical to that used to analyze hnRNP L binding sites in CD4+ cells. (b) Nucleotides of each
type of transcript feature were enumerated within hnRNP L binding sites for both resting and
stimulated conditions. Proximal introns are defined as intronic regions within 300nt of an exon. (c
and d) Z-scores for the enrichment of hexamers within binding sites in resting (c) and stimulated
(d) cells were calculated by comparing observed hexamer frequencies within CLIP-defined
hnRNP L binding sites to randomized binding profiles within bound transcripts. (Insets) The top
20 hexamers were aligned to generate sequence logos.
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Figure 1.4. Gene expression levels do not globally correlate with CLIP tag density.
CLIP tag density for resting (a) or stimulated (b) JSL1 cells was computed as RPKM by
enumerating total uniquely aligned CLIP tags for each gene, then dividing by the gene length in
kilobases, then dividing by the total number of uniquely aligned CLIP tags in the dataset. This
normalized binding signal was compared to gene expression RPKM values obtained previously
by RNA-seq (Martinez et al., 2012) and adjusted R2 values were obtained by simple linear
regression.

CLIP-seq identifies consistent binding profiles in JSL1 and CD4+ T cells
Given the similarity between the sequence features and genomic annotations of
the hnRNP L binding profiles obtained in CD4+ and JSL1 T cells, I asked how consistent
the binding of hnRNP L was between cell types and growth conditions. By calculating
the percentage of total overlapping nucleotides for the two cell types, or for the two
conditions, I found significantly greater overlap between the hnRNP L CLIP samples
from the four cell populations than between binding profiles subjected to permutation
(Figure 1.5a). For each cell type, I also investigated the number of peaks in resting cells
that fell within 50nt of a peak in the corresponding stimulated cells (Figure 1.5b and c).
For both CD4+ and JSL1 cells, at least one-third of the peaks are shared between the
resting and stimulated conditions by this logic. I defined a further ∼50% of binding sites
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as “biased,” based on the observation of reads in both cell states, although these reads
reach significance thresholds under only one of the two conditions. Indeed, at most
∼20% of hnRNP L binding sites in any cell appear to be truly condition specific, in that
reads are identified in only one of the growth states investigated. While this minority
population of condition-specific binding events may be of interest (see below), our data
clearly demonstrate that the bulk of hnRNP L binding is conserved between primary and
cultured T cells as well as between resting and stimulated states. Specifically, I identified
a set of 4,585 common hnRNP L binding regions that are present in all four cell types
analyzed. These common regions occupy 2,460 genes in the T cell transcriptome.
Importantly, among these common hnRNP L binding sites, I observed the two best
characterized hnRNP L functional sites of interaction, namely, the ESS1 regulatory
element in CD45 exon 494 (Figure 1.5d) and an autoregulatory intronic site in
HNRNPL108 (Figure 1.5e).
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Figure 1.5. CLIP-seq identifies common hnRNP L-RNA interactions among primary
and cultured T cells. (a) The percentages of overlapping nucleotides for different binding profiles
were computed transcriptome-wide. The P value was ∼0 for all pairwise overlaps of the data
compared to the overlap of 100 permutations of resting and stimulated CD4+ binding profiles
randomized within bound transcripts (control). (b and c) Total binding sites in resting and
stimulated binding profiles for CD4+ (b) and JSL1 (c) cells were classified as shared, biased, or
condition specific as described in Materials and Methods and in Results. (d and e) UCSC
Genome Browser view of CD45 exon 4 (d) or intron 6 from HNRNPL (e), showing binding profiles
from four experimental conditions. Bars above the gene schematics indicate previously identified
binding sites for hnRNP L (ESS1 in CD45 and CA region in HNRNPL).

hnRNP L binds transcripts from the Wnt and TCR signaling pathways
Given the presence of known targets of hnRNP L regulatory function the
common binding regions, I focused on this set of 4,585 binding events to identify new
functional targets of hnRNP L and to begin to understand how this protein influences T
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cell development and function. First, I analyzed the KEGG pathways enriched the
common target genes. Genes involved in Wnt signaling (P = 1.67e−4) and T cell
receptor (TCR) signaling (P = 0.0011) are in the most overrepresented pathways among
hnRNP L-bound transcripts (Table 1.4). Importantly, Wnt signaling is critical for thymic
development109, while TCR signaling is essential for both the development and the
function of T cells110. I also analyzed biological process GO terms with DAVID, which
revealed a strong enrichment of terms related to transcription and RNA-based gene
regulation among common hnRNP L-bound transcripts (Table 1.4). Together, these
analyses suggest that hnRNP L may broadly affect T cell function both directly, by
regulating key signaling pathways, and indirectly, by altering the expression of other
DNA- and RNA-binding proteins that control gene expression.

Table 1.4. Transcripts with common hnRNP L binding sites were extracted from
hnRNP L binding profiles of both cell types, from both cellular conditions. DAVID was used
to analyze cellular pathways (KEGG) and biological processes (GOTERM_BP_FAT)
overrepresented among common hnRNP L targets, at an FDR cutoff of 0.1. All significantly
enriched targets are reported. P values were adjusted for multiple hypothesis testing by the
Bonferroni correction.
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Novel targets of hnRNP L-dependent splicing regulation
There are numerous mechanisms by which the binding of hnRNP L to a
transcript may influence its expression, including regulation of transcription, stability, and
efficiency of processing. Because hnRNP L is best characterized as a splicing regulatory
protein, I focused on determining new targets of hnRNP L splicing regulation. I first
identified several instances in which common hnRNP L binding regions (as defined
above) were located in introns flanking known alternative exons, then I and others
assayed the inclusion of these exons in JSL1 cells depleted of hnRNP L (Figure 1.6a) by
semiquantitative radioactive RT-PCR. In agreement with the prediction from Table 1 that
hnRNP L regulates genes involved in TCR signaling, T cell development, and RNA
synthesis and processing, I found that hnRNP L depletion significantly alters the
inclusion of known variable exons in the genes encoding the RNA-binding protein PUM2
(Figure 1.6b) and the transcription factors NFAT, BCL11A, and TCF3, which are
involved in T cell developmental and activation pathways111,112,112,113,113 (Figure 1.6c to
e). I also observed hnRNP L-dependent alternative splicing of the mitogen-activated
protein (MAP) kinase TAK1 and the GTPase ACAP1, which regulate NF-κB signaling
upon immune signaling114,115,115, and of CCAR1, a coactivator required for Wntdependent gene activation116 (Figure 1.6f to h). For all these genes, inclusion of the
variable exon either regulates overall protein expression (NFAT5 and CCAR1) or alters
the domain structure of the protein (PUM2, BCL11A, TCF3, TAK1, and ACAP1) (see
Discussion). Therefore, hnRNP L-regulated splicing of these genes is likely to impact T
cell development and signaling, in agreement with the prediction from Table 1 and the
phenotype of hnRNP L thymic deletion mice97.
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Figure 1.6. HnRNP L regulates exon inclusion of transcripts important to T cell
development and signaling. (a) Lysates from wild-type cells and from cells stably transfected
with a lentivirus carrying shRNA targeted to hnRNP L (L-KD) were immunoblotted using
antibodies against hnRNP L or tubulin to assess loading. (b to h) Representative RT-PCR
analyses of the indicated genes. Gray and black boxes represent the variable and constitutive
exons, respectively, while the black line represents introns. Blue boxes represent the hnRNP L
binding sites (see Fig. S3 in the supplemental material for an expanded browser view of CLIP
data). The percentages of inclusion (% Inc) of the variable exons are averages for at least three
independent experiments; standard deviations (SD) are shown. (e) a1 and a2 represent mutually
exclusive exons. (h) The dashed box denotes the poison exon, while % alt represents the
percentage of inclusion of the poison exon relative to the three isoforms.

The case of CCAR1 is particularly interesting, since Dr. Shankarling and I
discovered that the binding of hnRNP L is in fact not in an intron but rather in an
unannotated poison exon (i.e., an exon containing a stop codon). The fact that hnRNP L
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strongly represses this CCAR1 poison exon, together with our previous data on hnRNP
L-mediated repression of CD45 exon 494, suggests that although binding of hnRNP L to
exons is rare (Figure 1.2c and 1.3b), these events represent robust repressive activity of
hnRNP L. Consistently, I identified ∼60 genes that contain common hnRNP L binding
sites within or overlapping an exon. For five of these hnRNP L-bound exons tested, the
variable exon is markedly upregulated upon hnRNP L depletion (Figure 1.7). Importantly,
these hnRNP L-regulated exons include those in genes encoding splicing factors
(ZRANB2), cell surface receptors (SPG11, IL2RG), intracellular signaling proteins
(ARAP1), and a transcription coactivator (SS18), all of which have potential roles in T
cell biology.

Figure 1.7. Binding of hnRNP L within
exons represses exon inclusion. (a to e)
Representative RT-PCR analyses of the
indicated genes, as described in the legend to
Fig. 6. The percentages of inclusion of the
variable exons are averages from at least
three independent experiments; standard
deviations (SD) are shown. The asterisk in
panel d indicates a nonspecific PCR product.
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5′ splice site (5′ss) strength is a determinant of hnRNP L function
In addition to their functional implications, the newly identified targets of hnRNP
L-mediated splicing regulation presented in Fig. 6 and 7 demonstrate the breadth of the
mechanism of hnRNP L function. While exonic binding appears to correlate with hnRNP
L-dependent repression (Figure 1.7), I observed no clear correlation between intron
binding and hnRNP L-dependent splicing regulation. For instance, reduction of hnRNP L
levels increases the inclusion of the variable exon of PUM2, whereas it decreases the
inclusion of the variable exon in BCL11A, despite binding on either side of the exon in
both instances. Conversely, hnRNP L appears to enhance variable exon inclusion
whether it is bound to the upstream (NFAT5) or the downstream (TAK1) intron.
Moreover, ∼50% of exons containing or flanked by common hnRNP L binding sites that I
and others in the lab tested for splicing displayed no change in inclusion in response to
hnRNP L depletion. This lack of defined correlation between binding location and
function is consistent both with our previous studies demonstrating that factors in
addition to the location of hnRNP L binding determine its functional impact on splicing44
and with other studies that have revealed that CLIP-defined binding sites for hnRNPs
are not strong predictors of splicing regulation117,118,118.
To determine if I could increase our ability to utilize the CLIP-defined hnRNP L
binding sites to identify novel targets of hnRNP L-mediated splicing regulation, I grouped
the 27 exons tested by a variety of parameters, such as intron length, position of the
CLIP site, and splice site strength. Strikingly, I find that hnRNP L-dependent splicing
regulation correlates best with the strength of the 5′ splice site of the alternative exon.
Specifically, no alternative exons with 5′ss scores of 10 or greater (maxEntScan119) were
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regulated by hnRNP L, even when multiple common binding sites were detected close to
the variable exon. In contrast, all of the hnRNP L-regulated exons had 5′ss scores less
than 9.5, and 70% of the alternative exons with scores less than 9.5 exhibited hnRNP Ldependent regulation. Notably, no other single feature encompassed all of the 14
validated hnRNP L regulatory events with a positive predictive value of 70% or more.
To further validate the relevance of 5′ splice site strength, I and others in the lab
tested an additional 14 exons in functionally important genes for hnRNP L-dependent
splicing regulation. These exons were chosen with a range of 5′ss scores, including two
in the window between 9.5 and 10 that was not represented in our initial exon set. In
agreement with our predictions, I find that neither exon with a 5′ss score above 9.9
exhibits changes in splicing upon depletion of hnRNP L, while 8 of the 12 exons with 5′ss
scores less than 9.9 are regulated by hnRNP L (Figure 1.8). Therefore, I conclude that
5′ss strength is an important criterion in determining regulation by hnRNP L and can be
applied to CLIP-identified physical targets to increase the discovery power of functional
targets of hnRNP L-regulated splicing. Importantly, using these criteria, I and others in
the lab have identified a total of 20 previously unrecognized targets of hnRNP Lmediated splicing regulation, all of which are genes implicated in critical signaling and
gene expression pathways in T cells, thus providing further insight into the functional role
of hnRNP L in T cell biology.
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Fig 1.8. Validation of hnRNP L targets based on 5′ splice site strength. (a to h)
Representative RT-PCR analysis of the indicated genes, as described in the legend to Fig. 6. 5′ss
scores, as calculated by MaxEntScan, are shown for the alternative exons. The percentages of
inclusion of the variable exons are averages from at least three independent experiments, and
standard deviations (SD) are shown.

Condition specificity of hnRNP L binding
My analysis of the transcriptome-wide binding of hnRNP L has thus far been
focused on the binding sites that are present in all four T cell populations tested, since
these reveal much about the ubiquitous role of hnRNP L in T cell biology. However, as
mentioned above, I did identify a subset of hnRNP L RNA interactions in both cell types
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that are condition specific, occurring either entirely in resting samples or entirely in
stimulated samples, with no reads observed under the opposite condition (Figure 1.5b
and c). To further investigate the nature of these condition-specific events, I analyzed
changes in gene expression for these resting-state-specific and stimulated-state-specific
binding sites, using gene expression data that our lab had obtained previously for JSL1
cells. I found that the majority of condition-specific sites are in genes whose expression
does not differ significantly between resting and stimulated samples, demonstrating that
the difference in association with hnRNP L is not a secondary consequence of
differential gene expression (Figure 9a and b). I also found that these condition-specific
binding sites maintain the general bias toward CA repeats that is seen in the common
sites (Figure 1.9c and d), although this bias is less dramatic, particularly within the
stimulation-specific peaks. While the possibility of direct condition-specific regulation of
hnRNP L binding is not inconsistent with previous studies in T cells, there are no data to
directly support such a model. Moreover, I found that the discovery of condition-specific
peaks is diminished with increasing requirement for biological replication of a binding site
(Table 1.5). Therefore, it remains possible that only a minor subset of the conditionspecific peaks I have defined here truly represent signal-regulated changes in the
binding of hnRNP L, while the majority reflect false positives due to limited local
sequencing depth and biological noise.
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Fig 1.9. Condition-specific binding sites in JSL1 cells are not due to changes in
transcript expression. (a and b) The difference in the gene expression level (expressed as the
number of RNA-Seq reads per kilobase of transcript per million reads [RPKM]) between resting
and stimulated JSL1 cells was calculated as log2(RPKM for stimulated cells/RPKM for resting
cells) from preexisting data (24) and was plotted for all transcripts bearing resting-state-specific
(a) or stimulated-state-specific (b) binding sites in JSL1 cells. (c) Hexamer enrichment for all
resting-state-specific sites that are not in genes with a ≤−0.5 change in gene expression (as
indicated by the gray bar in panel a). (Inset) Sequence logo generated by multiple alignment of
the top 20 hexamers. (d) Hexamer enrichment for all stimulated-state-specific sites that are not in
genes with a ≥0.5 change in gene expression (as indicated in panel b). (Inset) Sequence logo
generated by multiple alignment of the top 20 hexamers.
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Table 1.5. Condition-specific binding sites at various replicate stringencies. Total
binding sites and condition specific sites when requiring support from 1, 2, or 3 biologic replicates.
Support from two biologic replicates is the threshold used for all the data in this document.

Discussion
hnRNP L has been shown to be necessary for thymic maturation97, suggesting
that this protein plays a widespread role in shaping the proteomes of developing and
mature T cells. Here we utilize CLIP-seq to identify hnRNP L binding targets within
human CD4+ T cells and within a cell line commonly used for mechanistic studies of T
cell biology. Importantly, the data I present here provide the first transcriptome-wide
analysis of the RNA targets of hnRNP L in primary human lymphoid cells and offer novel
insight into functional targets of hnRNP L in T cells.
Because the primary goal of this study was to identify novel targets of hnRNP L
activity relevant to T cell function, I focused on the most conserved of the hnRNP L
binding events in protein-coding genes. Using these sites, I have identified 20 new
65

targets of hnRNP L splicing regulation. These targets include genes required for T cell
signaling, such as the genes for PTK2B120, FYN121, NFAT5112, and TAK1114, genes
required for T cell development (the genes for TCF3122, Bcl11A111,123,123, and NFAT5112),
and the WNT signaling pathway mediator CCAR1116. Additional hnRNP L targets include
other receptor and signaling proteins (SPG11, IL2RG, ACAP1, ARAP1, WNK1,
PPIP5K2, and ITGA6), transcription factors (GPBP1, SS18), and RNA binding proteins
(PUM2, ZRANB2, HNRNPC, and LUC7L), all of which may broadly influence signaling
and gene expression patterns in T cells. These validated targets are consistent with the
enrichment of common hnRNP L binding regions in genes involved in TCR and Wnt
signaling pathways and proteins involved in transcription and RNA processing.
Of particular interest is the hnRNP L-dependent regulation of TCF3, PTK2B, and
FYN, since these proteins are known to be essential for the proper development and
function of T cells. In the case of FYN, we show that hnRNP L is responsible for
promoting the preferential inclusion of the second mutually exclusive exon relative to the
first (Figure 1.6g). Inclusion of the second exon gives rise to the FynT isoform, which is
preferentially expressed in hematopoietic cells and displays altered catalytic activity
relative to FynB (including the first alternative exon)121. Mice that specifically lack the
FynT isoform have a marked defect in T cell signaling during thymic development124.
Similarly, hnRNP L promotes the expression of the hematopoiesis-specific smaller
PTK2B isoform, which exhibits a substrate profile distinct from that of the larger
isoform120. Like FYN, PTK2B is required for appropriate T cell activation by promoting
signaling through the interleukin 2 (IL-2) and LFA-1 receptors125,126,126. Lastly, the TCF3
gene encodes the E12 and E47 E-box transcription factors through alternative inclusion
of the mutually exclusive exons127. These data demonstrate that hnRNP L modulates the
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relative expression of these factors, favoring the E12 isoform. Interestingly, ectopic
overexpression of E47, as would be predicted to occur upon depletion of hnRNP L, has
been shown to cause inappropriate activation of the immunoglobulin locus in pre-T cells,
which would inhibit normal T cell development128. Therefore, while the exact
contributions of FYN, PTK2B, and TCF3 misregulation to the phenotype of hnRNP Ldeficient mice remain to be tested, changes in the splicing of any of these proteins upon
depletion of hnRNP L in thymocytes could be sufficient to explain the developmental
defects observed in vivo41.
Finally, in addition to the identification of new targets of hnRNP L-dependent
splicing regulation, I also find enrichment of 3′ UTRs among the hnRNP L binding sites,
suggesting that hnRNP L may play a more widespread role in the regulation of 3′-end
processing or miRNA binding than was suggested by the few instances reported
previously54,54,90. I also observe binding of hnRNP L outside of protein-coding genes.
While the majority of these interactions are isolated events, such binding may indicate
additional activities of hnRNP L in the maturation of noncoding RNAs or the control of
antisense transcription. In sum, the spectrum of binding events we identify here by CLIPseq is fully consistent with known and predicted activities of hnRNP L, has identified
several new targets of hnRNP L splicing regulation among genes critical for T cell
development and function, and underscores the scope of the functional interactions of
this abundant protein with a diverse repertoire of RNAs in T cells.
Because T cell activation by antigens is an essential component in T cell
physiology, we analyzed both the binding and splicing activities of hnRNP L in both
resting and activated T cell states. Proper protein expression in these two cell states is
critical for maintaining appropriate functioning of the immune system. Aberrant protein
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expression in resting cells can lead to hyperproliferation and autoimmunity, while
incorrect protein expression in activated T cells hinders the body's ability to respond to
foreign antigens. Previously, our lab has identified ∼180 exons for which inclusion is
significantly regulated upon T cell stimulation107. While there is no evidence that the
activity of hnRNP L is altered in response to T cell activation or directly drives these
activation-induced changes in splicing, this protein has been shown to critically influence
the expression of at least three of these exons (CD45 exons 4 to 6) in both resting and
activated T cells. Furthermore, loss of hnRNP L-dependent repression of these exons
contributes to autoimmune defects129,130,130.
Importantly, I find common sites for hnRNP L binding around CD45 (PTPRC)
exons 4 to 6 under all four cell conditions tested here (Figure 1.3d). I also observe
common hnRNP L binding sites in 25 other signal-regulated genes, including 4 for which
we have validated the function of hnRNP L in regulating exon inclusion in at least one
cell state (the genes for TAK1, PTK2B, LUC7L, and FYN [Figure 1.4 and 1.6]).
Interestingly, in three of these cases (TAK1, LUC7L, and FYN), depletion of hnRNP L is
observed to influence splicing only under one cell condition, despite the fact that robust
binding is observed under both conditions. Such condition-specific function was also
observed for hnRNP L-dependent regulation of Bcl11A and SS18 despite the presence
of common binding sites. Importantly, condition-specific effects of hnRNP L depletion are
an expected result due to the combinatorial regulation of splicing. In other words, most
splicing events are determined by the interplay of multiple regulatory proteins. Therefore,
the requirement for any one protein is influenced by the presence or absence of other
proteins. For instance, the stimulation-specific requirement for hnRNP L in repressing
the LUC7L exon likely reflects the presence of a more efficient repressor protein that
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specifically associates with LUC7L in resting cells and compensates for the loss of
hnRNP L under resting conditions. Alternatively, condition-specific effects of hnRNP L
might reflect regulation of the intrinsic activity of hnRNP L upon T cell activation,
although such regulation has not been described and would have to be gene specific.
Finally, in addition to the correlation of common binding sites with conditionspecific function in some cases, I also detect a subset of binding sites that are apparent
only in resting or stimulated T cells and cannot be explained solely by differences in the
availability of transcripts. Notably, there are ∼40 genes with condition-specific binding
events among the previously defined signal-responsive splicing targets. While further
study will be required to determine the biological relevance of these and other apparently
condition specific binding sites, I note that a subset of hexamers enriched among the
JSL1 stimulation-specific binding sites are distinct from the typical CA repeat element
and are not enriched in the resting-state-specific or total binding site sets. Interestingly,
these stimulation-specific hexamers contain motifs, such as TCT repeats and poly(C)
elements, similar to those of known binding sites of other hnRNPs, such as PTB (hnRNP
I) and hnRNP K and hnRNP E2, respectively89. Therefore, it is possible that hnRNP I, K,
or E2 directs at least a subset of hnRNP L binding events in stimulated cells. I also note
the possibility that stimulation of T cells results in a posttranslational modification(s) of
hnRNP L that alters its binding affinity and/or specificity. While such regulation of hnRNP
L binding has not been reported in T cells, at least two reports have suggested that
phosphorylation of hnRNP L in other cell types can alter its ability to recognize specific
RNA target sequences131,132,132. I emphasize, however, that less than 10% of the total
binding events detected for hnRNP L appear to be condition specific, and this number
decreases further with increased stringency of peak calling. Therefore, whatever
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mechanism(s) is at play to direct condition-specific binding of hnRNP L, the majority of
hnRNP L interactions remain unaffected, underscoring the consistency of hnRNP L
association with the transcriptome in both resting and activated T cells.
An inherent limitation of CLIP-seq analysis is that the method identifies physical
interactions but provides no information regarding function. Therefore, a challenge in
moving forward from such studies is how to identify which physical interactions are
meaningful for any given function of interest. In some cases, “RNA maps” have been
constructed to correlate binding location with splicing function; however, the construction
of these maps requires knowledge of a large number of functional targets, so they are
not suitable for de novo discovery. Furthermore, our lab and others have shown
previously that hnRNP L can function as an enhancer or a repressor from similar
locations within an exon44,44,90, suggesting that location is not a primary determinant of
hnRNP L splicing activity. Indeed, simply scoring for proximity of a conserved hnRNP L
binding site to a known alternative exon provided only ∼50% confidence of hnRNP Ldependent splicing.
As an alternative approach to better prediction of binding sites that correspond to
splicing regulation, I scored a range of features of the first 28 test exons I investigated
for hnRNP L-dependent splicing regulation and found that the strength of the 5′ss of the
alternative exon was the strongest predictor of hnRNP L activity. Using this criterion, we
then identified another eight targets of hnRNP L-regulated splicing, with a positive
predictive value of ∼70%. Interestingly, 3 of the 4 alternative exons that were not
regulated by hnRNP L despite a low 5′ss score were flanked by introns that were each
>10 kb long, whereas all of the hnRNP L-regulated exons were flanked by at least one
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intron of <9 kb. Therefore, intron length may provide additional predictive power in
identifying targets of hnRNP L splicing regulation.
In addition to the predictive power of 5′ss strength, the fact that this feature
correlated best with hnRNP L-regulated splicing has important mechanistic implications.
Previously, our lab has shown that 5′ss strength influences the ability of hnRNP L to
regulate a model exon and that at least one mechanism by which hnRNP L acts is
remodeling of the interaction of the U1 snRNA with the 5′ss region44,46,46. Interestingly, I
have identified 26 hnRNP L-bound exons within our CLIP data that have the sequence
hallmarks of the U1 remodeling mechanism, including the exon in PUM2 that we have
validated as strongly repressed by hnRNP L (Figure 1.4b). Therefore, these CLIP data
provide further evidence of the importance of 5′ss identity in the mechanism by which
hnRNP L regulates T cell biology, and they set the stage for further investigation of the
determinants of hnRNP L binding and function.
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CHAPTER 2 -DISCOVERY OF hnRNP L-REGULATED ALTERNATIVE SPLICING
WITH RASL-seq and mRNA-seq

Introduction

We previously reported an analysis of transcriptome-wide hnRNP L-RNA
interactions in cultured and primary human T cells133. These data provide detailed
insights into the landscape of hnRNP L physical target pre-mRNAs, but the overlap
between physical and functional targets is not complete: many pre-mRNAs with hnRNP
L CLIP-seq peaks within and around alternative exons demonstrated no splicing
changes upon hnRNP L depletion by RT-PCR validation experiments. Similarly, as
hnRNP L cross-regulates other splicing factors134 including the hnRNP L-regulated
alternative splicing events in PUM2, ZRANB2, HNRNPC, and LUC7L which were
discovered through our CLIP-seq analysis, the potential for indirect effects on splicing
following hnRNP L depletion create a situation in which binding does not necessarily
implicate splicing regulatory function nor vice versa. These dual, reciprocal caveats
have motivated the development of integrative genomics approaches that combine
CLIP-seq and mRNA-seq experiments to separate potentially direct splicing regulatory
targets from potentially indirect targets33,33,62,62,118,118,135.
The integrative genomics approach relies on genome-wide identification of
splicing regulatory targets of the splicing factor under study. Early splicing regulatory
studies utilized microarray technology, an early breakthrough in transcriptomics79. One
of the major limitations of microarray studies is the inability to discover alternative
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splicing events that do not have oligonucleotide probes specifically designed to them.
Our discovery of an unannotated poison exon in the CCAR1 pre-mRNA whose inclusion
is regulated by hnRNP L133 underscores the importance of de novo discovery capability
in the analysis of hnRNP L splicing regulatory function. Technological advances in nextgeneration sequencing have made RNA sequencing affordable in recent years, and this
technology has found application in comparative analysis of RBP-depleted and mockdepleted transcriptomes, spurring a wave of software development efforts aimed at
applying statistical analysis to splicing changes observed between RNA-seq
datasets85,86,86. These experiments typically involve depletion or overexpression of the
protein under study followed by RNA extraction, RNA-seq library preparation,
sequencing, alignment, and analysis of aligned reads. Statistical analysis of quantitative
changes in splice junction utilization between two sample groups can identify alternative
splicing events that are significantly responsive to protein depletion or overexpression,
providing evidence that those splicing events could be under direct or indirect control by
that protein.
I previously described the discovery of novel hnRNP L-dependent splicing
regulation in pre-mRNAs encoding proteins with important roles in T cell biology133. The
discovery of these events by CLIP-seq analysis coupled with the generally low overlap
between binding and function observed in integrative genomics studies62 suggests that
there could exist a plethora of hnRNP L-responsive alternative splicing events which
CLIP-seq will not reveal. Additionally, indirect regulation of splicing events, while
incapable of revealing mechanistic insights into regulated alternative splicing by hnRNP
L-RNA interactions, can unveil the role hnRNP L plays in an interconnected network of
splicing regulators.
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While recent software advances have made statistical comparisons of splicing
between RNA-seq libraries possible, analyses still must be tailored to fit the specifics of
the experiment. RNA-seq specific splicing analysis software such as MATS, the
Multivariate Analysis of Transcript Splicing86, provide many parameters which must be
fine-tuned, including null hypothesis cutoffs, replicate composition, variance estimation,
and scoring metrics. While little objective evidence exists to guide the optimization of
these parameters, utilization of a Gold Standards RT-PCR dataset allows analysts to
converge upon the set of parameters to software such as MATS that generates
predictions in maximal agreement with previously generated RT-PCR results. To this
end, our lab has previously generated a large dataset of RT-PCR validations for PMAresponsive splicing in JSL1 T cells107. I leverage the power of this PMA-responsive
dataset to optimize an analysis of hnRNP L from RNA-seq datasets and apply these
parameters to generate splicing predictions of high positive predictive value.
While RNA-seq provides high breadth-of-coverage across transcriptomes,
spliced junctions represent a minority of the sequence space in aligned RNA-seq reads.
For this reason, RNA-mediated oligonucleotide Annealing, Selection, and Ligation
followed by next-generation sequencing (RASL-seq) was developed by Fu lab at UCSD
to provide high sequencing depth at splicing junctions known to be alternatively utilized
in various conditions such as development136. Our lab has employed RASL-seq to study
regulated splicing events that respond to other treatments such as CELF2 depletion,
demonstrating the utility of this approach in uncovering alternative splicing events
responsive to depletion of RNA binding proteins in our JSL1 T cells. In this chapter, I
combine the breadth of RNA-seq with the depth of RASL-seq to provide an additional
dimension to the discovery of hnRNP L-regulated alternative splicing events, a process
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that overcomes the shortcomings of both experiments by combining their
complementary advantages as discovery tools.
This complementary next-generation sequencing design uncovers a wide scope
of hnRNP L-responsive alternative exon utilization in T cells with high rate of RT-PCR
validation. Target transcripts are enriched for splicing factors, transcription factors, and
epigenetic factors, but hnRNP L depletion does not induce global or subglobal
differential gene expression. Finally, these data, coupled with the CLIP-seq analysis I
previously reported133 provide the foundation for integrative genomic analysis.

Results
To identify the impact of hnRNP L transcriptome-wide in pre-mRNA processing in
these cells, our lab employed a complementary genomics approach to provide high
depth- and breadth-of-coverage across the JSL1 transcriptome of hnRNP L-depleted or
mock-depleted cells. I first performed hnRNP L depletion using an antisense morpholino
oligonucleotide (AMO, see Materials and Methods), reducing hnRNP L protein levels by
~50% (figure 2.1b, Western blot). To generate high breadth-of-coverage sequencing
data, I utilized paired-end mRNA sequencing to query splicing junctions from AMOtransfected or mock-transfected RNA extracts. The resulting aligned sequence read
pairs provide transcriptome-wide coverage, facilitating discovery of previously unknown
hnRNP L-responsive pre-mRNA splicing events.
A technician in our lab, Michael Mallory, subsequently developed JSL1 T cell
sublines stably transduced with a lentivirus containing a doxycycline-inducible shRNA
directed against the HNRNP L transcript. Using this distinct knockdown approach, he
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depleted hnRNP L in both unstimulated (resting) and PMA-stimulated cells, providing
independent physiological conditions for the identification of hnRNP L-responsive premRNA processing events (figure 2.1a). The lentiviral knockdown approach also
depleted hnRNP L protein levels by ~50% (figure 2.1b), which, taken together with the
AMO knockdown strategy, provided a robust experimental design with independent
mechanisms of action.
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Figure 2.1. Complementary high-throughput sequencing approaches identify
hnRNP L-dependent alternative splicing events in JSL1 T cells. a.) Experimental design in
which unstimulated and stimulated JSL1 T cells were independently depleted of hnRNP L by prior
to RNA and protein extraction. b) Western blot of hnRNP L depletion by AMO or lentiviral
shRNA. c.) Regression analysis comparing cassette exon inclusion changes for significant
predictions from RASL-seq and mRNA-seq. d.) Scatterplot of inclusion level changes between
unstimulated and stimulated conditions by both sequencing methods. e.) RT-PCR validation of
splicing predictions. (Panel b courtesy of Michael Mallory.)
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To increase sequencing depth at known alternative splice junctions, we
collaborated with the laboratory of Dr. Xiang-Dong Fu at UCSC, who prepared RASLseq libraries from induced or uninduced lentiviral shRNA-transduced JSL1 cells. Taken
together, the resulting datasets generated high breadth-of-coverage from the mRNA-seq
aligned reads, querying over 70,000 splice junctions, and high depth-of-coverage across
the splice junctions queried by RASL-seq (table 2.1).
Experiment

Total reads

Junction pairs
queried

RASL-seq
RNA-seq

67,264,257
403,942,906

3,287
70,546

Reads per
junction pair
(median)
59
13

Reads per
junction pair
(m.a.d.)
87
19

Table 2.1. Sequencing depth by RASL-seq and mRNA-seq. Total reads generated for
each experiment, the total count of unique junction pairs queried by analysis of aligned reads,
and median with accompanying median absolute deviation (m.a.d.) are provided for each
experiment. RNA-seq reads per junction pair were generated by the Tophat aligner (see
Materials and Methods) and reported in the MATS output.

To analyze splicing changes from RNA-seq data, I utilized the unstimulated and
stimulated conditions that were not subject to hnRNP L depletion to optimize the positive
predictive value as measured by existing RT-PCR data. Specifically, the lab has
previously generated 169 “gold standard” RT-PCR results for cassette exon inclusion
levels in unstimulated and stimulated conditions. These gold standard RT-PCR results
are performed in at least triplicate replications, and include exons that exhibit statistically
significant (p < 0.05, T-test) and large magnitude (inclusion level change of at least 10%
in either positive or negative direction) inclusion changes, as well as a cohort of negative
results for exons that do not exhibit stimulation-responsive inclusion level changes. In
total, there were 27 exons with stimulation-inducible exon skipping (deltaPSI <= -10), 25
exons with stimulation-inducible inclusion (deltaPSI >= 10), and 117 remaining RT-PCR
results that were considered as negative (figure 2.2). Importantly, this gold standard RT78

PCR validation dataset contains a much broader set of RT-PCR results than I and others
in the lab have generated for hnRNP L-responsive alternative splicing, therefore I used
this dataset to optimize the computational parameters for splicing analysis from mRNAseq data.

Figure 2.2.
Stimulation-responsive
RT-PCR results for 169
exons used as gold
standards for optimization
of RNA-seq detection of
alternative splicing.
Histogram displaying count
of exons at each inclusion
level change (deltaPSI)
observed by RT-PCR. Red
indicates the bins (width
equal to 1 deltaPSI) with
deltaPSI <= -10, indicating
decreased inclusion upon
stimulation. Green indicates
the bins with deltaPSI >=
10, indicative of increased
inclusion upon stimulation.

I utilized the MATS algorithm86, a multivariate Bayesian splicing analysis
program, to quantify exon inclusion changes between sample groups and their
associated statistical significances. While MATS has been demonstrated to provide
accurate alternative splicing predictions in other datasets, the values of parameters
available for the algorithm need to be fine-tuned to a given sequencing dataset to
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account for variations in sequencing depth, variance between samples within sample
groups and between sample groups, and experimental design. By utilizing an
exhaustive sampling of combinations of different parameters that MATS uses to identify
splicing targets, I generated a total of 88 different MATS analyses for stimulationinduced alternative splicing. I then utilized the 169 gold standard RT-PCR results to
evaluate each of these different MATS analyses. I first extracted the positive and
negative predictions from each analysis and scored these as True Positive (TP), False
Positive (FP), True Negative (TP), or False Negative (FN). I then used these values to
construct confusion matrices and extract confusion matrix-derived signal detection
metrics, including positive predictive value (PPV, True Positive divided by the sum of
True Positive and False Positive), negative predictive value (NPV, True Negative divided
by the sum of True Negative and False Negative), and overall accuracy (ACC, the sum
of True Positive and True Negative divided by the sum of all predictions). By comparing
the 88 different MATS analyses, I identified the set of parameters (see Materials and
Methods) that led to the highest PPV and ACC, achieving a positive predictive value of
93% and an overall accuracy of 80% (figure 2.3). This set of MATS parameters was
then used to identify hnRNP L-responsive splicing in response to hnRNP L knockdown.

Figure 2.3. Confusion matrix for the MATS invocation that led to the highest PPV
and ACC. These data indicate that if this MATS analysis had been used to generate positive
predictions that were then tested by RT-PCR, a validation rate of 93% would be achieved.
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Applying the optimized MATS parameters to the analysis of hnRNP L-depleted
and mock-depleted sample groups in both unstimulated and stimulated growth
conditions allows discovery of transcriptome-wide alternative splicing mediated by
hnRNP L. While the degree to which these optimized parameters allows generalization
across different RNA-seq analyses, the fact that the parameters were optimized for
detection of alternative splicing within the RNA-seq samples I generated and yielded the
highest degree of Positive Predictive Value as established by RT-PCR validation within
our lab, this set of parameters is evidence that these parameters are indeed optimal for
the detection of hnRNP L-responsive alternative splicing. I applied inclusion level and
significance filters to subset alternative exons that exhibit an inclusion level change of at
least 10% in either positive or negative directions upon hnRNP L depletion, with an
accompanying p-value less than 0.05. This analysis identifies 814 and 630 hnRNP Lresponsive cassette exons in unstimulated and stimulated cells, respectively.
Additionally, I extracted a subset of cassette exons that do not respond to hnRNP L
depletion by applying maximal inclusion level change constraints of 3% and excluding
any exons with a p-value less than 0.05. This analysis identifies a set of 33,489 and
26,792 cassette exons in unstimulated and stimulated conditions, respectively. These
results demonstrate that hnRNP L regulates inclusion of a specific subset of exons, with
a much greater population of exons exhibiting no significant changes in inclusion.
In order to complement the high breadth-of-coverage provided by mRNA-seq
data, we analyzed RASL-seq data generated by our collaborators at UCSD in the Fu lab
(table 2.1). RASL-seq utilizes a custom-designed pool of splice-junction directed
oligonucleotide probes that anneal across utilized junctions in RNA samples.
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Subsequent capture of annealed oligonucleotides followed by high-throughput
sequencing allows accurate quantification of relative junction utilization across matched
probe pairs. Utilizing this technology, the Fu lab quantified over 5,500 junction pairs
using a probe pool they have previously designed to known alternative splicing junctions.
The Fu lab provided initial processing of the sequence reads, extracting junction pair
read counts. We then further analyzed these data by excluding junction pairs that had
fewer than 10 reads on average across replicates, resulting in 3,286 junction pairs to
analyze. I applied identical deltaPSI and p-value constraints to these junction pairs,
generating a total of 111 and 77 cassette exons with significant hnRNP L-responsive
inclusion level changes in unstimulated and stimulated JSL1 cells, respectively.
I then developed a bioinformatics pipeline to integrate splicing data from RASLseq and the PPV-optimized MATS RNA-seq analysis to identify cassette exons that
exhibit hnRNP L depletion-responsive inclusion changes of at least 10 deltaPSI, where
positive deltaPSI is evidence of increased exon inclusion in hnRNP L-depleted versus
mock-depleted transcriptomes. Importantly, deltaPSI estimates obtained from both
sequencing studies are included for exons queried by both experiments. Statistically
significant alternative splicing predictions from both experiments were well correlated in
both unstimulated (p=7.45e-16) and stimulated (p=7.41e-13) conditions (figure 2.1c),
despite the technical differences between RASL-seq and mRNA-seq. I observed an
even higher degree of correlation between the two cellular conditions within each
experiment (figure 2.1d), providing evidence that hnRNP L-regulation of alternative
cassette exon splicing is largely shared between conditions.
RT-PCR validation of 47 novel predictions of hnRNP L-responsive alternative
splicing generated an overall 72.34% validation rate, with experimentally determined
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inclusion level changes well correlated with predictions (R2 = 0.56 and 0.83 for
unstimulated and stimulated cells, respectively, figure 2.1e). Taken together, these
results demonstrate the high confidence of our splicing predictions and their utility in
identifying novel instances of hnRNP L-mediated alternative splicing.

hnRNP L regulates exon inclusion in transcription factors, epigenetic regulators,
and splicing factors
To determine the impact of hnRNP L-regulated alternative splicing in JSL1 cells, I
used GO analysis to identify functional categories enriched within the set of genes that
contains repressed exons and the set of genes within enhanced exons (table 2.2). I
observed an enrichment for RNA binding proteins among genes containing hnRNP Lenhanced cassette exons, and genes harboring repressed exons were strongly enriched
for transcription factors and chromatin modifiers.
Regulation

Category

Term

Count

P value

Fold
Enrichment

Enhanced

MF

RNA binding

15

0.0161

1.98

Repressed

BP

Transcription

54

8.17E-4

1.54

BP

Chromatin
modification

15

0.00175

2.61

BP

Regulation of
transcription

59

0.00378

1.40

MF

Transcription
regulator
activity

37

0.0116

1.49

BP

Chromosome
organization

18

0.0132

1.90
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Table 2.2. GO terms enriched in mRNAs harboring hnRNP L-enhanced or –
repressed exons compared to mRNAs expressed in JSL1 cells.

Upon observing that hnRNP L represses exon splicing in transcripts encoding
DNA-binding proteins, I next tested the hypothesis that hnRNP L depletion results in
differential gene expression. Using mRNA-seq aligned reads, I employed a normalized
linear model implemented in the limma package for the R statistical language to identify
transcripts that exhibit at least a 1.5 log2 expression difference between hnRNP Ldepleted and mock-depleted conditions with an accompanying p-value below 0.05
(figure 2.4b, hnRNP L depletion in unstimulated cells; figure 2.4c, hnRNP L depletion in
stimulated cells). As a positive control, I used the same analysis to identify gene
expression changes between unstimulated and stimulated cells. In agreement with prior
studies, I found a strong signature of upregulation of genes involved in T cell activation
(figure 2.5), with 4.56% of expressed genes exhibiting significant expression changes of
at least 1.5 log2 (figure 2.4a). I then performed subsequent validation of differential
gene expression estimates from RNA-seq by qRT-PCR, which demonstrated excellent
agreement between fold changes estimated by RNA-seq and fold changes observed by
qRT-PCR (R2 = 0.7, figure 2.4d), confirming the validity of this gene expression change
analysis and the ability of qRT-PCR to confirm these changes.
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Figure 2.4. Gene expression analysis of hnRNP L-responsive differential gene
expression. a.) Volcano plot of differential mRNA expression following PMA stimulation of JSL1
revealed by mRNA-seq analysis. b.) Volcano plot of hnRNP L depletion-induced differential
mRNA expression in unstimulated JSL1 cells. c.) Volcano plot of hnRNP L depletion-induced
mRNA gene expression in PMA-stimulated cells. d.) qPCR validation of PMA-induced differential
transcript levels with linear regression. e.) qPCR validation of hnRNP L depletion-induced
differential transcript levels normalized to actin.
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Figure 2.5. GO terms enriched in PMA-induced genes. Genes with expression
changes of at least 1.5 log2 that had a p-value less than 0.05 were analyzed for enrichment of
functional categories using DAVID software.

In contrast to stimulation-induced gene expression changes, applying the same
analysis to hnRNP L depletion-induced differential gene expression reveals significant
expression changes only a small subset of genes in unstimulated and stimulated
conditions (0.63% and 0.76% of expressed genes, figure 2.4b and 2.4c, respectively),
and these genes exhibit fold changes of greatly reduced ranges (compare to figure
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2.4a). Subsequent qRT-PCR analysis demonstrated little correlation between fold
change estimated from RNA-seq data and fold change observed by qRT-PCR (R2 =
0.13, figure 2.4e), which elicited gene expression change values close to zero. From
this analysis I concluded that while the differential gene expression analysis using
mRNA-seq data is capable of sensitively and specifically identifying gene expression
changes as demonstrated by the stimulation-responsive genes, hnRNP L depletion does
not result in gene expression changes of high magnitude, and qRT-PCR validation
demonstrates that gene expression changes are not discernible from zero.

Discussion

I report here an analysis of hnRNP L-responsive alternative splicing in JSL1 cells
that combines the high breadth-of-coverage of mRNA-seq with the high depth-ofcoverage of RASL-seq. Importantly, mRNA-seq analysis was optimized for confusion
matrix-derived signal detection metrics utilizing a set of gold standard RT-PCR data that
were generated in our laboratory from the same cell line. I find that RASL-seq and RNAseq predictions are well correlated with each other in unstimulated and stimulated cells,
and each experiment is very highly correlated between cell states. These results
demonstrate that hnRNP L splicing regulation is highly consistent between unstimulated
and stimulated T cells, in agreement with my previous finding that the majority of hnRNP
L localization is not altered upon stimulation as measured by CLIP-seq.
I identify hnRNP L-responsive alternative splicing events in transcripts encoding
RNA binding proteins, a result that is consistent with prior transcriptomics studies of
splicing factors, which often report significant cross-regulation of splicing factors62. Our
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results extend existing observations of hnRNP L-responsive splicing in the pre-mRNAs
encoding other splicing factors134 and add hnRNP L to the growing list of splicing factors
that exist not in isolation, but within a network of interconnected splicing events that work
together to control the splicing of the transcriptome.
In addition to RNA binding proteins, DNA binding proteins are enriched among
hnRNP L functional targets, including transcription factors, chromatin modifiers, and
other epigenetic regulators. This observation led me to test the hypothesis that hnRNP
L might be involved in control of gene expression. This hypothesis is supported by prior
studies linking hnRNP L to the mediator complex137, to miRNA regulation54 and to
alternative splicing in poison exons, as we discovered for CCAR1133. Interestingly, while
a computational analysis of PMA-induced differential gene expression identifies a broad
pattern of upregulated genes enriched for activation-related functional categories, the
same analysis applied to hnRNP L depletion-induced differential gene expression
identifies comparatively few genes with statistically significant gene expression changes
greater than 1.5 log2. Subsequent qRT-PCR validation of PMA-induced expression
changes provides high correlation between expression changes obtained from RNA-seq
and from qRT-PCR analyses, confirming the accuracy of the RNA-seq and qRT-PCR
analyses. However, qRT-PCR validation of hnRNP L-responsive gene expression
targets revealed little correlation between RNA-seq and qRT-PCR expression changes,
indicating the possibility that the few genes with hnRNP L-responsive gene expression
changes in the RNA-seq analysis were due to sequencing noise and/or chance variation
instead of bona fide hnRNP L regulation of gene expression.
Another possible explanation for the lack of widespread gene expression
changes in my experiments is timecourse. PMA stimulation results in engagement of
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membrane-proximal cell signaling pathways that in turn result in post-translational
modification changes, such as decreased phosphorylation of ERK1 and ERK2138, which
results in differential gene expression by activity changes induced by post-translation
modifications. In contrast, hnRNP L-responsive alternative splicing in transcription
factors and epigenetic regulators could take considerably more time to result in gene
expression changes, as the shift in isoforms induced by hnRNP L knockdown requires
nuclear export and translation into protein before these isoform shifts even manifest at
the level of the proteome. For this reason, I cannot rule out the potential for hnRNP L
regulation of gene expression in T cells, however for experimental reasons, hnRNP L
depletion cannot be carried out over a longer time course with the current technology.
Complementary next-generation sequencing approaches here reveal a broad set
of hnRNP L functional targets in T cells, however the mechanism(s) by which hnRNP L
regulates alternative splicing is only known for a handful of cases. Importantly, our lab
has previously described that hnRNP L can regulate alternative splicing in both
directions: enhancement and repression, and that a balance of multiple factors, including
co-associated proteins, splice site strengths, and location of binding may work together
to determine hnRNP L splicing regulatory activity. Knowledge of the functional targets of
hnRNP L in T cells sets the stage for integrative genomic analysis, opening new
avenues for computational dissection of the combinatorial control of pre-mRNA splicing
by hnRNP L.
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CHAPTER 3 - INTEGRATIVE GENOMIC ANALYSIS OF hnRNP L SPLICING
REGULATORY FUNCTION

Introduction
I have previously reported transcriptome-wide analyses of hnRNP L physical and
functional targets. CLIP-seq analysis revealed the landscape of hnRNP L-RNA
interactions, and RNA-seq and RASL-seq analysis has identified hundreds of exons
whose inclusion level exhibits significant changes upon hnRNP L depletion. Integrative
genomic analysis aims to combine binding and function data to provide insights into the
positional dependence of RNA binding protein occupancy on splicing regulation.
Integrative genomics techniques have been previously applied to several other
splicing factors, including members of the hnRNP and SR protein families62. This
analysis often features graphics known as RNA maps which relate the fraction of
regulated cassette exons containing a CLIP-seq peak to each nucleotide within and
around enhanced, repressed, and unresponsive exons. RNA maps are a useful
exploratory tool that provide insight into the positions of RNA binding protein interaction
from which direct regulation of splicing is likely to be achieved. Even before the
development of the CLIP-seq experiment, RNA mapping was used to relate the position
of RNA binding protein motifs to enhanced and repressed cassettes. This approach was
used to demonstrate a strategy used by the hnRNP protein PTB to repress splicing from
upstream or exonic positions and to activate splicing from downstream positions135.
These analyses demonstrate the importance of determining the positional dependence
of protein-RNA interactions on splicing regulation.
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Several important limitations to the integrative genomics approach exist. First,
the overlap between binding and function is generally low. As a consequence of this,
the majority of exons with hnRNP L CLIP-seq peaks either within or adjacent to the exon
are unresponsive to hnRNP L depletion. Conversely, the fraction of hnRNP-responsive
exons containing CLIP-seq peaks within 300nt of the exons is typically 5-10%. This
relatively low degree of overlap between binding and function is mysterious, but is likely
to arise from a combination of factors including indirect regulation of splicing, false
negative CLIP-seq sites due to low transcript expression or low mappability, false
positive functional targets due to chance variation, or other factors.
Even with the caveat that the overlap between binding and function is typically
low in integrative genomic studies, mechanistic insights can be empirically derived
through these analyses. Several important examples exist in the literature. First,
integrative genomic analysis revealed that hnRNP A1 has statistically enriched binding
within repressed exons, consistent with prior in vitro and in vivo studies of hnRNP A1
splicing regulation, which highlight a direct repressive role62. In contrast, another hnRNP
protein, hnRNP A2/B1, does not display enrichment for exonic interactions, but instead
binds on both sides of the exon. Two other hnRNP proteins, hnRNP F and hnRNP U, do
not display any enrichment for binding within or around repressed exons, but instead
have enrichment upstream of enhanced exons. These binding patterns are summarized
in table 3.1.
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Protein:
hnRNP A1

Repressor binding
pattern:
Exonic

Enhancer Binding
pattern:
none

hnRNP A2/B1

Flanking

Far upstream?

hnRNP F

None

75nt upstream

hnRNP H1

Upstream of C2?

hnRNP M

Downstream?

hnRNP U

None

Upstream, within, and
downstream
Upstream, within, and
downstream
Upstream and downstream

Table 3.1. Mechanistic hypothesis for splicing regulation by hnRNP proteins
derived from prior integrative genomics studies. RNA maps from studies that overlaid CLIPseq binding data with transcriptome-wide functional data provide empirical insights into the
locations within and around regulated exons that display increased binding relative to
unresponsive exons.

Importantly, mechanistic hypotheses can be derived from these studies. First,
hnRNP A1 is thought to act as a splicing repressor through exonic interactions, as is the
case for CD45 exon 446. In contrast, hnRNP H1 may enhance splicing through exonic
interactions. hnRNP A2/B1 displays enriched binding upstream of and downstream of
repressed exons but not within the exons, consistent with a loop-out model in which
hemophilic protein interactions bring the upstream and downstream RNA regions into
close proximity, occluding the exon and its splice sites in a loop. hnRNP M displays
markedly increased binding upstream of, within, and downstream of repressed exons
(table 1), indicative of a mechanism in which the protein first binds to a high-affinity site,
then through hemophilic protein-protein interactions spreads across neighboring RNA
regions to occlude splice sites. While these hypotheses are purely empirical, they
provide valuable insight that may guide detailed biochemical studies.
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While other hnRNP proteins have been studied with integrative genomic
analysis, important features such as splice site strengths are rarely included. Prior
studies by our lab have implicated splice site strengths as important determinants of
hnRNP L splicing regulation. In this chapter, I extract additional combinatorial features
such as splice site strengths and exon/intron lengths to provide insights into the
mechanisms by which hnRNP L positively and negatively regulates alternative splicing in
a combinatorial manner.
We have previously described dozens of validated cases of hnRNP L-regulated
alternative cassette exon splicing, however the mechanisms by which hnRNP L directly
or indirectly regulates these functional targets remain unknown. Additionally, prior
studies have demonstrated that location of interactions, splice site strengths, and coassociated proteins establish combinatorial control of splicing by hnRNP L. In this
chapter, I use integrative genomic analysis to combine binding and functional data to
generate mechanistic hypotheses about how hnRNP L positively and negatively
regulates exon inclusion.
Importantly, I find that hnRNP L is enriched for binding within, upstream of, and
downstream of repressed exons. In contrast, hnRNP L-enhanced exons do not display
enrichment of hnRNP L interactions, suggesting indirect regulation. Importantly, hnRNP
L-enhanced exons are flanked by short, GC-rich introns and are characterized by
decreased nucleosome occupancy. These results indicate a possible epigenetic
mechanism by which hnRNP L enhances splicing.
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Results

Like other splicing regulatory proteins, hnRNP L can both enhance and repress
alternative exon splicing, but the mechanisms by which these opposing regulatory
functions may be effected by hnRNP L remain unclear. To investigate the features that
distinguish enhanced from repressed exons in our splicing predictions, I first compiled an
RNA map of hnRNP L-enhanced and –repressed exons, comparing to a stringentlydefined set of unresponsive exons that meet the requirement of an inclusion level
change (deltaPSI) of less than 3% in either direction as well as a p-value greater than or
equal to 0.05. To provide an additional level of stringency, the unresponsive exons were
required to meet these cutoffs in both unstimulated (resting) and stimulated cells, and
additionally these exons must have been queried by both RASL-seq and RNA-seq,
meeting the stringent criteria in both experiment. This represents the highest level of
stringency I can apply to define hnRNP L-unresponsive exons, and these requirements
resulted in a set of 250 unresponsive exons.
Prior analyses have suggested that splice site strength plays a role in hnRNP Lregulated alternative splicing44,133,133. To compare splice site strengths among
responsive and unresponsive cassettes, I extracted splice site scores using the
MaxEntScan algorithm for each of the four splice sites in cassettes (Figure 3.1). I
observed that both repressed and enhanced exons have weaker 3’ splice sites (3’ss)
than those found in unresponsive cassettes (repressed p=0.0293, enhanced p=6.51e-6,
t-test), and that enhanced exons have even weaker 3’ss than repressed exons
(p=0.013). This analysis demonstrates a critical role for 3’ss in determination of both the
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responsiveness and the directionality of response to hnRNP L depletion, confirming prior
studies.

Figure 3.1. Splice site strengths in hnRNP L-responsive and –unresponsive
cassettes. Splice site sequences for the four splice sites in hnRNP L-responsive or –
unresponsive cassettes were scored with the maxEntScan method. Plots are arranged from left
to right in 5’ to 3’ order: a) the 3’ splice site of the C1 exon, b) the 5’ splice site of the alternative
exon, c) the 5’ splice site of the alternative exon, and d) the 3’ splice site of the C2 exon.

Given our prior observation that hnRNP L can repress and enhance splicing of
exons that have CLIP-seq binding sites upstream and/or downstream of the exon, I next
investigated the possibility of positional dependence of hnRNP L occupancy on splicing
outcomes by overlaying hnRNP L CLIP-seq data within and around splice sites within
cassettes, a computational technique known as RNA mapping (figure 3.2). By
computing the fraction of repressed exons occupied by hnRNP L CLIP-seq binding sites
at single-nucleotide resolution and comparing to unresponsive cassettes, I observed a
marked increase in hnRNP L occupancy 100nt upstream and 40nt downstream of
alternative exons’ 3’ss. I also observed increased hnRNP L occupancy downstream of
the exons’ 5’ss, demonstrating that hnRNP L repression is associated with protein-RNA
interactions in exonic and exon-proximal intervals. A similar comparison of enhanced
exons to unresponsive exons demonstrates that a lower total fraction of enhanced
cassettes contain hnRNP L CLIP-seq binding sites at any given position, and the overall
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pattern is similar to unresponsive exons. This analysis provides evidence that hnRNP L
directly represses alternative exon inclusion through exonic and exon-proximal proteinRNA interactions, and that enhancement is not associated with an enrichment of hnRNP
L occupancy within these RNA regions.

Figure 3.2. Positional dependence of hnRNP L splicing regulation: the hnRNP L
RNA map. The fraction of hnRNP L-responsive and –unresponsive cassettes containing hnRNP
L CLIP-seq peaks is plotted at nucleotide resolution separately for (a) hnRNP L-repressed
cassettes and for (b) hnRNP L-enhanced cassettes. Unresponsive cassettes (gray) are plotted
as a negative control.

As exon and intron length have both been implicated in exon inclusion and
alternative splicing139, I compared intron and exon lengths in hnRNP L-responsive and –
unresponsive cassettes (Figure 3.3). Surprisingly, I observed that the introns upstream
(I1) or downstream (I2) of enhanced exons are significantly shorter than those flanking
repressed exons (I1 p=0.00077, I2 p=0.03924, t-test). Additionally, both types of
regulated cassettes have longer alternative exons than unresponsive exons (repressed
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p=0.0157, enhanced p=0.04451). These data indicate alternative exon length as a
potential feature involved in hnRNP L regulation of alternative exon inclusion and
implicate intron length as a feature that differentiates repressed from enhanced
cassettes.

Figure 3.3. Exon and intron lengths in hnRNP L-responsive and –unresponsive
cassettes. Lengths of exons and introns (intron lengths expressed as log10) for the 5 exons and
introns are plotted from left to right in 5’ to 3’ order: a) C1 exon length, b) I1 intron length, c)
alternative exon length, d) I2 intron length, and e) C2 exon length. Statistical hypotheses were
tested using non-log-transformed lengths.

Having observed a spatial hnRNP L binding signal within and around repressed
but not enhanced exons, I applied a statistical analysis to the upstream, exonic, and
downstream intervals around hnRNP L-responsive and –unresponsive exons (figure
3.4). I observed a statistically significant increase in the fraction of L-repressed exons
containing at least one CLIP-seq site within the exon or within the exon-proximal
upstream or downstream 300nt regions when compared to unresponsive or enhanced
cassettes (p < 0.001 for all comparisons between repressed and any other sample
group). In contrast, enhanced cassettes are not enriched for hnRNP L occupancy in any
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of these regions, even when the interval is widened to the entire flanking introns. These
data provide further evidence for a direct repressive role for hnRNP L from exonic or
proximal intronic positions on either side of the regulated exon.

Figure 3.4. Repression of splicing by hnRNP L is associated with exonic and
periexonic interactions. The fraction of upstream 300nt intervals, exonic intervals, and
downstream 300nt intervals containing at least one hnRNP L CLIP-seq peak is plotted for three
sample groups: hnRNP L-repressed exons, hnRNP L-enhanced exons, and unresponsive exons.

Upon observing that hnRNP L occupancy is not enriched within enhanced
cassettes, I next hypothesized that another splicing factor with hnRNP L-dependent
expression and/or activity might mediate indirect enhancement of splicing. To examine
this possibility, I developed an exon-directed de novo motif enrichment strategy to elicit
sequence features enriched within and around exons after partitioning for hnRNP L
occupancy (see Materials and Methods). Importantly, this motif enrichment analysis is
specifically designed to identify motifs enriched in indirect splicing targets. First, I
extracted potential indirect splicing targets of hnRNP L by partitioning cassettes into
bound or unbound based on the presence or absence of any hnRNP L CLIP-seq binding
site within the cassette. I then compared hexanucleotide sequences enriched in
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intervals upstream of, downstream of, or within the enhanced or repressed exons
against background sequences extracted from the same regions (upstream, exonic, or
downstream) from all refSeq internal exons (see Materials and Methods). Subsequent
statistical analysis allows elicitation of potential cis-regulatory motifs that could provide
insight into the regulation of hnRNP L-responsive exons that do not have hnRNP L
CLIP-seq sites within exonic or periexonic regions of the pre-mRNA.
I found no sequences to be significantly enriched upstream of, within, or
downstream of hnRNP L-repressed exons that are not bound by hnRNP L (figure 3.5a).
In contrast, a GC-rich sequence feature was found to be enriched upstream of and
within enhanced and unbound exons (most significant hexamer is CCGCGG, logo of all
significant hexamers is displayed). A further comparison of the fraction of all hnRNP Lrepressed, -enhanced, and –unresponsive cassettes that have the GC-rich motif within
or upstream of the alternative exon demonstrates that this sequence feature is
significantly depleted in repressed cassettes.
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Figure 3.5. A GC-rich motif is enriched upstream of and within indirectly hnRNP Lenhanced exons. To investigate possible mechanisms of indirect enhancement of splicing by
hnRNP L, the cassette exons enhanced by L with no CLIP-seq peaks in the entire cassette were
first extracted (a). Sequences from upstream (-300 to -20nt), exonic (+3 to -3nt), and
downstream (+6 to +300nt) were extracted, avoiding the splice site sequences themselves.
Binomial comparison of the fraction of sequences containing at least one occurrence of each
kmer of length 6nt was performed, using cognate intervals from all refSeq internal exons as a
background. All significant hexamers were then aligned and a motif logo is presented, with the
lowest p-value from the hexamers in the mutliple sequence alignment displayed. (b) The fraction
of hnRNP L-repressed, -enhanced, and –unresponsive exons containing any of the significant
hexamers displayed in the motif logos in (a) within the upstream and exonic intervals are plotted.
Unlike in (a), the entire sets of exons are investigated, demonstrating global enrichment/depletion
of the GC-rich motifs. (c) The hnRNP L-repressed, -enhanced, and –unresponsive exons were
partitioned into by occurrence of any of the significant hexamers displayed in (a) within the
upstream and exonic intervals, and flanking intron lengths were plotted on a log10 scale.

These results demonstrate that a GC-rich sequence feature is significantly
enriched in hnRNP L-enhanced exons and significantly depleted in hnRNP L-repressed
exons when compared to unresponsive exons (figure 3.5b). Another feature that
strongly differentiates hnRNP L-enhanced exons in the shortness of the flanking introns.
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I next investigated the possibility that these two features co-occurred within the hnRNP
L-enhanced exons. I first partitioned the hnRNP L-enhanced exons by the occurrence of
any of the significantly enriched hexamers. The set of enhanced exons that contain the
GC-rich motif either upstream or within the exon indeed have shorter upstream and
downstream introns than the total enhanced exons or the enhanced exons that do not
have the motif (figure 3.5c upstream intron, figure 3.5d downstream intron). This finding
suggests an association between short introns and the GC-rich motif, as has been
previously described on a transcriptome-wide level139,140,140. In support of a global
association between this set of GC-rich motifs and short flanking introns, identical
partitioning of hnRNP L-repressed and –unresponsive cassettes also results in the
subset of both classes of cassettes that contain the motif displaying shorter flanking
introns. In sum, a GC-rich motif is enriched within and upstream of hnRNP L-enhanced
exons, and this GC-rich motif is associated with short flanking introns across all sets of
exons investigated, suggesting the motif and the shortness of introns are globally
associated in a manner that is not specific to hnRNP L-enhanced exons.
These results, combined with prior global observations of two distinct classes of
exons based on intron length and GC content139,140,140, suggest the possibility that there
is a fundamental mechanistic difference between the manner in which hnRNP Lenhanced exons are recognized by the splicing machinery, and it is this difference that
might explain the manner in which hnRNP L may enhance splicing of exons that are not
subject to direct physical interaction.
An alternative hypothesis for indirect enhancement of splicing by hnRNP L is via
another splicing factor that engages the GC-rich motif enriched within and upstream of
enhanced exons. Recent technological advancements have enabled the in vitro
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characterization of RNA binding protein recognition specificities141,142,142. I conducted a
literature search for potential RNA binding proteins that might engage the GC-rich motif
identified upstream of and within hnRNP L-enhanced alternative exons, identifying 4
candidate proteins: SRSF2 (SC35), RBM4, Y14, and FUS. A technician in our lab,
Michael Mallory, then used protein extracts from hnRNP L-depleted or mock-depleted
JSL1 cells to test for hnRNP L-responsive changes in protein level or migration.
Importantly, no consistent changes were observed in any of the 4 proteins tested,
suggesting that hnRNP L depletion does not induce changes in the concentration of any
of these RNA binding proteins.
Prior transcriptome-wide studies have identified nucleosome occupancy as a
demarcating factor for exons that are flanked by long, GC-poor introns. This type of
exon is common in the human transcriptome. However, exons flanked by short, GC-rich
introns do not display a marked increase in nucleosome occupancy when compared to
the flanking introns. To investigate the possibility that hnRNP L-enhanced exons and –
repressed exons have different patterns of exonic nucleosome occupancy, I extracted
the average %GC at single-nucleotide resolution for the same intervals examined in the
hnRNP L RNA map (figure 3.6). Consistent with the de novo motif enrichment results,
the hnRNP L-enhanced exons display increased GC content upstream of, within, and
downstream of the alternative exons. However, compared to hnRNP L-repressed exons
and to hnRNP L-unresponsive exons, hnRNP L-enhanced exons display a reduction in
the GC-content differential between the exonic and perixonic regions for the 5’ splice site
(figure 3.6a) and the 3’ splice site (figure 3.6b).
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Figure 3.6. GC architecture for hnRNP L-responsive and –unresponsive exons.
Average fraction of nucleotides that are G or C at each nucleotide for a 300nt window containing
50nt of exonic sequence and 300nt of flanking intronic sequence were separately computed for
hnRNP L-enhanced, hnRNP L-unresponsive, and hnRNP L-repressed exons. The splice donor
and acceptor nucleotides are demarcated by zero and 1 values for the GT..AG dinucleotide
sequences that are core features of the respective splice sites.

I subsequently quantified the mean %GC for equal-sized 50nt intervals on either
side of the two splice sites for enhanced, repressed, and unresponsive exons and
computed the difference between exonic %GC and intronic %GC (figure 3.7).
Importantly, I defined the downstream GC differential as mean %GC of the last 50
nucleotides of the exon (up to but not including the final 3nt of the exon that are part of
the 5’ splice site) minus the mean %GC of the first 50 nucleotides of the downstream
intron (excluding the initial 6nt of the intron that are part of the 5’ splice site). The
downstream GC differential for hnRNP L-enhanced exons is much lower than that for
repressed or unresponsive exons (1.3% versus 6.8% and 5.6%, respectively). This
suggests that hnRNP L-enhanced exons might display reduced nucleosome occupancy,
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as has been observed globally for exons flanked by short introns. It is worth noting that
the upstream GC differential was not as notably deficient for hnRNP L-enhanced exons,
although this can potentially be explained by sequence constraints imposed by
polypyrimidine tracts located upstream
of the exons.

Figure 3.7. Upstream and
downstream GC content
differentials across splice sites in
hnRNP L-responsive and –
unresponsive cassettes. Mean
%GC for 50nt intervals on both sides
of both splice sites for hnRNP Lunresponsive exons (gray), repressed
exons (red), and enhanced exons
(green) were computed as exonic
minus intronic mean %GC.

Nucleosome occupancy is a demarcating feature of human exons flanked by
long introns. Compared to flanking intronic regions, the exonic DNA of human genes
displays an increase in nucleosome occupancy as evidenced by nucleosome-sensitive
DNA sequencing methodologies such as bisulfite sequencing. This increased
nucleosome occupancy is thought to enhance spliceosomal assembly at exons that are
buried in long introns by slowing transcription. This increase in nucleosome occupancy
is associated with a pronounced GC-content cliff at the two splice sites of the exons: the
GC content of the exon is higher than its neighboring introns.
To investigate the hypothesis that hnRNP L-enhanced exons display reduced
nucleosome occupancy relative to their flanking intronic regions, I extracted nucleosome
occupancy scores for hnRNP L-enhanced, hnRNP L-repressed, and hnRNPL104

unresponsive exons from ENCODE MNase-seq data (K562 cells). In agreement with
previous studies of nucleosome occupancy, hnRNP L-unresponsive exons display
elevated nucleosome occupancy within the exon relative to the surrounding periexonic
intervals (figure 3.8). Similarly, hnRNP L-repressed exons are demarcated by increased
nucleosome occupancy, even when partitioned for absence of hnRNP L CLIP-seq peaks
(unbound). In contrast, I observed a reduction in the degree of nucleosome occupancy
in hnRNP L-enhanced exons, especially visible at the 5’ splice site, around which the GC
content differential was strikingly low for enhanced exons (figure 3.8b).

Figure 3.8. Nucleosome occupancy map of hnRNP L splicing regulation. Average
nucleosome occupancy signals at each nucleotide for hnRNP L-repressed, hnRNP L-enhanced,
and hnRNP L-unresponsive exons are plotted. Additional series for enhanced exons that have
no hnRNP L CLIP-seq peaks in the entire cassette and for repressed exons that do have at least
one hnRNP L CLIP-seq peak in the entire cassette are plotted. Nucleosome occupancy data
were extracted from ENCODE K562 cells.
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Discussion
In this chapter, I used integrative genomic analysis to explore the features that
characterize hnRNP L repressed and enhanced exons. Importantly, I identify
enrichment of hnRNP L-RNA interactions within, upstream of, and downstream of
repressed exons. This analysis suggests that hnRNP L represses splicing through both
splice sites, potentially by blocking access to splice sites by the splicing machinery,
preventing the early steps of spliceosome assembly.
In contrast to other splicing factors that have been studied by integrative
genomics techniques, hnRNP L does not demonstrate enrichment for interactions within
or around enhanced exons. This demonstrates that the majority of splicing
enhancement by hnRNP L is likely indirect. A motif enrichment approach identified a
GC-rich motif within and upstream of L-enhanced exons. While this finding initially
raised the possibility of secondary effects via another splicing factor that is itself
responsive to hnRNP L depletion, subsequent analysis demonstrated that this
hypothesis in unsupported. The technician in our lab, Michael Mallory, used western
blotting to investigate protein level of RBM4, RBM8a, SC35, and FUS in response to
hnRNP L knockdown. These candidate proteins were identified based on affinity studies
such as RNAcompete and RNA Bind-N-Seq141,142,142. Importantly, none of these proteins
demonstrated hnRNP L-responsive changes in protein level.
Transcriptome-wide analysis by Gil Ast and colleagues has identified an
association between short flanking introns and a leveled GC-architecture139. This class
of exons was found to be depleted in nucleosome occupancy when compared to exons
with long flanking introns and a well-defined GC content differential between exon and
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introns. All of these features are associated with hnRNP L-enhanced exons. This
finding raised the possibility that hnRNP L-enhanced exons are more susceptible to
alterations in chromatin because they are already poorly defined by nucleosome
occupancy. Nucleosome occupancy and the epigenetic modifications of histone proteins
play an important role in splicing outcomes, and the dynamic interrelationship between
RNA and chromatin is a subject of increasing appreciation.
Recent work in the Reinberg group physically and functionally links hnRNP L to
histone methylation. The human Set2 complex, also known as the KMT3a complex, is
responsible for trimethylation of lysine 36 on the histone H3 protein (H3K36me3). This
epigenetic mark is associated with actively transcribed regions and is known to recruit
the histone deacetylase Rpd3 in yeast143. Subsequent deacetylation of open reading
frames protects against internal transcription initiation144. In humans, hnRNP L
copurifies with the C-terminal half of the KMT3a complex and is required for its
H3K36me3 activity in vivo145. Importantly, this requirement is likely physical as hnRNP
L knockdown does not deplete the KMT3a complex.
The H3K36me3 modification is enriched at exon-intron boundaries in humans,
suggesting that this modification marks exons within gene bodies146. The finding that
hnRNP L depletion globally reduces the H3K36me3 modification suggests a functional
link between transcription of nascent pre-mRNA and the H3K36me3 mark that
demarcates exons by hnRNP L. I hypothesize that hnRNP L knockdown in JSL1 T cells
reduces the H3K36me3 mark in a global manner and that hnRNP L-enhanced exons are
particularly sensitive to reduction in H3K36me3 because they are poorly demarcated by
nucleosomes in the first place and have short flanking introns. Transcription through
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these exons rapidly exposes competing downstream splice sites, which are preferentially
utilized by the spliceosome upon hnRNP L knockdown.
In sum, integrative genomic analysis provides support for a model in which
hnRNP L directly represses exon inclusion through interactions within or near exons. In
contrast, hnRNP L enhanced splicing indirectly through a potential epigenetic
mechanism. These results significantly expand our knowledge of splicing control by
hnRNP L and raise interesting hypotheses about the interplay between RNA and
chromatin.
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APPENDIX 1: INVESTIGATING DDX17-RNA INTERACTIONS IN RIFT VALLEY
FEVER VIRUS INFECTION

Introduction
In previous chapters I related how Ganesh Shankarling and I cooperated to
perform and analyze hnRNP L CLIP-seq. Specifially, my contribution was in the analysis
of the hnRNP L CLIP-seq data, including developing software pipelines for peak calling
and the use of parallel execution on grid-based compute clusters. While my focus was
on hnRNP L, it is important to note that the pipeline I developed is generalizable to other
CLIP-seq experiments. The first test and demonstration of the ability to generalize my
pipeline for the analysis of other proteins came from a collaboration with the group of
Sara Cherry to study the RNA binding of a DEAD-box RNA helicase, DDX17, that was
found in a knockdown screen to restrict the replication of an RNA virus, Rift Valley Fever
Virus (RVFV).
The CLIP library for DDX17 was prepared by Ryan Moy and Ganesh Shankarling
from human cells that had been infected with RFVF. Once sequencing of the library was
complete I carried out alignment of the reads to a metagenome index containing the
chromosomes of the human genome and the RNA segments of the viral genome, and
completed the subsequent bioinformatic analysis. To my knowledge, this is the first
demonstration of metagenomic CLIP-seq. The success of this analysis provides strong
evidence that CLIP-seq is a useful tool to investigate host-pathogen interactions,
expanding the utility of CLIP-seq as an experimental protocol.
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In this appendix, I provide a report of computational analysis of CLIP-seq data
that I carried out. This appendix, combined with the second appendix to this thesis,
provide a valuable set of comparisons: three proteins that were subjected to CLIP-seq
library preparation by the same individual, Ganesh Shankarling, and were analyzed by
the same individual, myself, with minor variations in the analysis as required by the
details of each experiment. In the concluding chapter of my thesis, I provide a
comparison between the results of the computational analysis of these three CLIP-seq
experiments with the aim of identifying key similarities and differences.

Results

Because DEAD-box helicases function as RNA-binding proteins, the Cherry lab
hypothesized that DDX17 may directly bind RVFV RNAs to inhibit viral replication. To
determine the specific RNAs bound to endogenous DDX17, Ryan Moy, graduate student
with Sara Cherry, performed CLIP-seq. Briefly, uninfected or RVFV-infected U2OS cells
were UV-irradiated, and endogenous DDX17-bound RNAs were digested to ∼100 nt
fragments, immunoprecipitated from cell lysates with anti-DDX17 or anti-FLAG as a
control, and radiolabeled for visualization. DDX17 was efficiently depleted from the
lysates with anti-DDX17 but not anti-FLAG antibodies (Figure A1.1a). Autoradiography
of RNA-protein complexes revealed extensive signal for anti-DDX17 but not anti-FLAG
immunoprecipitations, suggesting enrichment for DDX17-bound RNAs (Figure A1.1b).
cDNA libraries were then generated from purified RNAs and submitted for Illumina deepsequencing.
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Figure A1.1. CLIP-Seq Analysis of DDX17-Bound RNAs from Uninfected and RVFVInfected U2OS Cells. (a) Immunoblot of DDX17 from uninfected or RVFV-infected U2OS cells
with immunoprecipitation (IP) using anti-DDX17 or anti-FLAG (control). Input, IP, and unbound
fractions are shown, with high efficiency of DDX17 IP. (b) Autoradiograph of immunopurified and
32P-labeled DDX17-RNA complexes transferred to nitrocellulose membrane.
Immunoprecipitation with anti-FLAG as a control shows high specificity of the DDX17-RNA signal.
(c) Flowchart of CLIP-seq alignment and processing pipeline, resulting in alignment clusters. (d)
Alignment clusters overlapping annotated regions of the genome (refSeq) were further searched
for significant peaks, and the overlap between infected and uninfected DDX17 significant CLIP-
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seq peaks (FDR < 0.001) in protein-coding genes from refSeq at increasing peak height is
plotted. R2 = 0.88. (e) Percentage of total nucleotides under significant CLIP-seq peaks within
refSeq protein-coding genes broken down into transcript feature types extracted from refSeq. (f)
Composite motif logo of the multiple sequence alignment of the 20 most enriched hexamers
under significant CLIP-seq peaks within protein-coding genes as identified by Z score, comparing
hexamer frequencies to 100 permutations of binding-site locations within bound transcripts for
uninfected (top) or infected (bottom) cells.

From three pooled DDX17-CLIP experiments, ∼80 million raw reads and ∼90
million raw reads were obtained from uninfected and infected cells, respectively (Figure
A1.1c). To process these DDX17 CLIP-seq reads, I first generated a composite genome
index incorporating the hg19 human genome and three genomic segments of RVFV (L,
M, S), with over 55% of reads aligning unambiguously to the composite genome (unique
alignments). Collapsed alignments were obtained by removing PCR duplicates and
retaining only one alignment for each 5′ coordinate. Genomic intervals with at least two
overlapping alignments were clustered together generating the alignment clusters. This
yielded 733,542 clusters for uninfected cells and 426,135 clusters from RVFV-infected
cells. Alignment clusters within human pre-mRNA loci were further searched for
significant peaks (false discovery rate [FDR] < 0.001) using an empirical algorithm147.
This analytical approach which separates significant DDX17 binding sites in human premRNAs (peaks) from potential interaction sites that are not within pre-mRNAs (alignment
clusters) is required to identify DDX17-RNA interactions that occur outside of annotated
transcripts, for instance to intergenic miRNA loci without annotated pri-miRNA transcripts
or intracellular RVFV RNAs.
DDX17 pre-mRNA peaks showed strong overlap between uninfected and
infected cells (Figure A1.1d), indicating that the overall profile of DDX17-bound cellular
RNAs is similar during infection. Next, we determined the transcript features of DDX17
pre-mRNA peaks (Figure A1.1e). Interestingly, DDX17 peaks were enriched in coding
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exons, 5′ UTRs, and 3′ UTRs, suggesting that DDX17 preferentially binds mature
mRNA. Hexamer enrichment analysis of CLIP-seq peaks within protein-coding genes
showed a bias for CT- and CA-repeat elements (Figure A1.1f). Together, these data
indicate both location and sequence preference for DDX17 binding to mRNAs.
To understand the functional targets of DDX17, I used DAVID to identify KEGG
GO terms enriched among protein-coding genes associated with DDX17 CLIP-seq
peaks. I observed enrichment for cell adhesion as well as several cellular signaling
pathways (Figure A1.2a). Intriguingly, one of the most overrepresented KEGG pathways
was mitogen-activated protein kinase (MAPK) signaling (Figure A1.2b). Previous data
suggest that MAPK-activated protein kinase 2 (MK2) physically interacts with DDX5 to
control its localization, and that DDX5/DDX17 regulate splicing of p38 MAPK148,149,149.
Thus, DDX17-bound RNAs identified in our experiments overlap with known targets in
MAPK signaling, suggesting that the CLIP-seq peaks reflect the biological activity of
DDX17.
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Figure A1.2. KEGG and GO Term and Pathway Analysis of DDX17-Bound RNAs. (a)
Plot of p values for enriched KEGG GO terms using DAVID of protein-coding genes bound by
significant DDX17 CLIP-seq peaks in either infected or uninfected cells. (b) KEGG pathway
diagram of the MAPK signaling pathway genes intersecting significant DDX17 CLIP-seq peaks.

In addition to roles in transcriptional regulation and alternative splicing, DDX17
has been linked to miRNA biogenesis. DDX5 and DDX17 are components of the
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Microprocessor complex, which processes the pri-miRNA transcript into the 60–70 nt
stem-loop intermediate known as the pre-miRNA150,151,151,152,152,153,153. Loss of DDX17
results in decreased expression of a subset but not all miRNAs152. Therefore, as further
validation of our CLIP-seq data, I also analyzed the intersection of DDX17 CLIP signal
with annotated miRNA stem loops.
I observed 160 pri-miRNA loci that were associated with DDX17 CLIP clusters.
There was strong correlation in normalized CLIP signal within pri-miRNAs from
uninfected and RVFV-infected samples (Figure A1.3a), suggesting that similar primiRNAs are bound by DDX17 in uninfected and infected cells. In contrast, I found no
correlation between CLIP-seq signal and level of miRNA expression reported in a
previous study of small RNAs in U2OS cells, indicating that DDX17 clusters represent
bias for certain miRNAs independent of expression level (Figure A1.3b). Among DDX17bound miRNAs, miR-663a, miR-99b, and miR-6087 were some of the most highly
represented miRNAs (Figure A1.3c). Analysis of DDX17 CLIP signal in relation to the
predicted pri-miRNA stem loop showed that DDX17 clusters were preferentially localized
immediately 5′ and 3′ to the center of the loop (Figure A1.3d). These data suggest that
DDX17 interactions are strongest with the stem region of the miRNA hairpin rather than
the loop. Analysis of overrepresented hexamers in DDX17-associated miRNAs did not
show any enrichment of the CA- or CT-repeat elements found with the DDX17 mRNA
peaks. Furthermore, de novo analysis of the bound pri-miRNAs identified no significantly
enriched motifs compared to total pri-miRNA background. Thus, the interaction of
DDX17 with pri-miRNAs is likely determined by RNA secondary structure.
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Figure A1.3. DDX17 Directly Binds miRNA Stem Loops in Human U2OS Cells. (a)
Normalized CLIP-seq signal (TPKM, tags per kilobase of pre-miRNA per million CLIP-seq reads)
in pre-miRNA hairpin loci with CLIP signal extracted from miRBase. Linear regression of infected
TPKM on uninfected TPKM is plotted, R2 = 0.79. (b) Scatterplot of miRNAs that are bound;
normalized pre-miRNA expression (RPKM) from small RNA-seq and the mean of normalized
CLIP-seq signal (TPKM) between infected and uninfected U2OS cells are plotted, R2 = 0.001. (c)
Alignment clusters overlapping miRBase pre-miRNA hairpin loci on the UCSC genome browser
with uninfected cells colored black and infected cells colored red. (d) RNA map of DDX17 CLIP
signal in pre-miRNA hairpins. Fraction of 160 hairpins bound is plotted at single-nucleotide
resolution relative to the center of the stem loop.

To determine whether DDX17 regulation of miRNA biogenesis is directly involved
in antiviral defense, Ryan Moy then silenced the Microprocessor component Drosha in
U2OS cells. Loss of Drosha had no impact on RVFV replication, suggesting that the
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antiviral mechanism of DDX17 is independent of Drosha and the canonical miRNA
pathway. Using luciferase reporter assays as previously described154, Ryan also found
that Rm62 is not required for siRNA- or miRNA-mediated silencing in Drosophila cells.
These data indicate that DDX17 does not act through RNAi to restrict RVFV infection.
Next, I tested whether DDX17 directly interacts with viral RNA by analyzing the
overlap of DDX17 CLIP clusters with the RVFV genome. I observed multiple DDX17
clusters, with the highest signal on the M and S segments (Figure A1.4a). These data
suggest that DDX17 binds RVFV RNA in infected U2OS cells. In addition, DDX17 viral
clustersdid not overlap with CA- and CT-repeat motifs, suggesting that DDX17-viral
interactions are not dependent on these elements.
Because viral RNAs are often highly structured and DDX17 was enriched at the
stem region of pri-miRNA hairpins, we hypothesized that DDX17 may recognize
structured elements in RVFV RNAs. Indeed, we observed a prominent CLIP cluster
within the intergenic region (IGR) on the S segment (between N and NSs). The IGR on
other ambisense bunyaviruses has been shown to form a highly complementary
sequence that folds into a hairpin to control transcription termination155. This IGR in the
RVFV antigenome similarly forms a hairpin that generates the majority of virus-derived
siRNAs in infected Drosophila and mosquito cells156. We defined a 75 nt RNA that
overlaps the largest S segment DDX17 CLIP cluster within the IGR on the genome
strand, which is predicted to form a hairpin structure that resembles miRNA stem loops
(Figure A1.4b). Ryan Moy synthesized this RNA in vitro using T7 RNA polymerase to
test whether it is bound by DDX17. Biotinylated DDX17 peak RVFV RNA efficiently
precipitated DDX17 from U2OS cell lysates in a dose-dependent manner, demonstrating
that DDX17 physically interacts with RVFV RNA and validating our CLIP-seq results
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(Figure A1.4c). In contrast, a nonspecific control from RVFV RNA not bound in our CLIPseq data set did not precipitate DDX17 (Figure A1.4d).

Figure A1.4. DDX17 Binds RVFV RNA to Restrict Viral Infection. (a) DDX17 CLIP-seq
clusters aligned to the RVFV tripartite genome, plotted 3′ to 5′ (genome orientation) along the x
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axis. Binding sites that map to the genome are below and to the antigenome are above the line.
CLIP-seq signal intensity (black) is measured in total overlapping reads at each nucleotide
position. (b) Predicted secondary structure of a 75 nt RNA from DDX17 CLIP peak on the RVFV
S segment between N and NSs as determined by RNA fold (asterisk in A). (c) The 75 nt DDX17
CLIP peak RNA from (B) was synthesized by T7 in vitro transcription and biotinylated.
Biotinylated RVFV RNA was incubated with U2OS cell protein lysates and immunoprecipitated,
and DDX17-RVFV RNA complexes were analyzed by immunoblot. (d) RNA-protein interaction
assays were performed as in (C) using the biotinylated RVFV stem loop and nonspecific control
RNA from RVFV not bound in the DDX17 CLIP-seq data set. (e) Representative immunoblot of
U2OS cells transfected with the indicated siRNAs and infected with SINV WT or SINV encoding
the RVFV hairpin (SINV-hp) 8 hpi. (f) Representative immunoblot of Drosophila cells treated with
control (β-gal) or Rm62 dsRNA and infected with SINV WT or SINV-hp 24 hpi (moi = 0.3). (g)
Representative IF images of DDX17 and RVFV N from uninfected or infected U2OS cells 12 hpi
(helicase, green; RVFV N,red; nuclei, blue). (h) Representative IF images of DDX5 and RVFV N
from uninfected or infected U2OS cells 12 hpi (helicase, green; RVFV N, red; nuclei, blue). (All
panels except for A and B courtesy of Ryan Moy.)

To determine whether DDX17 binding on viral RNA can directly restrict viral
infection, the lab of Dr. Ben tenOever cloned the RVFV DDX17 hairpin into the 3′ UTR of
SINV under the control of a subgenomic promoter (SINV-hp). This same strategy has
been previously shown to tolerate the insertion of noncoding hairpin RNAs (Shapiro et
al., 2010). We found that control cells supported substantially less infection of SINV-hp
compared to wild-type (WT) SINV (Figure A1.4e). Furthermore, whereas depletion of
DDX17 led to modest increases in SINV capsid production of WT virus, loss of DDX17
led to large increases in capsid production from SINV-hp virus (Figure A1.4e). In
addition, we tested whether this RVFV hairpin also impacted SINV replication in
Drosophila cells. WT SINV was unaffected by the loss of Rm62 (Figure A1.4f).
Moreover, as we found in human cells, control RNAi-treated cells supported less
infection of SINV-hp than WT SINV, and depletion of Rm62 led to a large increase in
SINV capsid production from SINV-hp virus (Figure A1.4f). A second DDX17 peak at the
5′ end of the S genomic segment was also predicted to form a hairpin, and cloning this
hairpin into SINV (SINV-5′hp) also sensitized the virus to DDX17 restriction in Drosophila
and human cells. Together, these data demonstrate that the presence of a DDX17119

binding site on viral RNA is restrictive and that this repression can be alleviated by loss
of DDX17 across hosts.

The Cherry lab next assessed the localization of DDX17 and DDX5 during
infection by immunofluorescence, as RVFV and SINV RNA replication occur exclusively
in the cytoplasm. RNAi was used to validate the specificity of these antibodies for
immunofluorescence. As previously reported157, DDX17 was found in the nucleus in
uninfected cells (Figure A1.4g). At 12 hpi, however, we observed some DDX17 staining
in cytosolic puncta that colocalized with RVFV nucleocapsid protein N, which coats viral
RNA and facilitates replication (Figure A1.4g). In contrast, DDX5 remained in the
nucleus in the presence and absence of infection (Figure A1.4h), suggesting a distinct
localization pattern for DDX17. Collectively, these data suggest that DDX17 may gain
access to cytosolic RVFV replication complexes during infection and bind viral RNA to
antagonize viral replication.

Discussion

This study represents one of the first applications of CLIP-seq to study RNA
helicase-RNA interactions. In this study, DDX17 was found to restrict replication of an
RNA virus through direct interactions. Importantly, we demonstrate that CLIP-seq can
be used to study interactions between a host RNA binding protein and the RNAs of an
intracellular pathogen.
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Much of the computational analysis presented in this appendix utilized core
components that I had previously developed to analyze hnRNP L CLIP-seq data. One
important difference is the alignment of reads. In this experiment, reads were aligned
against a composite metagenome index (see Materials and Methods) containing the
chromosomes of the human genome plus the three RNA segments of the Rift Valley
Fever Virus genome. This alignment strategy was developed to most closely
recapitulate the available RNA substrates for DDX17 interactions within the cell.
Notably, this alignment strategy was critical to allow discovery of the DDX17-RVFV
interaction site that, when cloned into a virus that is not restricted by DDX17, confers
restrictivity. The biological relevance of this interaction site therefore underscores the
importance of the metagenomic index technique for host-pathogen studies using CLIPseq.
As expected based on prior studies of DDX17-miRNA interactions, a subset of
expressed miRNAs were targets of DDX17 interactions in the U2OS cells under study.
Interestingly, DDX17 appears to engage the double-stranded regions of the miRNAs
preferentially over the loop region (figure A1.3d), a finding consistent with DDX17’s RNA
helicase activity in the human miRNA biogenesis pathway. This finding suggests that
the data from this study could be useful to the scientific community beyond the context of
virology and intracellular immunology. Indeed, recent studies have highlighted DEAD
box RNA helicases, including DDX17, in tumorigenesis and tumor migration.
In analyzing the human pre-mRNA features that are occupied by DDX17 CLIPseq peaks, I observed an increase in 3’UTR occupancy upon infection with RVFV (figure
A1.1e). This finding is particularly interesting because the functional significance of
DDX17-3’UTR interactions is unknown. Two hypotheses might explain this
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phenomenon. First, infection with RVFV could alter DDX17-mRNA interactions such
that an increase in DDX17-3’UTR interactions results. Alternatively, infection with RVFV
could alter the expression of genes and/or the length of 3’UTRs such that a broader
expanse of DDX17-3’UTR interaction sites is made available. While this study utilized
mRNA-seq data from U2OS cells, only uninfected cell data was available, and
investigating the potential for RVFV-dependent alterations in the host cell transcriptome
is not currently possible. However, this finding presents an exciting opportunity for
further study.
In conclusion, this study represents a fruitful collaboration between the Lynch
and Cherry labs that allowed both labs to broaden their scientific horizons. In the
Conclusion chapter of this thesis, I synthesize the CLIP-seq analyses of hnRNP L,
DDX17, and CELF2.
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APPENDIX 2: CLIP-SEQ ANALYSIS OF CELF2-RNA INTERACTIONS IN T CELLS

Introduction

We have previously demonstrated the use of CLIP-seq to analyze protein-RNA
interactions for hnRNP L and DDX17. While hnRNP L expression and activity were
found to be consistent between unstimulated and stimulated T cells, our lab has
previously described a broad pattern of stimulation-induced alternative splicing in T cells
using transcriptome sequencing107, suggesting that other splicing factors may respond to
T cell stimulation with altered activity, thus controlling the stimulation-responsive splicing
phenotype. In support of this, I previously performed motif enrichment analysis of
stimulation-responsive exons and found multiple sequence features to be enriched107,
suggestive of a network of splicing factors that control activation-induced alternative
splicing. However, the contribution of individual splicing factors to T cell stimulationinduced alternative splicing is largely unknown.
One example of activation-induced alternative splicing that our lab has studied
using biochemical techniques is LEF1 exon 6158. LEF1 is a transcription factor that
drives expression of the T cell receptor (TCR) alpha subunit159. Upon T cell stimulation,
LEF1 exon 6 inclusion is increased. Importantly, this exon encodes a portion of the
context-regulatory domain (CRD) of LEF1 that is required for optimal gene-expression
enhancer activity160. Our lab has previously demonstrated that the stimulation-induced
alternative splicing of LEF1 exon 6 is driven by the splicing factor CELF2158. CELF2
binds to UG-rich, evolutionarily conserved sequences on both sides of LEF1 exon 6.
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CELF2 expression increases upon stimulation, resulting in higher levels of CELF2
binding in these periexonic sequences. Importantly, CELF2 is an enhancer of LEF1
exon 6 inclusion because knockdown of CELF2 reduced exon inclusion.
These studies of LEF1 exon 6 suggest that CELF2 is one splicing factor that links
T cell stimulation to alternative splicing. However, the transcriptome-wide occupancy of
CELF2 is unknown. While the study of CELF2 is the chief focus of other students in the
lab, this project provided the basis for another productive collaboration in which I was
able to utilize software tools developed for hnRNP L analysis on a new protein, and one
with expression and activity that are altered by T cell stimulation.
Importantly, the post-doc in our lab that performed the CLIP-seq library
preparations for hnRNP L and DDX17 also prepared CLIP-seq libraries for CELF2 in
unstimulated and stimulated JSL1 cells. The resulting CLIP-seq reads were processed
by the same computational pipeline that was developed for hnRNP L and DDX17,
providing an ideal opportunity to compare the results of these three CLIP-seq
experiments and derive insights into common features of the CLIP-seq findings and also
unique, distinguishing characteristics of each study.

Results

To identify transcriptome-wide CELF2-RNA interactions in T cells, Ganesh
Shankarling prepared CLIP-seq libraries from unstimulated and stimulated JSL1 cells.
Importantly, these conditions are identical to those utilized in the CLIP-seq analysis of
hnRNP L. The library preparation was identical to that utilized in the CLIP-seq analysis
of hnRNP L and DDX17 except for one modification. One key step in the computational
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analysis of CLIP-seq reads is to remove PCR duplicates. When more than one CLIPseq read aligns to the same genomic locus, it is not possible to discern whether multiple
oligonucleotide fragments were present in the immunoprecipitated RNA or whether a
single fragment gave rise to multiple reads by PCR duplication. For this reason,
duplicates are entirely removed and only one alignment is allowed at each position in the
genome. This removal of PCR duplicates results in considerable reduction of the size of
the aligned reads relative to the size of the raw reads.
To compensate for this, Ganesh employed a barcoding strategy which allows
discrimination of PCR duplicates from multiple distinct RNA fragments. Before the PCR
reactions are performed, each CLIP sample is split into three aliquots and unique
hexanucleotide barcodes are ligated to each (figure A2.1). After sequencing of the
resulting libraries, each of the three barcoded aliquots from the same CLIP sample are
aligned separately to the genome and PCR duplicates are removed. Then, the three
aliquots from each sample are combined, allowing a maximum of three reads to align to
the same genomic position within each CLIP sample. This strategy aims to increase the
sensitivity of the CLIP-seq peak caller.
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Figure A2.1. Triplicate barcoding strategy for CELF2 CLIP-seq. Unstimulated and
stimulated sample groups of JSL1 cells were subjected to UV crosslinking (top) in triplicate. After
immunoprecipitation of CELF2-RNA complexes and isolation of fragmented RNAs, each replicate
was split into three identical aliquots before PCR amplification (only one sample is diagrammed).
Each aliquot was ligated to a different oligonucleotide barcode. Reads from each uniquelybarcoded aliquot were separately aligned to the genome and PCR duplicates removed,
generating “collapsed alignments” (middle). Finally, each aliquot’s unique alignments were
combined to recreate the individual replicates, a process which allows a maximum of three reads
to align to the same genomic position (bottom).

In total, 277 million raw reads were generated, from which 122 million were
mapped to the human genome (figure A2.2a). Removal of PCR duplicates left 7.8
million alignments remaining, suggesting a high degree of duplication in the aligned
reads. Importantly, although only a small fraction of the human genome is contained
within the refSeq annotation, almost all CELF2 CLIP-seq reads aligned to portions of the
human genome contained within the refSeq annotations. Subsequent combining of the
aligned reads (as demonstrated in Figure A2.1) allowed me to identify 49,962 significant
CELF2 peaks in unstimulated JSL1 cells and 52,249 peaks in stimulated cells. These
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peaks were subjected to further analysis using software tools developed for hnRNP L
CLIP-seq.

Figure A2.2. Summary of CELF2 CLIP-seq analysis. a) Total counts of raw reads,
unique alignments (reads that aligned to one and only one position in the hg19 build of the human
genome), collapsed alignments (unique alignments that have had PCR duplicates removed), and
collapsed alignments within refSeq transcriptome annotation are displayed. Total numbers of
CLIP-seq peaks identified by an identical algorithm to that used in the analysis of hnRNP L CLIPseq experiments are also displayed (see Materials and Methods). b) Barplot of the fraction of
nucleotides covered by CELF2 CLIP-seq peaks in unstimulated and stimulated JSL1 T cells
occupying each of five categories of annotation.

First, I examined the fraction of the total genomic footprint covered by CELF2
CLIP-seq peaks is annotated as 5’UTR, 3’UTR, exon, proximal intron (within 300nt of an
exon), or distal intron. For this analysis, I used the refSeq transcriptome annotation, as
was performed for hnRNP L CLIP-seq analysis. Importantly, the CLIP-seq peak caller
only searches refSeq transcripts for peaks, so every nucleotide covered by CELF2 CLIPseq peaks may be uniquely classified under these five categories. By comparing the
fraction of nucleotides under CELF2 CLIP-seq peaks within each of these five categories
to the fraction of the total refSeq transcriptome annotation that is composed of each
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category, a relative enrichment for 3’UTR interactions is evident (figure A2.2b). This
enrichment of CELF2 for 3’UTR interactions is potential evidence of a broader role for
CELF2 in 3’ end processing or splicing within 3’ UTRs. Interestingly, CELF1, a related
RNA binding protein from the same Elav-like factor family (CELF family), binds to GUrich elements in the 3’UTRs of human mRNAs to trigger mRNA decay161. A recent
CLIP-seq analysis of CELF1 in mouse cardiac tissue similarly identified enrichment of
CELF1 CLIP-seq peaks within 3’UTRs162. Taken together, these results suggest that
CELF2, similar to CELF1, is enriched for 3’UTR interactions, and suggests a possible
interplay between CELF2 and mRNA stability. This is particularly interesting given that
CELF2 is strictly nuclear in localization, while CELF1 resides in both cytoplasmic and
nuclear protein fractions in JSL1 cells.
To identify enriched motifs within CELF2 CLIP-seq peaks, I used the Z-score
motif enrichment algorithm directed at kmers of length 6 (hexamers). Histograms of Z
scores for hexamer enrichment display a long right tail, indicating a subpopulation of
hexamers are enriched relative to permuted background (figure A2.3). I used multiple
sequence alignment to generate a motif logo of the top 20 most enriched hexamers
(inset). The resulting motifs display a marked bias toward UGU trinucleotides in both
unstimulated (figure A2.3a) and stimulated (figure A2.3b) CLIP-seq peaks. This motif
preference is in agreement with the motif preference of CELF1 as identified by
SELEX163, providing further evidence of the similarity between CELF1 and CELF2 at the
level of motif preference. Interestingly, the motif preference of CELF2 is not drastically
altered by cell stimulation, despite the fact that the splicing regulatory activity of CELF2
changes upon stimulation, as is the case with LEF1 exon 6158.
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Figure A2.3. CELF2 CLIP-seq motif enrichment analysis. Unstimulated (a) and
stimulated (b) CELF2 CLIP-seq peaks were permuted 100 times within the refSeq transcripts to
which they align and hexamer frequencies within the actual CLIP-seq peaks were compared to
the mean and standard deviation for that hexamer across the 100 iterations of independent
permutations. The Z-score is reported as the number of standard deviations away from the mean
permuted frequency, with positive values denoting enrichment and negative values depletion.
Inset: a composite motif logo generated from multiple sequence alignment of the top 20
hexamers by Z score.

Finally, other individuals in our lab have performed functional studies of CELF2
splicing regulation using RASL-seq. While these results are not detailed here, one
interesting hypothesis that arose from the results of CELF2 functional studies is the
possibility of a regulatory interplay between CELF2 and RBFOX, another splicing
regulator. One hypothesis that these results raised is that CEFL2 and RBFOX
coregulate splicing by colocalization. To explore this hypothesis further, I examined the
extent and the significance of overlap between CELF2 and RBFOX CLIP-seq sites. For
this analysis, I used RBFOX CLIP-seq samples from mouse brain tissue. To control for
differences in the software used to process RBFOX CLIP-seq data, I reprocessed the
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data from this study with the same pipeline used to process hnRNP L and CELF2 CLIPseq experiments.
To compare the overlap between CELF2 and RBFOX, I first computed the
overlap between CELF2 CLIP-seq peaks in unstimulated and stimulated JSL1 cells
(table A2.1). More than 62% of CELF2 CLIP-seq peaks in unstimulated JSL1 cells have
some degree of overlap with CELF2 CLIP-seq peaks in stimulated cells. To assess the
significance of this overlap, I permuted the unstimulated CELF2 CLIP-seq peaks within
the transcripts that contain them. This permutation process estimates the degree of
overlap between two sets of CLIP-seq peaks due to random chance, given the size and
number of CLIP-seq peaks within each transcript that was a physical target of the protein
under study. When unstimulated CELF2 JSL1 peaks are permuted in this manner, the
fraction of peaks that overlap stimulated CELF2 peaks falls below 5%. As a negative
control, I examined the overlap between CELF2 and hnRNP L and hnRNP A1 CLIP-seq
peaks, for which I have no evidence of a functional relationship. The degree of overlap
between CELF2 and hnRNP L is less than 4%, and the overlap between CELF2 and
hnRNP A1 is not more than 1%, indicating that only a small fraction of CELF2-RNA
interaction sites are also physical targets of these two hnRNP proteins.
Finally, I compared the overlap between CELF2, hnRNP A1, hnRNP L, and
RBFOX. Despite the fact that RBFOX CLIP-seq was performed in a different tissue and
in a different organism, there is a greater than 3x higher overlap between CELF2 and
RBFOX CLIP-seq peaks than expected by randomization. Notably, this is not true for
the overlap between hnRNP L and RBFOX or for the overlap between hnRNP A1 and
RBFOX. While the total degree of overlap between CELF2 and RBFOX is low, at least
some of this might be attributable to the imperfect conversion between the mouse
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genome coordinates to human genome coordinates (liftOver). Additionally, the fact that
the species and the tissue are both different begs a large measure of caution when
interpreting these results.
Unstimulated CELF2
JSL1

Stimulated CELF2
JSL1

hnRNP A1

Mouse Brain RBFOX

Percent
Percent
Percent
Percent
Percent randomized Percent randomized Percent randomized Percent randomized
overlap: overlap:
overlap: overlap:
overlap: overlap:
overlap: overlap:
hnRNP L
Unstimulated
CELF2 JSL1

3.24

2.20

2.86

2.02

0.17

0.12

0.77

0.62

62.41

4.75

1.00

0.32

3.65

1.11

0.42

0.22

3.09

0.96

2.33

1.25

Stimulated
CELF2 JSL1
hnRNP A1

Table A2.1. CELF2 CLIP-seq overlap matrix. The fraction of CELF2 CLIP-seq peaks in
unstimulated and stimulated JSL1 cells was compared to a panel of other CLIP-seq studies. Each
CLIP-seq study was reprocessed by the identical pipeline as used to generate CELF2 peaks.
One of the two sets of CLIP-seq peaks was then permuted within the transcripts in which they
occur and the fraction of these permuted peaks that overlap the other set of CLIP-seq peaks (e.g.
CELF2 versus hnRNP A1) was computed.

Discussion

CELF2 is a splicing regulator that has differential regulatory function in
unstimulated and stimulated JSL1 cells. Because of this, CELF2 might play a broad role
in reshaping the transcriptome upon stimulation. The mechanisms by which signalinducible alternative splicing events are regulated remain unknown.
Here, I present an analysis of CELF2-RNA interactions using CLIP-seq. While
the functional impact of CELF2 on the T cell transcriptome is the subject of study for
other individuals in the lab, Ganesh Shankarling prepared CELF2 CLIP-seq libraries in
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unstimulated and stimulated cells using a similar approach to that employed for hnRNP
L CLIP-seq library preparation. This provides an important level of experimental control
when comparing hnRNP L and CELF2 CLIP-seq datasets. However, one modification
was added to the library preparation protocol: multiplexed barcoding within individual
samples (figure A2.1). To provide the ability to detect multicopy CLIP fragments within
the background of PCR duplication, Ganesh split each CLIP sample into three aliquots
and ligated a unique barcode onto each aliquot. This allowed me to retain up to three
copies of alignments that map to the same genomic position because the finding of
these three copies cannot be attributable to PCR duplication.
Motif enrichment analysis of CELF2 identifies UGU trinucleotide repeats.
Notably, the most enriched motifs in unstimulated CELF2 CLIP-seq peaks are visibly
similar to those in stimulated CELF2 CLIP-seq peaks, suggesting that cell stimulation
does not alter the sequence specificity of this RNA binding protein. One possible
interpretation of this result is that the difference in CELF2’s splicing regulatory function
that results as a consequence of cell stimulation is not attributable to a difference in RNA
recognition; instead, in both cell states, CELF2 engages UG-rich and UGU-containing
sequences.
Another hypothesis for how CELF2 can have differential function in unstimulated
and stimulated cells is an alteration in the RNA sites occupied by CELF2 that is
attributable to differences in CELF2 protein expression. For instance, CELF2 mRNA
and protein levels are higher in stimulated cells than in unstimulated cells, and this could
result in an increase in the number of sites bound by CELF2 in stimulated cells.
However, an analysis of the degree of overlap between CLIP-seq peaks in unstimulated
and stimulated cells found that a majority of the CLIP-seq peaks overlap between the
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two conditions. Notably, this overlap is more than 13 times higher than that expected by
randomization. This, combined with the finding of similar total numbers of CELF2 CLIPseq peaks between the two conditions, suggests that the majority of CELF2-RNA
interaction sites are physical targets in both unstimulated and stimulated cells.
These results motivate other hypotheses that might explain the differences in
CELF2 splicing regulatory function between unstimulated and stimulated cells. One
possibility is that CELF2 is differentially modified at the protein level between
unstimulated and stimulated cells and that these modifications can account for the
functional differences. While CELF2 largely engages the same RNA sites in both cell
conditions, the consequences of that engagement may be altered by post-translational
modifications. For example, CELF2 might recruit snRNP proteins or splicing
coactivators in unstimulated cells, but inhibit snRNP/coactivator recruitment in stimulated
cells due to post-translational modifications. Other students in the lab have utilized
mass spectrometry to investigate this interesting hypothesis.
Finally, I have demonstrated the use of a permutation algorithm to estimate the
significance of the degree of overlap between two CLIP-seq samples. Indeed, the
overlap between CELF2 and RBFOX CLIP-seq sites is three times higher than that
expected based on randomization. This analysis raises the hypothesis that CELF2 and
RBFOX could establish functional interplay by interacting with the same or neighboring
RNA sites. This hypothesis is particularly interesting because a recent analysis of
CELF1 splicing regulation in muscle tissue identified a functional interplay between
CELF1 and MBNL1, another splicing regulatory protein. In this case, CELF1 and
MBNL1 are mutually antagonistic and interact with neighboring or overlapping RNA
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sites. This style of coregulation could be at play in JSL1 cells in the case of the
functional interplay between CELF2 and RBFOX.
In sum, CLIP-seq analysis of CELF2 raises several functional hypotheses about
the stimulation-responsive alterations in splicing regulation. These results provide a
foundation for further biochemical studies.
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CONCLUSION

The advent of high-throughput genetic sequencing technology has ushered in the
post-genomic era. One of the first major discoveries that accompanied informatic
studies of the first draft of the human genome was a puzzling paucity of gene count
relative to protein count. Early transcriptome annotations identified ~25,000
recognizable genes within the human genome, and while subsequent efforts have
expanded our appreciation of the coding potential of the human genome, including
species such as lincRNAs and upstream antisense transcripts, the human proteome
appears to be contain many more proteins than the number of genes in the human
genome could directly account for.
One of the mechanisms by which humans generate rich proteomic complexity
from the human genome is by alternative pre-mRNA processing such as alternative
splicing. High-throughput sequencing studies of expressed transcripts in a diversity of
human cell types has expanded our appreciation of the degree and extent to which
human pre-mRNAs are alternatively processed to generate multiple isoforms with
distinct coding potential. Alternative pre-mRNA processing is also subject to control by
development and intercellular signaling, adding a dynamic dimension to the coding
potential of the human genome.
Alternative pre-mRNA processing is regulated by the combinatorial activities of
cis- and trans-acting features which work in concert to dictate the processing of a premRNA. While biochemical studies have provided mechanistic insights into alternative
splicing events at the single-gene level, the extent to which these insights apply to the
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rest of the transcriptome is unclear. In this thesis, I demonstrate the use of integrative
genomics to study alternative splicing on the transcriptome-wide scale. In particular, I
utilize CLIP-seq and bioinformatics analysis to identify hnRNP L-RNA interactions in
human T lymphocytes. I then use RNA sequencing to identify alternative splicing events
that respond to hnRNP L depletion. Finally, I use integrative genomic analysis to
examine the pattern of features associated with hnRNP L-responsive splicing.

CLIP-seq identifies hnRNP L-RNA interactions in JSL1 and CD4+ human T
lymphocytes
Our lab has previously used biochemical methods and molecular biology to study
hnRNP L-responsive alternative splicing events in T cells. Importantly, our lab has
identified instances in which hnRNP L interacts directly with exonic RNA to repress exon
inclusion. Splice site strength and co-associated proteins impact this regulation,
suggesting a combinatorial code or splicing control by hnRNP L. However, the extent to
which the conclusions of these studies generalize to the rest of the T cell transcriptome
is unclear. To assess the transcriptomic impact of hnRNP L, we first utilized CLIP-seq to
identify hnRNP L-RNA interaction sites. The identification of hnRNP L-RNA interaction
sites is a crucial component of the transcriptome-wide analysis of hnRNP L splicing
regulatory function.
Ganesh Shankarling prepared hnRNP L CLIP-seq libraries in unstimulated and
stimulated cells of two types. First, he utilized JSL1 cells, a monoclonal, Jurkat-derived,
immortalized T lymphocyte cell line. These cells have been utilized by our lab and
others to study alternative splicing in cultured cells. Additionally, he prepared hnRNP L
CLIP-seq libraries using primary human CD4+ T cells purified from peripheral blood
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mononuclear cells. The addition of these primary human CD4+ samples allows us to
compare findings from JSL1 cells and assess the extent to which experimental results
from immortalized cells may generalize to primary cells. Second, unstimulated and
stimulated conditions from both types of cells were utilized. While there is no prior
evidence from our lab or others that the activity of hnRNP L responds to cell stimulation,
the inclusion of these two physiologic conditions provides another layer of biological
replication because the transcriptome is altered at the expression and processing level
by stimulation107. The inclusion of two cell conditions in addition to two cell types
therefore expands the experimental conditions of this study, adding breadth to our
experimental and analytical results and conclusions.
Using bioinformatic analysis of hnRNP L CLIP-seq reads, I identified over
100,000 unique interaction sites (peaks). Importantly, I found a high degree of overlap
between hnRNP L peaks identified from unstimulated and stimulated cells, suggesting
that the majority of hnRNP L interactions are not altered by cell stimulation. This finding
is consistent with prior biochemical studies of hnRNP L-regulated alternative splicing
events in which the splicing control by hnRNP L is not altered by cell stimulation, and
also consistent with the fact that hnRNP L protein levels and nucleocytoplasmic
localization are not altered by stimulation. I also identified a high degree of overlap
between hnRNP L-RNA interaction sites identified in JSL1 cells and those identified in
primary human CD4+ cells, which supports the JSL1 cell line as a model for studying
hnRNP L splicing control.
Consistent with in vitro studies of the consensus sequence for hnRNP L-RNA
interactions, I identified a CA-rich motif as most enriched within hnRNP L CLIP-seq
peaks. Notably, the two most strongly enriched hexamers within hnRNP L CLIP-seq
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peaks were CACACA and ACACAC, the two pure CA or AC dinucleotide repeat
hexamer sequences. This motif preference is consistent between T cell types and
stimulation states.
Importantly, the CLIP-seq peaks were used to identify novel instances of hnRNP
L-regulated alternative splicing. I first identified exons with hnRNP L peaks within the
exon or within the upstream or downstream introns. Ganesh and I, along with others in
the lab, then used hnRNP L-depleted or mock-depleted RNA extracts to quantify splicing
changes by RT-PCR. This approach identified 27 cases of hnRNP L-regulated splicing
events. These studies of hnRNP L-RNA interaction sites form the foundation for
functional genomics studies of hnRNP L splicing control.

High-throughput sequencing approaches identify hnRNP L-responsive alternative
splicing events in JSL1 T cells

Having identified hnRNP L-RNA interaction sites using CLIP-seq, I next studied
the splicing regulatory role of hnRNP L in JSL1 T cells using genomics approaches.
Using separate knockdown techniques, I depleted hnRNP L to approximately 50% of
normal levels. These dual knockdown methods provide an important control for offtarget effects and also provide a degree of experimental redundancy. I then utilized
complementary high-throughput sequencing techniques to identify hnRNP L-responsive
splicing events. I combined the high depth-of-coverage of RASL-seq with the high
breadth-of-coverage of RNA-seq, resulting in high correlation between the splicing
predictions generated by both experiments. This approach increased the positive
predictive value of splicing predictions when compared to either experiment alone.
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I identified hundreds of exons with inclusion level changes that respond
significantly to hnRNP L depletion. Through gene ontology analysis, I found that these
targets are enriched for RNA and DNA-binding functional categories, as well as
chromatin modifiers and other epigenetic factors. This finding suggests an interplay
between hnRNP L and chromatin. An additional analysis of other types of alternative
splicing, such as intron retention and alternative 5’ or 3’ splice site utilization, produced a
much smaller volume of predictions, suggesting that the primary splicing regulatory
activity of hnRNP L is cassette-type alternative exons.
A gene expression change analysis that successfully captured stimulationresponsive upregulation of immune response genes identified very few hnRNP Lresponsive differential gene expression events. One possible explanation for the
inability of the RNA-seq data to detect hnRNP L-responsive gene expression changes
that validate by qRT-PCR is the timecourse of the study. The RNA-seq experiment
utilized transient transfection of antisense morpholino oligonucleotides to deplete hnRNP
L. For this reason, RNA extracts can be generated between 24 and 60 hours, before
which cells have not yet recovered from electroporation, but after which the extent of
knockdown begins to subside as hnRNP L protein expression returns to normal levels. It
is possible that gene expression changes induced by hnRNP L depletion take longer to
manifest because hnRNP L regulates splicing of transcripts that encode transcription
factors and epigenetic regulators. In order for the function of these proteins to be altered
as a consequence of hnRNP L depletion, the isoform shift induced by hnRNP L
depletion requires translation into protein in order to generate a shift in the proteome. In
contrast, cell stimulation results in intracellular signaling that results in rapid posttranslational modifications on transcription factors. This process could result in gene
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expression changes that are observable by RNA-seq during the timecourse utilized by
this study. These differences in the mechanisms by which signaling and splicing result
in changes in gene expression could explain the lack of hnRNP L-responsive gene
expression events in comparison to stimulation-responsive gene expression changes.
Another hypothesis for the lack of hnRNP L-responsive gene expression events
even though hnRNP L regulates splicing in transcription factors and epigenetic
regulators is that the consequence of this hnRNP L splicing control is not gene
expression change. Recent studies have highlighted the interplay between DNA binding
proteins such as CTCF and splicing. Additionally, the role that chromatin state plays in
determining splicing outcomes has become appreciated. Taken together, these studies
suggest that DNA and RNA existing in a regulatory interplay. These transcriptome-wide
functional studies of the control of RNA by hnRNP L form the foundation for integrative
genomics analysis.

Integrative genomics analysis identifies direct repressive and indirect enhancing
roles for hnRNP L in exon splicing

The above analyses have generated transcriptome-wide datasets of hnRNP L
binding and function. One key question in the study of hnRNP L splicing control is how
the position of binding relates to splicing regulatory outcome. Integrative genomics
analyses often involve computational analysis of RNA binding protein occupancy within
and around regulated alternative splicing events. The resulting visualizations,
sometimes referred to as RNA maps, can reveal insights into the positions of binding
associated with repression and enhancement of splicing. However, this approach
140

suffers from several major caveats. First, RNA maps are empirical analyses and any
visible trends are associative, not causal. Second, evidence suggests a combinatorial
code of splicing control, but features like splice site strengths, sequence composition,
exon/intron lengths, exon/intron ordinality, coassociated proteins, and secondary
structure are often not included in RNA maps. Finally, the overlap between binding
function is incomplete: CLIP-seq identified over 100,000 hnRNP L peaks in pre-mRNAs,
but not all of these peaks have hnRNP L-responsive alternative splicing events nearby.
Similarly, not all hnRNP L-responsive alternative splicing events are expected to have
CLIP-seq peaks nearby, based on integrative genomics studies of other hnRNP
proteins.
Prior integrative genomics analyses of other splicing regulators, including those
of hnRNP proteins, have also identified a relatively low overlap between binding and
function. At least two possible explanations for this exist. First, the highly
interconnected biology of splicing regulatory proteins could lead to high levels of indirect
effects. Splicing regulatory proteins regulate splicing and thereby protein expression of
other splicing factors, which in turn regulate other splicing factors. Depletion of one
splicing regulator, such as hnRNP L, induces systems-level alterations in the cell that
extend beyond other splicing regulators, for instance to DNA binding proteins and
epigenetic factors in the case of hnRNP L. These network effects potentiate the
indirection of splicing changes as a readout of the direct consequences of depletion of
the splicing regulator under study. Second, the methodology of high throughput
sequencing could provide partial discovery of splicing changes and/or RBP binding sites
due to sequence bias in library preparation, mapping errors or unequal mappability of
the genome, and low expression of mRNAs that results in low confidence of splicing
141

changes. Taken together, these caveats urge strong caution in interpreting the results of
integrative genomic analyses.
Despite these caveats, valuable information about hnRNP L splicing control can
be gained by combining CLIP-seq and RNA-seq results. First, hnRNP L-repressed
exons are strongly demarcated by hnRNP L peaks within the exon or in the upstream or
downstream periexonic regions. This observation supports a model in which hnRNP L
directly represses exon inclusion through exonic and exonic proximal interactions,
potentially by blocking access of the spliceosomal subunits to the 5’ and 3’ splice sites,
or potentially also by stabilizing snRNP/RNA interactions such that snRNP exchange is
not possible. This latter mechanism was first described in CD45 exon 4, which has an
exonic binding site for hnRNP L that was first identified biochemically and is successfully
captured in CLIP-seq. While genomics approaches do not discriminate between these
two possibilities, the strong association between exonic and periexonic hnRNP L
occupancy and repression of splicing indicates a direct mechanism by which hnRNP L
blocks exon inclusion.
In contrast, hnRNP L-enhanced exons are not significantly associated with
hnRNP L interactions when compared to a set of exons with inclusion levels that are not
altered by hnRNP L knockdown. This finding suggests indirect enhancement of splicing.
While hnRNP L-enhanced exons are not associated with CLIP-seq peaks, they are
flanked by short, GC-rich introns. These two features co-occur globally within the
human transcriptome, and are thought to represent a distinct class of exons which are
not strongly demarcated by nucleosome occupancy. In support of this, hnRNP Lenhanced exons are less occupied by nucleosomes than hnRNP L-repressed exons.
These results support a model in which hnRNP L-enhanced exons are generally more
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sensitive to alterations in chromatin than the majority of human exons, which have wellpositioned nucleosomes.
This model raises the question of how hnRNP L is linked to chromatin. Several
lines of evidence support a functional connection between hnRNP L and chromatin.
First, chromatin modifiers are enriched among hnRNP L splicing targets, including
enzymes with histone deacetylase and demethylase activity (HDAC10 and KDM6A,
respectively), proteins that recruit histone modifiers (HMG20A, e.g.), enzymes that
modify DNA (DNMT3B), and histone acetyltransferase complex subunits (EP400,
MORF4L2). While the alterations in the activity of these factors induced by hnRNP L
depletion is difficult to infer, the enrichment of epigenetic functional categories among
hnRNP L splicing targets is a surprising find.
As described in previous chapters, hnRNP L is physically associated with the
KMT3a (also known as SETD2) complex in humans and is essential to its H3K36me3
activity in vivo. This epigenetic mark is enriched at exon-intron boundaries and is an
important component of the “chromatin code” of pre-mRNA splicing. The observation
that hnRNP L-enhanced exons have reduced nucleosome occupancy raises the
hypothesis that they are particularly sensitive to global reductions in H3K36me3 levels
upon hnRNP L depletion.
To test this hypothesis, I propose a comparative chromatin immunoprecipitation
experiment to quantify H3K36me3 and total H3 levels in hnRNP L-depleted and mockdepleted JSL1 cells. I hypothesize that hnRNP L-enhanced exons have lower basal
levels of H3K36me3 due to reduced nucleosome occupancy, which can be quantified by
H3 ChIP-qPCR. Additionally, I propose knockdown of KMT3a and RT-PCR
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quantification of exon inclusion for exons that were indirectly enhanced by hnRNP L. I
hypothesize that KMT3a knockdown will reduce inclusion of these exons.
Because hnRNP L regulates splicing of other chromatin modifiers, including
histone deacetylases, it is possible that the effect of hnRNP L on chromatin occurs
independently of H3K36me3 or via a combination of multiple mechanisms. Further
exploration of chromatin modifications from ENCODE data may reveal deeper insights
into the chromatin state underlying hnRNP L-enhanced exons.
In sum, these findings highlight a direct repressive role for hnRNP L in pre-mRNA
splicing. In addition, an indirect role for hnRNP L in splicing enhancement highlights a
potential interplay between hnRNP L and chromatin. Future experiments are necessary
to test this hypothesis.

Comparison of CLIP-seq analyses

In this dissertation, I provide computational analysis of three distinct CLIP-seq
studies with the same software pipeline. Minor modifications to the pipeline were made
to reflect the experimental differences in each study, for example the incorporation of
uniquely barcoded aliquots in the CELF2 CLIP-seq experiment and the metagenome
index of Rift Valley Fever Virus-infected human cells in the DDX17 CLIP-seq study.
Combined with the hnRNP L CLIP-seq analysis, these three experiments provide
valuable comparisons and contrasts. Importantly, by comparing CLIP-seq studies
performed and analyzed by the same group using the same tools, a bigger picture of the
possible biases of CLIP-seq experiments emerges.
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First, CELF2 and hnRNP L CLIP-seq libraries were prepared from the same cells
in the same conditions: unstimulated and stimulated JSL1 cells. This identical setting
coupled with the fact that both of these proteins are splicing factors makes a comparison
particularly interesting. One major difference between the two CLIP-seq experiments
was the library preparation. In contrast to hnRNP L CLIP-seq, CELF2 CLIP samples
were split into three aliquots before PCR amplification, and unique barcodes were
ligated onto each aliquot. This allowed the computational discrimination of PCR
duplicates from true multicopy inserts. Despite this difference, the input to the CLIP-seq
peak caller was the same format, the only difference in the data being that in the case of
CELF2, up to three copies of a read aligned to the same genomic position were
possible. The peak caller therefore was identical in both experiments.
One of the first analyses of CLIP-seq peaks is motif enrichment. For both CELF2
and hnRNP L CLIP-seq peaks, an identical permutation algorithm was used to identify
enriched hexamers within CLIP-seq peaks as compared to permuted backgrounds.
Although standard CLIP-seq library preparation was utilized (in contrast to photoreactive
nucleoside crosslinking, or PAR-CLIP), there exists a possibility of crosslinking bias. If
this type of sequence bias were inherent to CLIP-seq in general, it would complicate the
interpretation of motif enrichment results.
If CLIP-seq were inherently biased towards specific nucleotides, one might
expect to see enrichment for that nucleotide within CLIP-seq motifs. However, all four
simple nucleotide repeat hexamers (TTTTTT, AAAAAA, CCCCC, and GGGGGG) are
depleted within CELF2 CLIP-seq peaks in both unstimulated and stimulated conditions
(table C1). These simple nucleotide repeat hexamers are also depleted in unstimulated
and stimulated CELF2 hnRNP L peaks, except for CCCCCC which is enriched.
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Because this hexamer is not enriched in CELF2 CLIP-seq peaks, it is likely that this
motif is enriched in hnRNP L CLIP-seq peaks due to sequence specificity of hnRNP LRNA interactions and not general sequence bias in UV crosslinking. Notably, this motif
is similar to the most enriched hexamers within hnRNP L CLIP-seq peaks, CACACA and
ACACAC. While these results demonstrate that homopolymeric hexamers are not
enriched generally across these two CLIP-seq experiments from the same cell line, the
possibility of systematic enrichment for shorter homopolymeric repeats still exists and
would require different motif enrichment strategies than those developed for this
dissertation to examine comprehensively.
Hexamer

Stimulated
hnRNP L Zscore
-14.32

Unstimulated
CELF2 Z-score

Stimulated
CELF2 Z-score

TTTTTT

Unstimulated
hnRNP L Zscore
-17.53

-8.14

-6.86

AAAAAA

-3.82

-2.24

-6.53

-7.56

CCCCCC

5.39

8.86

-1.83

-1.70

GGGGGG

-3.97

-2.86

-1.93

-1.95

Table C1. Homopolymeric hexamer enrichment analysis within hnRNP L and
CELF2 CLIP-seq peaks. Z-scores for each kmer of length 6nt (hexamers) were computed by
iterative randomization of CLIP-seq peaks within the transcripts that contain them, as described in
Materials and Methods and discussed in above chapters and appendices. To investigate the
possibility of systematic sequence bias in CLIP, Z-scores for each of the four possible
homopolymeric hexamers are displayed.

Another important permutation-based method was used in my analysis of CLIPseq peaks to estimate the significance of overlap between two sets of peaks. In this
analysis, one set of CLIP-seq peaks is held constant while the other is iteratively
permuted within the transcripts that contain the peaks, disallowing cross-transcript
randomization. If iterative permutation generates overlaps equal to or greater than the
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extent of overlap between the actual CLIP-seq peaks, there is insufficient evidence to
reject the null hypothesis that these two sets of CLIP-seq peaks are not spatially
associated with one another. This analysis was first used to compare the extent of
overlap between hnRNP L peaks in unstimulated and stimulated cells. I went on to use
this same analysis on CELF2 CLIP-seq peaks in unstimulated and stimulated cells to
investigate the possibility that cell stimulation alters CELF2-RNA interaction sites. This
hypothesis was particularly interesting due to the fact that CELF2 splicing regulatory
function is altered by cell stimulation. Finally, I used this analysis on DDX17 CLIP-seq
peaks from uninfected and infected U2OS cells to investigate the hypothesis that
infection alters DDX17-RNA interactions in the host cell transcriptome.
In all of these comparisons, the overlap between the two sets of CLIP-seq peaks
under comparison was greater than the overlap generated by permutation (table C2).
This analysis demonstrates that the global extent of overlap between CLIP-seq peaks is
greater than that expected by permutation, a process which simulates the null
hypothesis of uniform randomness in the positioning of CLIP-seq peaks. However, this
analysis does not generate transcript-level information, instead only the extent of global
overlap is considered. For this reason, it is still possible that protein-RNA interactions
within certain transcripts are different between the two sets of peaks under comparison.
Additionally, the number of reads aligning to a CLIP-seq peak is not considered, so
quantitative variations in the signal intensity of a CLIP-seq peak are discarded. It is
therefore also possible that global alterations in the heights of CLIP-seq peaks exist in a
consistent manner that is lost in this analysis because only the footprint of a peak is
utilized. Future developments in comparison of CLIP-seq datasets might provide
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valuable insight into the differences in protein-RNA interactions induced by cell signaling
or infection with pathogens.
CLIP-seq peaks
compared:
Unstimulated and
stimulated hnRNP
L
Unstimulated and
stimulated CELF2
Uninfected and
infected DDX17

Fraction of
overlapping peaks:
0.347

Fraction of permuted
overlap:
0.0128

Binomial p-value:

0.621

0.0448

< 2.2e-16

0.0826

0.00342

< 2.2e-16

< 2.2e-16

Table C2. Randomized overlap analysis between CLIP-seq binding profiles. A
permutation analysis of the significance of overlap between CLIP-seq binding profiles for hnRNP
L in unstimulated and stimulated JSL1 cells, for CELF2 in the same two conditions, and for
DDX17 in uninfected and RVFV-infected U2OS cells is provided. P-values were obtained using a
two-sided exact binomial test.

In all comparisons, the significance of the degree of overlap is statistically
significant by a binomial test. These results indicate that cell stimulation does not
globally alter either CELF2 or hnRNP L CLIP-seq sites. In addition, infection with Rift
Valley Fever Virus does not appear to globally alter DDX17-RNA interaction sites.
However, it is still possible that a subset of RNAs is subject to condition-specific or
infection-specific interactions. Such subtle changes in CLIP-seq peaks will require more
fine-grained analyses to detect.
In addition to the above information, CLIP-seq provides data on the transcript
features (e.g. 3’UTR, coding exon, 5’UTR, etc.) enriched within CLIP-seq peaks. These
data provide valuable insights into possible transcriptome-wide roles of an RBP in
previously unappreciated processes. I compared the transcript features of hnRNP L,
CELF2, and DDX17 CLIP-seq experiments (table C3). A further hnRNP L CLIP-seq
experiment in CD4+ cells is omitted from this table, but the findings were similar to
hnRNP L CLIP-seq in JSL1 cells (see above chapters).
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Transcript
Unstim.
Stim.
Unstim.
Stim.
Uninf.
Inf.
Total
feature
hnRNP L
hnRNP L
CELF2
CELF2
DDX17
DDX17
refSeq
Distal
86.98
88.21
69.66
72.73
58.54
71.48
87.32
intron
Proximal
6.14
5.83
9.29
8.64
11.0
14.66
7.64
intron
3’UTR
5.76
4.95
17.0
15.35
16.97
6.81
2.17
exon
Coding
0.98
0.87
3.39
2.74
9.9
4.58
2.46
exon
5’UTR
0.13
0.14
0.67
0.53
3.59
2.48
0.41
exon
Table C3. Transcript features within CLIP-seq peaks from hnRNP L, CELF2, and
DDX17. CLIP-seq experiments from hnRNP L and CELF2 (JSL1 cells) and from DDX17 (U2OS)
cells were analyzed by the same bioinformatics pipeline. The fraction of nucleotides overlapping
each of 5 types of transcript feature were calculated. Proximal intron is defined as intronic
sequence within 250nt of an annotated exon.

Several interesting findings arise when these experiments are examined
together. First, CELF2 CLIP-seq peaks are 7-fold enriched for 3’UTR interactions when
compared to the size of the 3’UTR footprint within the refSeq transcriptome. As
mentioned in the above appendix, 3’UTR interactions are a property of mRNA regulation
by CELF1, and this finding suggests that CELF2 may also regulate mRNA through
3’UTR interactions. Interestingly, all three proteins are enriched for 3’UTR interactions,
suggesting that at least some of CELF2’s 3’UTR bias might be explained by a
systematic bias toward 3’UTR localization in all CLIP-seq experiments. Second,
stimulation of JSL1 cells induces a slight yet noticeable shift toward distal intron
interactions for hnRNP L and CELF2, with commensurate loss in other types of
transcript features. Because this shift exists for both proteins, it is possible that the gene
expression changes induced by cell stimulation result in a transcriptome that has a
larger distal intronic footprint. Third, infection of U2OS cells with Rift Valley Fever Virus
results in a similar redistribution of DDX17 CLIP-seq peaks to distal intronic regions.
While striking, this result is difficult to interpret as DDX17-mRNA interactions are poorly
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understood because much of the focus on DDX17-RNA interactions has been centered
around the role this RNA helicase plays in the biogenesis of miRNAs.
In conclusion, I have presented computational analysis of three independent
CLIP-seq experiments in two cell types. By comparing motif enrichment analyses from
all three CLIP-seq experiments, I find little evidence for a homopolymeric sequence bias
in peaks defined these studies. This result lends credence to motif enrichment results
as reflective of the sequence specificity of the protein under study. For this reason,
CLIP-seq is a useful tool not only to study protein-RNA localization in the transcriptome,
but also to study sequence specificity of RNA binding proteins. Several high-throughput
methods to study sequence specificity of RNA binding proteins have been developed,
including RNAcompete and RNA Bind-n-seq. One caveat of in vitro studies of sequence
specificity for RNA binding proteins is that the protein has been removed from its cellular
context. Numerous biological factors could influence RBP-RNA interactions in vivo,
including posttranslational modification status, co-associated proteins, substrate
abundance, subcellular localization, and others. I propose that CLIP-seq provides
valuable insight into the sequence specificity of an RNA binding protein in its natural
cellular context.
Additionally, I describe a permutation algorithm for the analysis of the
significance of overlap between two sets of CLIP-seq peaks. While this analysis is an
important component of the study of an RNA binding protein in multiple cell states, as
presented here, several important caveats exist. As CLIP-seq analyses are increasingly
utilized to study RNA binding protein localizations across multiple cell types at various
developmental stages, software development efforts will be needed to identify
biologically relevant dynamics in the midst of a larger context of overlapping binding
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sites. Computational challenges such as these motivate the development of new tools
that are generalizable and useful in a variety of contexts.
Finally, I demonstrate a comparative analysis of the types of transcript features
engaged by hnRNP L, CELF2, and DDX17 in different cell states. This analysis
demonstrates the value of comparisons between CLIP-seq experiments and highlights a
potential role for CLIP-seq in studying the dynamics of protein-RNA interactions in
response to viral infection or cell signaling.

151

REFERENCES
1. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative
splicing. Nature. 2010;463(7280):457-463.
2. Wang ET, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue
transcriptomes. Nature. 2008;456(7221):470-476.
3. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing
complexity in the human transcriptome by high-throughput sequencing. Nat Genet.
2008;40(12):1413-1415.
4. Wahl MC, Will CL, Luhrmann R. The spliceosome: Design principles of a dynamic
RNP machine. Cell. 2009;136(4):701-718.
5. Chen M, Manley JL. Mechanisms of alternative splicing regulation: Insights from
molecular and genomics approaches. Nature Reviews Molecular Cell Biology.
2009;10(11):741-754.
6. Guth S, Valcarcel J. Kinetic role for mammalian SF1/BBP in spliceosome assembly
and function after polypyrimidine tract recognition by U2AF. J Biol Chem.
2000;275(48):38059-38066.
7. Cheng Z, Menees TM. RNA splicing and debranching viewed through analysis of RNA
lariats. Molecular Genetics & Genomics: MGG. 2011;286(5-6):395-410.

152

8. Hegele A, Kamburov A, Grossmann A, et al. Dynamic protein-protein interaction
wiring of the human spliceosome. Mol Cell. 2012;45(4):567-580.
9. Matlin AJ, Moore MJ. Spliceosome assembly and composition. Advances in
Experimental Medicine & Biology. 2007;623:14-35.
10. Inoue K, Hoshijima K, Sakamoto H, Shimura Y. Binding of the drosophila sex-lethal
gene product to the alternative splice site of transformer primary transcript. Nature.
1990;344(6265):461-463.
11. Hoshijima K, Inoue K, Higuchi I, Sakamoto H, Shimura Y. Control of doublesex
alternative splicing by transformer and transformer-2 in drosophila. Science.
1991;252(5007):833-836.
12. Valcarcel J, Singh R, Zamore PD, Green MR. The protein sex-lethal antagonizes the
splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature.
1993;362(6416):171-175.
13. Forch P, Merendino L, Martinez C, Valcarcel J. Modulation of msl-2 5' splice site
recognition by sex-lethal. Rna-A Publication of the Rna Society. 2001;7(9):1185-1191.
14. Zuo P, Maniatis T. The splicing factor U2AF35 mediates critical protein-protein
interactions in constitutive and enhancer-dependent splicing. Genes Dev.
1996;10(11):1356-1368.
15. Boucher L, Ouzounis CA, Enright AJ, Blencowe BJ. A genome-wide survey of RS
domain proteins. Rna-A Publication of the Rna Society. 2001;7(12):1693-1701.

153

16. Fu XD. The superfamily of arginine/serine-rich splicing factors. Rna-A Publication of
the Rna Society. 1995;1(7):663-680.
17. Ge H, Manley JL. A protein factor, ASF, controls cell-specific alternative splicing of
SV40 early pre-mRNA in vitro. Cell. 1990;62(1):25-34.
18. Krainer AR, Conway GC, Kozak D. The essential pre-mRNA splicing factor SF2
influences 5' splice site selection by activating proximal sites. Cell. 1990;62(1):35-42.
19. Zahler AM, Neugebauer KM, Lane WS, Roth MB. Distinct functions of SR proteins in
alternative pre-mRNA splicing. Science. 1993;260(5105):219-222.
20. Zahler AM, Roth MB. Distinct functions of SR proteins in recruitment of U1 small
nuclear ribonucleoprotein to alternative 5' splice sites. Proc Natl Acad Sci U S A.
1995;92(7):2642-2646.
21. Choi YD, Dreyfuss G. Isolation of the heterogeneous nuclear RNA-ribonucleoprotein
complex (hnRNP): A unique supramolecular assembly. Proc Natl Acad Sci U S A.
1984;81(23):7471-7475.
22. Pinol-Roma S, Choi YD, Matunis MJ, Dreyfuss G. Immunopurification of
heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNAbinding proteins. Genes Dev. 1988;2(2):215-227.
23. Mayeda A, Helfman DM, Krainer AR. Modulation of exon skipping and inclusion by
heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
Molecular & Cellular Biology. 1993;13(5):2993-3001.

154

24. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense:
Exonic mutations that affect splicing. Nature Reviews Genetics. 2002;3(4):285-298.
25. Kashima T, Rao N, David CJ, Manley JL. hnRNP A1 functions with specificity in
repression of SMN2 exon 7 splicing. Hum Mol Genet. 2007;16(24):3149-3159.
26. David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by
c-myc deregulate pyruvate kinase mRNA splicing in cancer. Nature.
2010;463(7279):364-368.
27. Zhu J, Mayeda A, Krainer AR. Exon identity established through differential
antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR
proteins. Mol Cell. 2001;8(6):1351-1361.
28. Martinez-Contreras R, Fisette JF, Nasim FU, Madden R, Cordeau M, Chabot B.
Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA
splicing. Plos Biology. 2006;4(2):e21.
29. Venables JP, Koh CS, Froehlich U, et al. Multiple and specific mRNA processing
targets for the major human hnRNP proteins. Molecular & Cellular Biology.
2008;28(19):6033-6043.
30. Oh Hk, Lee E, Jang HN, et al. hnRNP A1 contacts exon 5 to promote exon 6
inclusion of apoptotic fas gene. Apoptosis. 2013;18(7):825-835.
31. Das S, Krainer AR. Emerging functions of SRSF1, splicing factor and oncoprotein, in
RNA metabolism and cancer. Mol Cancer Res. 2014;12(9):1195-1204.

155

32. Cho S, Hoang A, Sinha R, et al. Interaction between the RNA binding domains of
ser-arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome
assembly. Proc Natl Acad Sci U S A. 2011;108(20):8233-8238.
33. Pandit S, Zhou Y, Shiue L, et al. Genome-wide analysis reveals SR protein
cooperation and competition in regulated splicing. Mol Cell. 2013;50(2):223-235.
34. Lynch KW. Consequences of regulated pre-mRNA splicing in the immune system.
Nature Reviews.Immunology. 2004;4(12):931-940.
35. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A. Dimerization-induced inhibition of
receptor protein tyrosine phosphatase function through an inhibitory wedge. Science.
1998;279(5347):88-91.
36. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerization of the
alternatively spliced isoforms. Nat Immunol. 2002;3(8):764-771.
37. Lynch KW, Weiss A. A model system for activation-induced alternative splicing of
CD45 pre-mRNA in T cells implicates protein kinase C and ras. Molecular & Cellular
Biology. 2000;20(1):70-80.
38. Lynch KW, Weiss A. A CD45 polymorphism associated with multiple sclerosis
disrupts an exonic splicing silencer. J Biol Chem. 2001;276(26):24341-24347.
39. Melton AA, Jackson J, Wang J, Lynch KW. Combinatorial control of signal-induced
exon repression by hnRNP L and PSF. Molecular & Cellular Biology. 2007;27(19):69726984.

156

40. Topp JD, Jackson J, Melton AA, Lynch KW. A cell-based screen for splicing
regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable
exon 4. Rna-A Publication of the Rna Society. 2008;14(10):2038-2049.
41. Gaudreau MC, Heyd F, Bastien R, Wilhelm B, Moroy T. Alternative splicing
controlled by heterogeneous nuclear ribonucleoprotein L regulates development,
proliferation, and migration of thymic pre-T cells. Journal of Immunology.
2012;188(11):5377-5388.
42. Shankarling G, Lynch KW. Minimal functional domains of paralogues hnRNP L and
hnRNP LL exhibit mechanistic differences in exonic splicing repression. Biochem J.
2013;453(2):271-279.
43. Oberdoerffer S, Moita LF, Neems D, Freitas RP, Hacohen N, Rao A. Regulation of
CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science.
2008;321(5889):686-691.
44. Motta-Mena LB, Heyd F, Lynch KW. Context-dependent regulatory mechanism of
the splicing factor hnRNP L. Mol Cell. 2010;37(2):223-234.
45. Tong A, Nguyen J, Lynch KW. Differential expression of CD45 isoforms is controlled
by the combined activity of basal and inducible splicing-regulatory elements in each of
the variable exons. J Biol Chem. 2005;280(46):38297-38304.
46. Chiou NT, Shankarling G, Lynch KW. hnRNP L and hnRNP A1 induce extended U1
snRNA interactions with an exon to repress spliceosome assembly. Mol Cell.
2013;49(5):972-982.
157

47. Lareau LF, Brenner SE. Regulation of splicing factors by alternative splicing and
NMD is conserved between kingdoms yet evolutionarily flexible. Mol Biol Evol. 2015.
48. Rossbach O, Hung LH, Schreiner S, et al. Auto- and cross-regulation of the hnRNP
L proteins by alternative splicing. Molecular & Cellular Biology. 2009;29(6):1442-1451.
49. Rosel M, Khaldoyanidi S, Zawadzki V, Zoller M. Involvement of CD44 variant isoform
v10 in progenitor cell adhesion and maturation. Exp Hematol. 1999;27(4):698-711.
50. Loh TJ, Cho S, Moon H, et al. hnRNP L inhibits CD44 V exon splicing through
interacting with its upstream intron. Biochim Biophys Acta. 2015.
51. Zoller M, Gupta P, Marhaba R, Vitacolonna M, Freyschmidt-Paul P. Anti-CD44mediated blockade of leukocyte migration in skin-associated immune diseases. J Leukoc
Biol. 2007;82(1):57-71.
52. Manten-Horst E, Danen EH, Smit L, et al. Expression of CD44 splice variants in
human cutaneous melanoma and melanoma cell lines is related to tumor progression
and metastatic potential. International Journal of Cancer. 1995;64(3):182-188.
53. Shih SC, Claffey KP. Regulation of human vascular endothelial growth factor mRNA
stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem.
1999;274(3):1359-1365.
54. Jafarifar F, Yao P, Eswarappa SM, Fox PL. Repression of VEGFA by CA-rich
element-binding microRNAs is modulated by hnRNP L. EMBO J. 2011;30(7):1324-1334.

158

55. Ule J, Jensen K, Mele A, Darnell RB. CLIP: A method for identifying protein-RNA
interaction sites in living cells. Methods (Duluth). 2005;37(4):376-386.
56. Darnell R. CLIP (cross-linking and immunoprecipitation) identification of RNAs bound
by a specific protein. Cold Spring Harbor protocols. 2012;2012(11):1146-1160.
57. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB. CLIP identifies novaregulated RNA networks in the brain. Science. 2003;302(5648):1212-1215.
58. Licatalosi DD, Mele A, Fak JJ, et al. HITS-CLIP yields genome-wide insights into
brain alternative RNA processing. Nature. 2008;456(7221):464-469.
59. Yeo GW, Coufal NG, Liang TY, Peng GE, Fu XD, Gage FH. An RNA code for the
FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells.
Nature Structural & Molecular Biology. 2009;16(2):130-137.
60. Sanford JR, Wang X, Mort M, et al. Splicing factor SFRS1 recognizes a functionally
diverse landscape of RNA transcripts. Genome Res. 2009;19(3):381-394.
61. Licatalosi DD, Yano M, Fak JJ, et al. Ptbp2 represses adult-specific splicing to
regulate the generation of neuronal precursors in the embryonic brain. Genes Dev.
2012;26(14):1626-1642.
62. Huelga SC, Vu AQ, Arnold JD, et al. Integrative genome-wide analysis reveals
cooperative regulation of alternative splicing by hnRNP proteins. Cell Reports.
2012;1(2):167-178.

159

63. Charizanis K, Lee KY, Batra R, et al. Muscleblind-like 2-mediated alternative splicing
in the developing brain and dysregulation in myotonic dystrophy. Neuron.
2012;75(3):437-450.
64. Pandit S, Zhou Y, Shiue L, et al. Genome-wide analysis reveals SR protein
cooperation and competition in regulated splicing. Mol Cell. 2013;50(2):223-235.
65. Weyn-Vanhentenryck SM, Mele A, Yan Q, et al. HITS-CLIP and integrative modeling
define the rbfox splicing-regulatory network linked to brain development and autism. Cell
Reports. 2014;6(6):1139-1152.
66. Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNAmRNA interaction maps. Nature. 2009;460(7254):479-486.
67. Zisoulis DG, Lovci MT, Wilbert ML, et al. Comprehensive discovery of endogenous
argonaute binding sites in caenorhabditis elegans. Nature Structural & Molecular
Biology. 2010;17(2):173-179.
68. Moore MJ, Zhang C, Gantman EC, Mele A, Darnell JC, Darnell RB. Mapping
argonaute and conventional RNA-binding protein interactions with RNA at singlenucleotide resolution using HITS-CLIP and CIMS analysis. Nature Protocols.
2014;9(2):263-293.
69. Bahn JH, Ahn J, Lin X, et al. Genomic analysis of ADAR1 binding and its
involvement in multiple RNA processing pathways. Nat Commun. 2015;6:6355.
70. Selvanathan SP, Graham GT, Erkizan HV, et al. Oncogenic fusion protein EWS-FLI1
is a network hub that regulates alternative splicing. Proc Natl Acad Sci U S A. 2015.
160

71. Hurt JA, Robertson AD, Burge CB. Global analyses of UPF1 binding and function
reveal expanded scope of nonsense-mediated mRNA decay. Genome Res.
2013;23(10):1636-1650.
72. Yang YC, Di C, Hu B, et al. CLIPdb: A CLIP-seq database for protein-RNA
interactions. BMC Genomics. 2015;16(1):51.
73. Shoemaker DD, Schadt EE, Armour CD, et al. Experimental annotation of the human
genome using microarray technology. Nature. 2001;409(6822):922-927.
74. Johnson JM, Castle J, Garrett-Engele P, et al. Genome-wide survey of human
alternative pre-mRNA splicing with exon junction microarrays. Science.
2003;302(5653):2141-2144.
75. Clark TA, Sugnet CW, Ares M Jr. Genomewide analysis of mRNA processing in
yeast using splicing-specific microarrays. Science. 2002;296(5569):907-910.
76. Pan Q, Shai O, Misquitta C, et al. Revealing global regulatory features of mammalian
alternative splicing using a quantitative microarray platform. Mol Cell. 2004;16(6):929941.
77. Blanchette M, Green RE, Brenner SE, Rio DC. Global analysis of positive and
negative pre-mRNA splicing regulators in drosophila. Genes Dev. 2005;19(11):13061314.
78. Sugnet CW, Srinivasan K, Clark TA, et al. Unusual intron conservation near tissueregulated exons found by splicing microarrays. PLoS Computational Biology.
2006;2(1):e4.
161

79. Blencowe BJ. Alternative splicing: New insights from global analyses. Cell.
2006;126(1):37-47.
80. Bentley DL. Rules of engagement: Co-transcriptional recruitment of pre-mRNA
processing factors. Curr Opin Cell Biol. 2005;17(3):251-256.
81. Dye MJ, Gromak N, Proudfoot NJ. Exon tethering in transcription by RNA
polymerase II. Mol Cell. 2006;21(6):849-859.
82. Wilhelm BT, Marguerat S, Watt S, et al. Dynamic repertoire of a eukaryotic
transcriptome surveyed at single-nucleotide resolution. Nature. 2008;453(7199):12391243.
83. Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative
splicing by deep sequencing of the human transcriptome. Science. 2008;321(5891):956960.
84. Trapnell C, Pachter L, Salzberg SL. TopHat: Discovering splice junctions with RNAseq. Bioinformatics. 2009;25(9):1105-1111.
85. Katz Y, Wang ET, Airoldi EM, Burge CB. Analysis and design of RNA sequencing
experiments for identifying isoform regulation. Nature Methods. 2010;7(12):1009-1015.
86. Shen S, Park JW, Huang J, et al. MATS: A bayesian framework for flexible detection
of differential alternative splicing from RNA-seq data. Nucleic Acids Res.
2012;40(8):e61.

162

87. Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: One protein multiple processes.
Bioessays. 2004;26(6):629-638.
88. Makeyev AV, Liebhaber SA. The poly(C)-binding proteins: A multiplicity of functions
and a search for mechanisms. Rna-A Publication of the Rna Society. 2002;8(3):265-278.
89. Martinez-Contreras R, Cloutier P, Shkreta L, Fisette JF, Revil T, Chabot B. hnRNP
proteins and splicing control. Advances in Experimental Medicine & Biology.
2007;623:123-147.
90. Hung LH, Heiner M, Hui J, Schreiner S, Benes V, Bindereif A. Diverse roles of
hnRNP L in mammalian mRNA processing: A combined microarray and RNAi analysis.
Rna-A Publication of the Rna Society. 2008;14(2):284-296.
91. Erkelenz S, Mueller WF, Evans MS, et al. Position-dependent splicing activation and
repression by SR and hnRNP proteins rely on common mechanisms. Rna-A Publication
of the Rna Society. 2013;19(1):96-102.
92. Martinez NM, Lynch KW. Control of alternative splicing in immune responses: Many
regulators, many predictions, much still to learn. Immunol Rev. 2013;253(1):216-236.
93. Ansel KM. RNA regulation of the immune system. Immunol Rev. 2013;253(1):5-11.
94. Rothrock CR, House AE, Lynch KW. HnRNP L represses exon splicing via a
regulated exonic splicing silencer. EMBO J. 2005;24(15):2792-2802.

163

95. Topp JD, Jackson J, Melton AA, Lynch KW. A cell-based screen for splicing
regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable
exon 4. Rna-A Publication of the Rna Society. 2008;14(10):2038-2049.
96. Tong A, Nguyen J, Lynch KW. Differential expression of CD45 isoforms is controlled
by the combined activity of basal and inducible splicing-regulatory elements in each of
the variable exons. J Biol Chem. 2005;280(46):38297-38304.
97. Gaudreau MC, Heyd F, Bastien R, Wilhelm B, Moroy T. Alternative splicing
controlled by heterogeneous nuclear ribonucleoprotein L regulates development,
proliferation, and migration of thymic pre-T cells. Journal of Immunology.
2012;188(11):5377-5388.
98. Hui J, Hung LH, Heiner M, et al. Intronic CA-repeat and CA-rich elements: A new
class of regulators of mammalian alternative splicing. EMBO J. 2005;24(11):1988-1998.
99. Hermiston ML, Xu Z, Majeti R, Weiss A. Reciprocal regulation of lymphocyte
activation by tyrosine kinases and phosphatases. J Clin Invest. 2002;109(1):9-14.
100. Preussner M, Schreiner S, Hung LH, et al. HnRNP L and L-like cooperate in
multiple-exon regulation of CD45 alternative splicing. Nucleic Acids Res.
2012;40(12):5666-5678.
101. Rothrock C, Cannon B, Hahm B, Lynch KW. A conserved signal-responsive
sequence mediates activation-induced alternative splicing of CD45. Mol Cell.
2003;12(5):1317-1324.

164

102. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerization of the
alternatively spliced isoforms. Nat Immunol. 2002;3(8):764-771.
103. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A. Dimerization-induced inhibition of
receptor protein tyrosine phosphatase function through an inhibitory wedge. Science.
1998;279(5347):88-91.
104. Ule J. High-throughput sequencing methods to study neuronal RNA-protein
interactions. Biochem Soc Trans. 2009;37(Pt 6):1278-1280.
105. Oberdoerffer S, Moita LF, Neems D, Freitas RP, Hacohen N, Rao A. Regulation of
CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science.
2008;321(5889):686-691.
106. Xue Y, Zhou Y, Wu T, et al. Genome-wide analysis of PTB-RNA interactions
reveals a strategy used by the general splicing repressor to modulate exon inclusion or
skipping. Mol Cell. 2009;36(6):996-1006.
107. Martinez NM, Pan Q, Cole BS, et al. Alternative splicing networks regulated by
signaling in human T cells. Rna-A Publication of the Rna Society. 2012;18(5):1029-1040.
108. Rossbach O, Hung LH, Schreiner S, et al. Auto- and cross-regulation of the hnRNP
L proteins by alternative splicing. Molecular & Cellular Biology. 2009;29(6):1442-1451.
109. Maillard I, Fang T, Pear WS. Regulation of lymphoid development, differentiation,
and function by the notch pathway. Annu Rev Immunol. 2005;23:945-974.

165

110. Weiss A. Molecular and genetic insights into the role of protein tyrosine kinases in T
cell receptor signaling. Clinical Immunology & Immunopathology. 1995;76(3 Pt 2):S15862.
111. Liu P, Keller JR, Ortiz M, et al. Bcl11a is essential for normal lymphoid
development. Nat Immunol. 2003;4(6):525-532.
112. Go WY, Liu X, Roti MA, Liu F, Ho SN. NFAT5/TonEBP mutant mice define osmotic
stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci U S A.
2004;101(29):10673-10678.
113. Ikawa T, Kawamoto H, Goldrath AW, Murre C. E proteins and notch signaling
cooperate to promote T cell lineage specification and commitment. J Exp Med.
2006;203(5):1329-1342.
114. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. The kinase TAK1 integrates
antigen and cytokine receptor signaling for T cell development, survival and function. Nat
Immunol. 2006;7(8):851-858.
115. Yamamoto-Furusho JK, Barnich N, Xavier R, Hisamatsu T, Podolsky DK. Centaurin
beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent
NF-kappaB activation. J Biol Chem. 2006;281(47):36060-36070.
116. Ou CY, Kim JH, Yang CK, Stallcup MR. Requirement of cell cycle and apoptosis
regulator 1 for target gene activation by wnt and beta-catenin and for anchorageindependent growth of human colon carcinoma cells. J Biol Chem. 2009;284(31):2062920637.
166

117. Huelga SC, Vu AQ, Arnold JD, et al. Integrative genome-wide analysis reveals
cooperative regulation of alternative splicing by hnRNP proteins. Cell Reports.
2012;1(2):167-178.
118. Lagier-Tourenne C, Polymenidou M, Hutt KR, et al. Divergent roles of ALS-linked
proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci.
2012;15(11):1488-1497.
119. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with
applications to RNA splicing signals. Journal of Computational Biology. 2004;11(23):377-394.
120. Dikic I, Dikic I, Schlessinger J. Identification of a new Pyk2 isoform implicated in
chemokine and antigen receptor signaling. J Biol Chem. 1998;273(23):14301-14308.
121. Davidson D, Viallet J, Veillette A. Unique catalytic properties dictate the enhanced
function of p59fynT, the hemopoietic cell-specific isoform of the fyn tyrosine protein
kinase, in T cells. Molecular & Cellular Biology. 1994;14(7):4554-4564.
122. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling
IL-2 signals that regulate T cell proliferation, survival, and fas-mediated activationinduced cell death. Immunity. 1999;11(3):281-288.
123. Yu Y, Wang J, Khaled W, et al. Bcl11a is essential for lymphoid development and
negatively regulates p53. J Exp Med. 2012;209(13):2467-2483.

167

124. Appleby MW, Gross JA, Cooke MP, Levin SD, Qian X, Perlmutter RM. Defective T
cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell. 1992;70(5):751763.
125. Beinke S, Phee H, Clingan JM, Schlessinger J, Matloubian M, Weiss A. Proline-rich
tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate. Proc Natl Acad Sci U
S A. 2010;107(37):16234-16239.
126. Miyazaki T, Takaoka A, Nogueira L, et al. Pyk2 is a downstream mediator of the IL2 receptor-coupled jak signaling pathway. Genes Dev. 1998;12(6):770-775.
127. Slattery C, Ryan MP, McMorrow T. E2A proteins: Regulators of cell phenotype in
normal physiology and disease. Int J Biochem Cell Biol. 2008;40(8):1431-1436.
128. Schlissel M, Voronova A, Baltimore D. Helix-loop-helix transcription factor E47
activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement
in a pre-T-cell line. Genes Dev. 1991;5(8):1367-1376.
129. Lynch KW, Weiss A. A CD45 polymorphism associated with multiple sclerosis
disrupts an exonic splicing silencer. J Biol Chem. 2001;276(26):24341-24347.
130. Jacobsen M, Schweer D, Ziegler A, et al. A point mutation in PTPRC is associated
with the development of multiple sclerosis. Nat Genet. 2000;26(4):495-499.
131. Liu G, Razanau A, Hai Y, et al. A conserved serine of heterogeneous nuclear
ribonucleoprotein L (hnRNP L) mediates depolarization-regulated alternative splicing of
potassium channels. J Biol Chem. 2012;287(27):22709-22716.

168

132. Goehe RW, Shultz JC, Murudkar C, et al. hnRNP L regulates the tumorigenic
capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. J Clin
Invest. 2010;120(11):3923-3939.
133. Shankarling G, Cole BS, Mallory MJ, Lynch KW. Transcriptome-wide RNA
interaction profiling reveals physical and functional targets of hnRNP L in human T cells.
Mol Cell Biol. 2014;34(1):71-83.
134. Rossbach O, Hung LH, Schreiner S, et al. Auto- and cross-regulation of the hnRNP
L proteins by alternative splicing. Molecular & Cellular Biology. 2009;29(6):1442-1451.
135. Xue Y, Zhou Y, Wu T, et al. Genome-wide analysis of PTB-RNA interactions
reveals a strategy used by the general splicing repressor to modulate exon inclusion or
skipping. Mol Cell. 2009;36(6):996-1006.
136. Li H, Qiu J, Fu XD. RASL-seq for massively parallel and quantitative analysis of
gene expression. Curr Protoc Mol Biol. 2012;Chapter 4:Unit 4.13.1-9.
137. Huang Y, Li W, Yao X, et al. Mediator complex regulates alternative mRNA
processing via the MED23 subunit. Mol Cell. 2012;45(4):459-469.
138. Kim JE, White FM. Quantitative analysis of phosphotyrosine signaling networks
triggered by CD3 and CD28 costimulation in jurkat cells. J Immunol. 2006;176(5):28332843.
139. Amit M, Donyo M, Hollander D, et al. Differential GC content between exons and
introns establishes distinct strategies of splice-site recognition. Cell Rep. 2012;1(5):543556.
169

140. Gelfman S, Cohen N, Yearim A, Ast G. DNA-methylation effect on cotranscriptional
splicing is dependent on GC architecture of the exon-intron structure. Genome Res.
2013;23(5):789-799.
141. Lambert N, Robertson A, Jangi M, McGeary S, Sharp PA, Burge CB. RNA bind-nseq: Quantitative assessment of the sequence and structural binding specificity of RNA
binding proteins. Mol Cell. 2014;54(5):887-900.
142. Ray D, Kazan H, Chan ET, et al. Rapid and systematic analysis of the RNA
recognition specificities of RNA-binding proteins. Nat Biotechnol. 2009;27(7):667-670.
143. Carrozza MJ, Li B, Florens L, et al. Histone H3 methylation by Set2 directs
deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription.
Cell. 2005;123(4):581-592.
144. Li B, Gogol M, Carey M, Lee D, Seidel C, Workman JL. Combined action of PHD
and chromo domains directs the Rpd3S HDAC to transcribed chromatin. Science.
2007;316(5827):1050-1054.
145. Yuan W, Xie J, Long C, et al. Heterogeneous nuclear ribonucleoprotein L is a
subunit of human KMT3a/Set2 complex required for H3 lys-36 trimethylation activity in
vivo. J Biol Chem. 2009;284(23):15701-15707.
146. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. Differential
chromatin marking of introns and expressed exons by H3K36me3. Nat Genet.
2009;41(3):376-381.

170

147. Shankarling G, Cole BS, Mallory MJ, Lynch KW. Transcriptome-wide RNA
interaction profiling reveals physical and functional targets of hnRNP L in human T cells.
Molecular & Cellular Biology. 2014;34(1):71-83.
148. Hong S, Noh H, Chen H, et al. Signaling by p38 MAPK stimulates nuclear
localization of the microprocessor component p68 for processing of selected primary
microRNAs. Science Signaling [Electronic Resource]. 2013;6(266):ra16.
149. Samaan S, Tranchevent LC, Dardenne E, et al. The Ddx5 and Ddx17 RNA
helicases are cornerstones in the complex regulatory array of steroid hormone-signaling
pathways. Nucleic Acids Res. 2014;42(4):2197-2207.
150. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHAmediated microRNA maturation. Nature. 2008;454(7200):56-61.
151. Gregory RI, Yan KP, Amuthan G, et al. The microprocessor complex mediates the
genesis of microRNAs. Nature. 2004;432(7014):235-240.
152. Mori M, Triboulet R, Mohseni M, et al. Hippo signaling regulates microprocessor
and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156(5):893906.
153. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation
of microRNA processing by p53. Nature. 2009;460(7254):529-533.
154. Sabin LR, Zhou R, Gruber JJ, et al. Ars2 regulates both miRNA- and siRNAdependent silencing and suppresses RNA virus infection in drosophila. Cell.
2009;138(2):340-351.
171

155. Emery VC, Bishop DH. Characterization of punta toro S mRNA species and
identification of an inverted complementary sequence in the intergenic region of punta
toro phlebovirus ambisense S RNA that is involved in mRNA transcription termination.
Virology. 1987;156(1):1-11.
156. Sabin LR, Zheng Q, Thekkat P, et al. Dicer-2 processes diverse viral RNA species.
PLoS ONE [Electronic Resource]. 2013;8(2):e55458.
157. Bortz E, Westera L, Maamary J, et al. Host- and strain-specific regulation of
influenza virus polymerase activity by interacting cellular proteins. mBio. 2011;2(4).
158. Mallory MJ, Jackson J, Weber B, Chi A, Heyd F, Lynch KW. Signal- and
development-dependent alternative splicing of LEF1 in T cells is controlled by CELF2.
Molecular & Cellular Biology. 2011;31(11):2184-2195.
159. Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/TCF action in development
and disease. Oncogene. 2006;25(57):7492-7504.
160. Carlsson P, Waterman ML, Jones KA. The hLEF/TCF-1 alpha HMG protein
contains a context-dependent transcriptional activation domain that induces the TCR
alpha enhancer in T cells. Genes Dev. 1993;7(12A):2418-2430.
161. Vlasova-St Louis I, Bohjanen PR. Coordinate regulation of mRNA decay networks
by GU-rich elements and CELF1. Curr Opin Genet Dev. 2011;21(4):444-451.
162. Wang ET, Ward AJ, Cherone J, et al. Antagonistic regulation of mRNA expression
and splicing by CELF and MBNL proteins. Genome Res. 2015.

172

163. Marquis J, Paillard L, Audic Y, et al. CUG-BP1/CELF1 requires UGU-rich
sequences for high-affinity binding. Biochem J. 2006;400(2):291-301.

173

